Allstate Life Insurance 10-Q 31 Oct 14 2014 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Sep. 30, 2014	Oct. 31, 2014
Document and Entity Information	'	'
Entity Registrant Name	'ALLSTATE LIFE INSURANCE CO	'
Entity Central Index Key	'0000352736	'
Document Type	'10-Q	'
Document Period End Date	30-Sep-14	'
Amendment Flag	'false	'
Current Fiscal Year End Date	'--12-31	'
Entity Current Reporting Status	'Yes	'
Entity Filer Category	'Non-accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	23,800
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q3	'

CONDENSED_CONSOLIDATED_STATEME

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Revenues	'	'	'	'
Premiums	$142	$147	$441	$442
Contract charges	192	264	652	788
Net investment income	461	621	1,612	1,861
Realized capital gains and losses:	'	'	'	'
Total other-than-temporary impairment losses	-19	-25	-41	-41
Portion of loss recognized in other comprehensive income	0	8	-1	-2
Net other-than-temporary impairment losses recognized in earnings	-19	-17	-42	-43
Sales and other realized capital gains and losses	47	1	60	104
Total realized capital gains and losses	28	-16	18	61
Total revenues	823	1,016	2,723	3,152
Costs and expenses	'	'	'	'
Contract benefits	356	422	1,101	1,199
Interest credited to contractholder funds	191	310	696	953
Amortization of deferred policy acquisition costs	36	73	124	177
Operating costs and expenses	75	102	232	333
Restructuring and related charges	-1	4	2	6
Interest expense	4	4	12	19
Total costs and expenses	661	915	2,167	2,687
Loss on disposition of operations	-27	-646	-71	-643
Income (loss) from operations before income tax expense (benefit)	135	-545	485	-178
Income tax expense (benefit)	51	-151	142	-43
Net income (loss)	84	-394	343	-135
Other comprehensive income (loss), after-tax	'	'	'	'
Change in unrealized net capital gains and losses	24	-45	345	-581
Change in unrealized foreign currency translation adjustments	0	0	1	0
Other comprehensive income (loss), after-tax	24	-45	346	-581
Comprehensive income (loss)	$108	($439)	$689	($716)

CONDENSED_CONSOLIDATED_STATEME1

CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Millions, unless otherwise specified
Investments	'	'
Fixed income securities	$28,090	$28,756
Mortgage loans	3,644	4,173
Equity securities, at fair value (cost $1,091 and $565)	1,229	650
Limited partnership interests	1,933	2,064
Short-term, at fair value (amortized cost $762 and $590)	762	590
Policy loans	617	623
Other	1,084	1,088
Total investments	37,359	37,944
Cash	191	93
Deferred policy acquisition costs	1,285	1,331
Reinsurance recoverables	2,587	2,754
Accrued investment income	340	358
Other assets	599	256
Separate Accounts	4,521	5,039
Assets held for sale	0	15,593
Total assets	46,882	63,368
Liabilities	'	'
Contractholder funds	22,139	23,604
Reserve for life-contingent contract benefits	11,672	11,589
Unearned premiums	5	6
Payable to affiliates, net	76	100
Other liabilities and accrued expenses	794	838
Deferred income taxes	1,341	941
Notes due to related parties	275	282
Separate Accounts	4,521	5,039
Liabilities held for sale	0	14,899
Total liabilities	40,823	57,298
Commitments and Contingent Liabilities (Note 8)	'	'
Shareholder’s Equity	'	'
Common stock, $227 par value, 23,800 shares authorized and outstanding	5	5
Additional capital paid-in	1,990	2,690
Retained income	2,790	2,447
Unrealized net capital gains and losses:	'	'
Unrealized net capital gains and losses on fixed income securities with OTTI	43	31
Other unrealized net capital gains and losses	1,440	997
Unrealized adjustment to DAC, DSI and insurance reserves	-211	-101
Total unrealized net capital gains and losses	1,272	927
Unrealized foreign currency translation adjustments	2	1
Total accumulated other comprehensive income	1,274	928
Total shareholder’s equity	6,059	6,070
Total liabilities and shareholder’s equity	46,882	63,368
Series A	'	'
Shareholder’s Equity	'	'
Redeemable preferred stock	0	0
Series B	'	'
Shareholder’s Equity	'	'
Redeemable preferred stock	$0	$0

CONDENSED_CONSOLIDATED_STATEME2

CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Parenthetical) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Millions, except Share data, unless otherwise specified
Fixed income securities, at fair value, amortized cost (in dollars)	$25,931	$27,427
Equity securities, at fair value, cost (in dollars)	1,091	565
Short-term, at fair value, amortized cost (in dollars)	$762	$590
Common stock, par value (in dollars per share)	$227	$227
Common stock, shares authorized	23,800	23,800
Common stock, shares outstanding	23,800	23,800
Series A	'	'
Redeemable preferred stock, par value (in dollars per share)	$100	$100
Redeemable preferred stock, shares authorized	1,500,000	1,500,000
Redeemable preferred stock, shares issued	0	0
Series B	'	'
Redeemable preferred stock, par value (in dollars per share)	$100	$100
Redeemable preferred stock, shares authorized	1,500,000	1,500,000
Redeemable preferred stock, shares issued	0	0

CONDENSED_CONSOLIDATED_STATEME3

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDER'S EQUITY (USD $)	Total	Common stock	Additional capital paid-in	Retained income	Accumulated other comprehensive income
In Millions, unless otherwise specified
Balance, beginning of period at Dec. 31, 2012	'	'	$3,190	$2,485	$1,633
Increase (decrease) in equity	'	'	'	'	'
Return of capital	'	'	0	'	'
Net income (loss)	-135	'	'	-135	'
Change in unrealized net capital gains and losses	-581	'	'	'	-581
Change in unrealized foreign currency translation adjustments	0	'	'	'	0
Balance, end of period at Sep. 30, 2013	6,597	5	3,190	2,350	1,052
Balance, beginning of period at Dec. 31, 2013	6,070	'	2,690	2,447	928
Increase (decrease) in equity	'	'	'	'	'
Return of capital	'	'	-700	'	'
Net income (loss)	343	'	'	343	'
Change in unrealized net capital gains and losses	345	'	'	'	345
Change in unrealized foreign currency translation adjustments	1	'	'	'	1
Balance, end of period at Sep. 30, 2014	$6,059	$5	$1,990	$2,790	$1,274

CONDENSED_CONSOLIDATED_STATEME4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities	'	'
Net income (loss)	$343	($135)
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Amortization and other non-cash items	-63	-57
Realized capital gains and losses	-18	-61
Loss on disposition of operations	71	643
Interest credited to contractholder funds	696	953
Changes in:	'	'
Policy benefits and other insurance reserves	-452	-474
Unearned premiums	-1	-2
Deferred policy acquisition costs	4	-10
Reinsurance recoverables, net	-6	-38
Income taxes	61	22
Other operating assets and liabilities	-179	-56
Net cash provided by operating activities	456	785
Proceeds from sales	'	'
Fixed income securities	2,486	3,199
Equity securities	326	164
Limited partnership interests	358	191
Mortgage loans	9	20
Other investments	25	37
Investment collections	'	'
Fixed income securities	1,485	3,525
Mortgage loans	795	693
Other investments	37	74
Investment purchases	'	'
Fixed income securities	-2,026	-3,524
Equity securities	-846	-356
Limited partnership interests	-482	-384
Mortgage loans	-194	-407
Other investments	-195	-78
Change in short-term investments, net	140	136
Change in policy loans and other investments, net	54	79
Disposition of operations	345	0
Net cash provided by investing activities	2,317	3,369
Cash flows from financing activities	'	'
Contractholder fund deposits	832	1,520
Contractholder fund withdrawals	-2,800	-5,429
Return of capital	-700	0
Repayment of notes due to related parties	-7	-210
Net cash used in financing activities	-2,675	-4,119
Cash classified as held for sale	0	-13
Net increase in cash	98	22
Cash at beginning of period	93	341
Cash at end of period	$191	$363

General

General	9 Months Ended
	Sep. 30, 2014
General	'
General	'
	General
	Basis of presentation
	The accompanying condensed consolidated financial statements include the accounts of Allstate Life Insurance Company (“ALIC”) and its wholly owned subsidiaries (collectively referred to as the “Company”).  ALIC is wholly owned by Allstate Insurance Company (“AIC”), which is wholly owned by Allstate Insurance Holdings, LLC, a wholly owned subsidiary of The Allstate Corporation (the “Corporation”).
	The condensed consolidated financial statements and notes as of September 30, 2014 and for the three-month and nine-month periods ended September 30, 2014 and 2013 are unaudited.  The condensed consolidated financial statements reflect all adjustments (consisting only of normal recurring accruals) which are, in the opinion of management, necessary for the fair presentation of the financial position, results of operations and cash flows for the interim periods.  These condensed consolidated financial statements and notes should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013.  The results of operations for the interim periods should not be considered indicative of results to be expected for the full year.  All significant intercompany accounts and transactions have been eliminated.
	Premiums and contract charges
	The following table summarizes premiums and contract charges by product.
	($ in millions)	Three months ended September 30,				Nine months ended September 30,
		2014		2013		2014		2013
	Premiums
	Traditional life insurance	$	120	$	114	$	365	$	342
	Immediate annuities with life contingencies	—		6		5		22
	Accident and health insurance	22		27		71		78
	Total premiums	142		147		441		442
	Contract charges
	Interest-sensitive life insurance	188		258		638		775
	Fixed annuities	4		6		14		13
	Total contract charges	192		264		652		788
	Total premiums and contract charges	$	334	$	411	$	1,093	$	1,230
	Pending accounting standard
	Accounting for Investments in Qualified Affordable Housing Projects
	In January 2014, the Financial Accounting Standards Board (“FASB”) issued guidance which allows entities that invest in certain qualified affordable housing projects through limited liability entities the option to account for these investments using the proportional amortization method if certain conditions are met.  Under the proportional amortization method, the entity amortizes the initial cost of the investment in proportion to the tax credits and other tax benefits received and recognizes the net investment performance in the income statement as a component of income tax expense or benefit.  The guidance is effective for reporting periods beginning after December 15, 2014 and is to be applied retrospectively.  The impact of adoption is not expected to be material to the Company’s results of operations and financial position.

Disposition

Disposition	9 Months Ended
	Sep. 30, 2014
Discontinued Operations and Disposal Groups [Abstract]	'
Disposition	'
	Disposition
	On April 1, 2014, the Company completed the sale of Lincoln Benefit Life Company (“LBL”), LBL’s life insurance business generated through independent master brokerage agencies, and all of LBL’s deferred fixed annuity and long-term care insurance business to Resolution Life Holdings, Inc.  The gross sale price was $797 million, representing $596 million of cash and the retention of tax benefits.  The loss on disposition increased by $28 million, pre-tax, ($29 million, after-tax) and $78 million, pre-tax, ($38 million, after-tax) in the three months and nine months ended September 30, 2014, respectively. The loss on disposition in the three months ended September 30, 2014 included the finalization of certain tax balances and other adjustments.
	In conjunction with the sale, the Company was required to establish a trust relating to the business that LBL continues to cede to ALIC.  This trust is required to have assets greater than or equal to the statutory reserves ceded by LBL to ALIC, measured on a monthly basis.  As of September 30, 2014, the trust holds $5.08 billion of investments, which are reported in the statement of financial position.
	The following table summarizes the assets and liabilities classified as held for sale as of December 31, 2013.
	($ in millions)
	Assets
	Investments
	Fixed income securities	$	10,167
	Mortgage loans	1,367
	Short-term investments	160
	Policy loans	198
	Other investments	91
	Total investments	11,983
	Cash	—
	Deferred policy acquisition costs	743
	Reinsurance recoverables, net	1,660
	Accrued investment income	109
	Other assets	79
	Separate Accounts	1,701
	Assets held for sale	16,275
	Less: Loss accrual	(682		)
	Total assets held for sale	$	15,593
	Liabilities
	Reserve for life-contingent contract benefits	$	1,894
	Contractholder funds	10,945
	Unearned premiums	12
	Deferred income taxes	151
	Other liabilities and accrued expenses	196
	Separate Accounts	1,701
	Total liabilities held for sale	$	14,899
	Included in shareholder’s equity was $85 million of accumulated other comprehensive income related to assets held for sale as of December 31, 2013.

Supplemental_Cash_Flow_Informa

Supplemental Cash Flow Information	9 Months Ended
	Sep. 30, 2014
Supplemental Cash Flow Information [Abstract]	'
Supplemental Cash Flow Information	'
	Supplemental Cash Flow Information
	Non-cash modifications of certain mortgage loans, fixed income securities, limited partnership interests and other investments, as well as mergers completed with equity securities, totaled $89 million and $259 million for the nine months ended September 30, 2014 and 2013, respectively.
	Liabilities for collateral received in conjunction with the Company’s securities lending program and over-the-counter (“OTC”) and cleared derivatives are reported in other liabilities and accrued expenses or other investments.  The accompanying cash flows are included in cash flows from operating activities in the Condensed Consolidated Statements of Cash Flows along with the activities resulting from management of the proceeds, which are as follows:
	($ in millions)	Nine months ended September 30,
		2014			2013
	Net change in proceeds managed
	Net change in short-term investments	$	(151	)	$	199
	Operating cash flow (used) provided	(151		)	199
	Net change in cash	—			(1		)
	Net change in proceeds managed	$	(151	)	$	198
	Net change in liabilities
	Liabilities for collateral, beginning of period	$	(328	)	$	(561	)
	Liabilities for collateral, end of period	(479		)	(363		)
	Operating cash flow provided (used)	$	151		$	(198	)

Investments

Investments	9 Months Ended
	Sep. 30, 2014
Investments [Abstract]	'
Investments	'
	Investments
	Fair values
	The amortized cost, gross unrealized gains and losses and fair value for fixed income securities are as follows:
	($ in millions)	Amortized			Gross unrealized						Fair
		cost			Gains			Losses			value
	30-Sep-14
	U.S. government and agencies	$	683		$	97		$	—		$	780
	Municipal	3,129			432			(14		)	3,547
	Corporate	19,550			1,579			(113		)	21,016
	Foreign government	660			80			(1		)	739
	Asset-backed securities (“ABS”)	723			18			(23		)	718
	Residential mortgage-backed securities (“RMBS”)	602			59			(5		)	656
	Commercial mortgage-backed securities (“CMBS”)	570			50			(3		)	617
	Redeemable preferred stock	14			3			—			17
	Total fixed income securities	$	25,931		$	2,318		$	(159	)	$	28,090
	31-Dec-13
	U.S. government and agencies	$	678		$	90		$	(2	)	$	766
	Municipal	3,135			231			(62		)	3,304
	Corporate	20,397			1,214			(295		)	21,316
	Foreign government	715			83			(6		)	792
	ABS	1,011			30			(34		)	1,007
	RMBS	752			50			(12		)	790
	CMBS	724			47			(7		)	764
	Redeemable preferred stock	15			2			—			17
	Total fixed income securities	$	27,427		$	1,747		$	(418	)	$	28,756
	Scheduled maturities
	The scheduled maturities for fixed income securities are as follows as of September 30, 2014:
	($ in millions)	Amortized			Fair
		cost			value
	Due in one year or less	$	1,282		$	1,304
	Due after one year through five years	5,163			5,602
	Due after five years through ten years	10,155			10,709
	Due after ten years	7,436			8,484
		24,036			26,099
	ABS, RMBS and CMBS	1,895			1,991
	Total	$	25,931		$	28,090
	Actual maturities may differ from those scheduled as a result of calls and make-whole payments by the issuers.  ABS, RMBS and CMBS are shown separately because of the potential for prepayment of principal prior to contractual maturity dates.
	Net investment income
	Net investment income is as follows:
	($ in millions)	Three months ended September 30,						Nine months ended September 30,
		2014			2013			2014			2013
	Fixed income securities	$	349		$	487		$	1,179		$	1,477
	Mortgage loans	48			91			188			269
	Equity securities	7			3			17			8
	Limited partnership interests	51			37			209			104
	Short-term investments	—			—			1			1
	Policy loans	10			12			30			36
	Other	15			18			43			50
	Investment income, before expense	480			648			1,667			1,945
	Investment expense	(19		)	(27		)	(55		)	(84		)
	Net investment income	$	461		$	621		$	1,612		$	1,861
	Realized capital gains and losses
	Realized capital gains and losses by asset type are as follows:
	($ in millions)	Three months ended September 30,						Nine months ended September 30,
		2014			2013			2014			2013
	Fixed income securities	$	(1	)	$	(12	)	$	(1	)	$	(6	)
	Mortgage loans	2			(6		)	3			19
	Equity securities	(5		)	5			11			37
	Limited partnership interests	28			—			(5		)	(3		)
	Derivatives	4			(5		)	7			14
	Other	—			2			3			—
	Realized capital gains and losses	$	28		$	(16	)	$	18		$	61
	Realized capital gains and losses by transaction type are as follows:
($ in millions)	Three months ended September 30,						Nine months ended September 30,
	2014			2013			2014			2013
Impairment write-downs	$	2		$	(10	)	$	(2	)	$	(28	)
Change in intent write-downs	(21		)	(7		)	(40		)	(15		)
Net other-than-temporary impairment losses recognized in earnings	(19		)	(17		)	(42		)	(43		)
Sales	43			6			51			90
Valuation and settlements of derivative instruments	4			(5		)	9			14
Realized capital gains and losses	$	28		$	(16	)	$	18		$	61
Gross gains of $23 million and $18 million and gross losses of $5 million and $16 million were realized on sales of fixed income and equity securities during the three months ended September 30, 2014 and 2013, respectively.  Gross gains of $76 million and $117 million and gross losses of $34 million and $40 million were realized on sales of fixed income and equity securities during the nine months ended September 30, 2014 and 2013, respectively.
Other-than-temporary impairment losses by asset type are as follows:
($ in millions)	Three months ended September 30, 2014									Nine months ended September 30, 2014
	Gross			Included			Net			Gross				Included				Net
				in OCI										in OCI
Fixed income securities:
Municipal	$	—		$	—		$	—		$	(1	)		$	—			$	(1	)
Corporate	(3		)	—			(3		)	(3		)		—				(3		)
ABS	—			—			—			(1		)		—				(1		)
RMBS	—			—			—			3				(1		)		2
Total fixed income securities	(3		)	—			(3		)	(2		)		(1		)		(3		)
Mortgage loans	2			—			2			6				—				6
Equity securities	(21		)	—			(21		)	(29		)		—				(29		)
Limited partnership interests	3			—			3			(16		)		—				(16		)
Other-than-temporary impairment losses	$	(19	)	$	—		$	(19	)	$	(41	)		$	(1	)		$	(42	)
	Three months ended September 30, 2013									Nine months ended September 30, 2013
	Gross			Included			Net			Gross				Included				Net
				in OCI										in OCI
Fixed income securities:
Municipal	$	—		$	—		$	—		$	(8	)		$	—			$	(8	)
ABS	—			—			—			—				(1		)		(1		)
RMBS	(5		)	4			(1		)	(4		)		3				(1		)
CMBS	(8		)	4			(4		)	(27		)		(4		)		(31		)
Total fixed income securities	(13		)	8			(5		)	(39		)		(2		)		(41		)
Mortgage loans	(6		)	—			(6		)	11				—				11
Equity securities	(4		)	—			(4		)	(5		)		—				(5		)
Limited partnership interests	(1		)	—			(1		)	(5		)		—				(5		)
Other	(1		)	—			(1		)	(3		)		—				(3		)
Other-than-temporary impairment losses	$	(25	)	$	8		$	(17	)	$	(41	)		$	(2	)		$	(43	)
The total amount of other-than-temporary impairment losses included in accumulated other comprehensive income at the time of impairment for fixed income securities, which were not included in earnings, are presented in the following table.  The amounts exclude $139 million and $164 million as of September 30, 2014 and December 31, 2013, respectively, of net unrealized gains related to changes in valuation of the fixed income securities subsequent to the impairment measurement date.
($ in millions)	September 30, 2014			December 31, 2013
Municipal	$	(5	)	$	(5	)
ABS	(6		)	(10		)
RMBS	(56		)	(90		)
CMBS	(5		)	(12		)
Total	$	(72	)	$	(117	)
Rollforwards of the cumulative credit losses recognized in earnings for fixed income securities held as of the end of the period are as follows:
($ in millions)	Three months ended September 30,						Nine months ended September 30,
	2014			2013			2014			2013
Beginning balance	$	(229	)	$	(318	)	$	(299	)	$	(345	)
Additional credit loss for securities previously other-than-temporarily impaired	—			—			2			(12		)
Additional credit loss for securities not previously other-than-temporarily impaired	(3		)	(2		)	(4		)	(19		)
Reduction in credit loss for securities disposed or collected	9			12			19			68
Reduction in credit loss for securities the Company has made the decision to sell or more likely than not will be required to sell	—			—			—			—
Change in credit loss due to accretion of increase in cash flows	1			—			1			—
Reduction in credit loss for securities sold in LBL disposition	—			—			59			—
Ending balance	$	(222	)	$	(308	)	$	(222	)	$	(308	)
The Company uses its best estimate of future cash flows expected to be collected from the fixed income security, discounted at the security’s original or current effective rate, as appropriate, to calculate a recovery value and determine whether a credit loss exists.  The determination of cash flow estimates is inherently subjective and methodologies may vary depending on facts and circumstances specific to the security.  All reasonably available information relevant to the collectability of the security, including past events, current conditions, and reasonable and supportable assumptions and forecasts, are considered when developing the estimate of cash flows expected to be collected.  That information generally includes, but is not limited to, the remaining payment terms of the security, prepayment speeds, foreign exchange rates, the financial condition and future earnings potential of the issue or issuer, expected defaults, expected recoveries, the value of underlying collateral, vintage, geographic concentration, available reserves or escrows, current subordination levels, third party guarantees and other credit enhancements.  Other information, such as industry analyst reports and forecasts, sector credit ratings, financial condition of the bond insurer for insured fixed income securities, and other market data relevant to the realizability of contractual cash flows, may also be considered.  The estimated fair value of collateral will be used to estimate recovery value if the Company determines that the security is dependent on the liquidation of collateral for ultimate settlement.  If the estimated recovery value is less than the amortized cost of the security, a credit loss exists and an other-than-temporary impairment for the difference between the estimated recovery value and amortized cost is recorded in earnings.  The portion of the unrealized loss related to factors other than credit remains classified in accumulated other comprehensive income.  If the Company determines that the fixed income security does not have sufficient cash flow or other information to estimate a recovery value for the security, the Company may conclude that the entire decline in fair value is deemed to be credit related and the loss is recorded in earnings.
Unrealized net capital gains and losses
Unrealized net capital gains and losses included in accumulated other comprehensive income are as follows:
($ in millions)	Fair value			Gross unrealized						Unrealized net gains (losses)
September 30, 2014				Gains			Losses
Fixed income securities	$	28,090		$	2,318		$	(159	)	$	2,159
Equity securities	1,229			138			—			138
Short-term investments	762			—			—			—
Derivative instruments (1)	(4		)	1			(5		)	(4		)
Equity method (“EMA”) limited partnerships (2)										(2		)
Unrealized net capital gains and losses, pre-tax										2,291
Amounts recognized for:
Insurance reserves (3)										(169		)
DAC and DSI (4)										(157		)
Amounts recognized										(326		)
Deferred income taxes										(693		)
Unrealized net capital gains and losses, after-tax										$	1,272
_______________
(1)	Included in the fair value of derivative instruments are $1 million classified as assets and $5 million classified as liabilities.
(2)	Unrealized net capital gains and losses for limited partnership interests represent the Company’s share of EMA limited partnerships’ other comprehensive income. Fair value and gross unrealized gains and losses are not applicable.
(3)	The insurance reserves adjustment represents the amount by which the reserve balance would increase if the net unrealized gains in the applicable product portfolios were realized and reinvested at current lower interest rates, resulting in a premium deficiency. Although the Company evaluates premium deficiencies on the combined performance of life insurance and immediate annuities with life contingencies, the adjustment primarily relates to structured settlement annuities with life contingencies, in addition to annuity buy-outs and certain payout annuities with life contingencies.
(4)	The DAC and DSI adjustment balance represents the amount by which the amortization of DAC and DSI would increase or decrease if the unrealized gains or losses in the respective product portfolios were realized.
($ in millions)	Fair value			Gross unrealized						Unrealized net gains (losses)
December 31, 2013				Gains			Losses
Fixed income securities	$	28,756		$	1,747		$	(418	)	$	1,329
Equity securities	650			90			(5		)	85
Short-term investments	590			—			—			—
Derivative instruments (1)	(13		)	1			(14		)	(13		)
EMA limited partnerships										(2		)
Investments classified as held for sale										190
Unrealized net capital gains and losses, pre-tax										1,589
Amounts recognized for:
Insurance reserves										—
DAC and DSI										(156		)
Amounts recognized										(156		)
Deferred income taxes										(506		)
Unrealized net capital gains and losses, after-tax										$	927
_______________
(1)	Included in the fair value of derivative instruments are $1 million classified as assets and $14 million classified as liabilities.
Change in unrealized net capital gains and losses
The change in unrealized net capital gains and losses for the nine months ended September 30, 2014 is as follows:
($ in millions)
Fixed income securities	$	830
Equity securities	53
Derivative instruments	9
Investments classified as held for sale	(190		)
Total	702
Amounts recognized for:
Insurance reserves	(169		)
DAC and DSI	(1		)
Amounts recognized	(170		)
Deferred income taxes	(187		)
Increase in unrealized net capital gains and losses, after-tax	$	345
Portfolio monitoring
The Company has a comprehensive portfolio monitoring process to identify and evaluate each fixed income and equity security whose carrying value may be other-than-temporarily impaired.
For each fixed income security in an unrealized loss position, the Company assesses whether management with the appropriate authority has made the decision to sell or whether it is more likely than not the Company will be required to sell the security before recovery of the amortized cost basis for reasons such as liquidity, contractual or regulatory purposes.  If a security meets either of these criteria, the security’s decline in fair value is considered other than temporary and is recorded in earnings.
If the Company has not made the decision to sell the fixed income security and it is not more likely than not the Company will be required to sell the fixed income security before recovery of its amortized cost basis, the Company evaluates whether it expects to receive cash flows sufficient to recover the entire amortized cost basis of the security.  The Company calculates the estimated recovery value by discounting the best estimate of future cash flows at the security’s original or current effective rate, as appropriate, and compares this to the amortized cost of the security.  If the Company does not expect to receive cash flows sufficient to recover the entire amortized cost basis of the fixed income security, the credit loss component of the impairment is recorded in earnings, with the remaining amount of the unrealized loss related to other factors recognized in other comprehensive income.
For equity securities, the Company considers various factors, including whether it has the intent and ability to hold the equity security for a period of time sufficient to recover its cost basis.  Where the Company lacks the intent and ability to hold to recovery, or believes the recovery period is extended, the equity security’s decline in fair value is considered other than temporary and is recorded in earnings.
For fixed income and equity securities managed by third parties, either the Company has contractually retained its decision making authority as it pertains to selling securities that are in an unrealized loss position or it recognizes any unrealized loss at the end of the period through a charge to earnings.
The Company’s portfolio monitoring process includes a quarterly review of all securities to identify instances where the fair value of a security compared to its amortized cost (for fixed income securities) or cost (for equity securities) is below established thresholds.  The process also includes the monitoring of other impairment indicators such as ratings, ratings downgrades and payment defaults.  The securities identified, in addition to other securities for which the Company may have a concern, are evaluated for potential other-than-temporary impairment using all reasonably available information relevant to the collectability or recovery of the security.  Inherent in the Company’s evaluation of other-than-temporary impairment for these fixed income and equity securities are assumptions and estimates about the financial condition and future earnings potential of the issue or issuer.  Some of the factors that may be considered in evaluating whether a decline in fair value is other than temporary are: 1) the financial condition, near-term and long-term prospects of the issue or issuer, including relevant industry specific market conditions and trends, geographic location and implications of rating agency actions and offering prices; 2) the specific reasons that a security is in an unrealized loss position, including overall market conditions which could affect liquidity; and 3) the length of time and extent to which the fair value has been less than amortized cost or cost.
The following table summarizes the gross unrealized losses and fair value of fixed income and equity securities by the length of time that individual securities have been in a continuous unrealized loss position.
	($ in millions)	Less than 12 months								12 months or more											Total
		Number		Fair			Unrealized			Number			Fair				Unrealized				unrealized
		of issues		value			losses			of issues			value				losses				losses
	September 30, 2014
	Fixed income securities
	U.S. government and agencies	2		$	21		$	—		—			$	—			$	—			$	—
	Municipal	12		98			(2		)	25			143				(12		)		(14		)
	Corporate	278		1,844			(33		)	119			1,064				(80		)		(113		)
	Foreign government	1		7			—			1			14				(1		)		(1		)
	ABS	18		129			(1		)	26			239				(22		)		(23		)
	RMBS	18		2			—			47			77				(5		)		(5		)
	CMBS	4		3			—			4			43				(3		)		(3		)
	Total fixed income securities	333		2,104			(36		)	222			1,580				(123		)		(159		)
	Equity securities	2		8			—			—			—				—				—
	Total fixed income and equity securities	335		$	2,112		$	(36	)	222			$	1,580			$	(123	)		$	(159	)
	Investment grade fixed income securities	143		$	1,133		$	(12	)	172			$	1,294			$	(87	)		$	(99	)
	Below investment grade fixed income securities	190		971			(24		)	50			286				(36		)		(60		)
	Total fixed income securities	333		$	2,104		$	(36	)	222			$	1,580			$	(123	)		$	(159	)
	December 31, 2013
	Fixed income securities
	U.S. government and agencies	4		$	76		$	(2	)	—			$	—			$	—			$	(2	)
	Municipal	63		347			(24		)	21			99				(38		)		(62		)
	Corporate	530		5,191			(224		)	48			467				(71		)		(295		)
	Foreign government	7		76			(4		)	1			13				(2		)		(6		)
	ABS	17		162			(1		)	42			400				(33		)		(34		)
	RMBS	35		42			(2		)	47			129				(10		)		(12		)
	CMBS	5		14			—			6			52				(7		)		(7		)
	Total fixed income securities	661		5,908			(257		)	165			1,160				(161		)		(418		)
	Equity securities	25		80			(5		)	—			—				—				(5		)
	Total fixed income and equity securities	686		$	5,988		$	(262	)	165			$	1,160			$	(161	)		$	(423	)
	Investment grade fixed income securities	526		$	5,272		$	(236	)	110			$	834			$	(112	)		$	(348	)
	Below investment grade fixed income securities	135		636			(21		)	55			326				(49		)		(70		)
	Total fixed income securities	661		$	5,908		$	(257	)	165			$	1,160			$	(161	)		$	(418	)
As of September 30, 2014, $121 million of unrealized losses are related to securities with an unrealized loss position less than 20% of amortized cost or cost, the degree of which suggests that these securities do not pose a high risk of being other-than-temporarily impaired.  Of the $121 million, $75 million are related to unrealized losses on investment grade fixed income securities.  Investment grade is defined as a security having a rating of Aaa, Aa, A or Baa from Moody’s, a rating of AAA, AA, A or BBB from Standards and Poor’s (“S&P”), Fitch, Dominion, Kroll or Realpoint, a rating of aaa, aa, a or bbb from A.M. Best, or a comparable internal rating if an externally provided rating is not available.  Unrealized losses on investment grade securities are principally related to increasing risk-free interest rates or widening credit spreads since the time of initial purchase.
As of September 30, 2014, the remaining $38 million of unrealized losses are related to securities in unrealized loss positions greater than or equal to 20% of amortized cost.  Investment grade fixed income securities comprising $24 million of these unrealized losses were evaluated based on factors such as discounted cash flows and the financial condition and near-term and long-term prospects of the issue or issuer and were determined to have adequate resources to fulfill contractual obligations.  Of the $38 million, $14 million are related to below investment grade fixed income securities.  Of these amounts, $10 million are related to below investment grade fixed income securities that had been in an unrealized loss position greater than or equal to 20% of amortized cost for a period of twelve or more consecutive months as of September 30, 2014.
ABS, RMBS and CMBS in an unrealized loss position were evaluated based on actual and projected collateral losses relative to the securities’ positions in the respective securitization trusts, security specific expectations of cash flows, and credit ratings.  This evaluation also takes into consideration credit enhancement, measured in terms of (i) subordination from other classes of securities in the trust that are contractually obligated to absorb losses before the class of security the Company owns, (ii) the expected impact of other structural features embedded in the securitization trust beneficial to the class of securities the Company owns, such as overcollateralization and excess spread, and (iii) for ABS and RMBS in an unrealized loss position, credit enhancements from reliable bond insurers, where applicable.  Municipal bonds in an unrealized loss position were evaluated based on the quality of the underlying assets.  Unrealized losses on equity securities are primarily related to temporary equity market fluctuations of securities that are expected to recover.
As of September 30, 2014, the Company has not made the decision to sell and it is not more likely than not the Company will be required to sell fixed income securities with unrealized losses before recovery of the amortized cost basis.  As of September 30, 2014, the Company had the intent and ability to hold equity securities with unrealized losses for a period of time sufficient for them to recover.
Limited partnerships
As of September 30, 2014 and December 31, 2013, the carrying value of equity method limited partnerships totaled $1.41 billion and $1.46 billion, respectively.  The Company recognizes an impairment loss for equity method limited partnerships when evidence demonstrates that the loss is other than temporary.  Evidence of a loss in value that is other than temporary may include the absence of an ability to recover the carrying amount of the investment or the inability of the investee to sustain a level of earnings that would justify the carrying amount of the investment.
As of September 30, 2014 and December 31, 2013, the carrying value for cost method limited partnerships was $526 million and $605 million, respectively.  To determine if an other-than-temporary impairment has occurred, the Company evaluates whether an impairment indicator has occurred in the period that may have a significant adverse effect on the carrying value of the investment.  Impairment indicators may include: significantly reduced valuations of the investments held by the limited partnerships; actual recent cash flows received being significantly less than expected cash flows; reduced valuations based on financing completed at a lower value; completed sale of a material underlying investment at a price significantly lower than expected; or any other adverse events since the last financial statements received that might affect the fair value of the investee’s capital.  Additionally, the Company’s portfolio monitoring process includes a quarterly review of all cost method limited partnerships to identify instances where the net asset value is below established thresholds for certain periods of time, as well as investments that are performing below expectations, for further impairment consideration.  If a cost method limited partnership is other-than-temporarily impaired, the carrying value is written down to fair value, generally estimated to be equivalent to the reported net asset value of the underlying funds.
Tax credit funds were reclassified from limited partnership interests to other assets as of June 30, 2014 since the return on these funds is in the form of tax credits rather than investment income.  These tax credit funds totaled $285 million as of September 30, 2014.
Mortgage loans
Mortgage loans are evaluated for impairment on a specific loan basis through a quarterly credit monitoring process and review of key credit quality indicators.  Mortgage loans are considered impaired when it is probable that the Company will not collect the contractual principal and interest.  Valuation allowances are established for impaired loans to reduce the carrying value to the fair value of the collateral less costs to sell or the present value of the loan’s expected future repayment cash flows discounted at the loan’s original effective interest rate.  Impaired mortgage loans may not have a valuation allowance when the fair value of the collateral less costs to sell is higher than the carrying value.  Valuation allowances are adjusted for subsequent changes in the fair value of the collateral less costs to sell.  Mortgage loans are charged off against their corresponding valuation allowances when there is no reasonable expectation of recovery.  The impairment evaluation is non-statistical in respect to the aggregate portfolio but considers facts and circumstances attributable to each loan.  It is not considered probable that additional impairment losses, beyond those identified on a specific loan basis, have been incurred as of September 30, 2014.
Accrual of income is suspended for mortgage loans that are in default or when full and timely collection of principal and interest payments is not probable.  Cash receipts on mortgage loans on nonaccrual status are generally recorded as a reduction of carrying value.
Debt service coverage ratio is considered a key credit quality indicator when mortgage loans are evaluated for impairment.  Debt service coverage ratio represents the amount of estimated cash flows from the property available to the borrower to meet principal and interest payment obligations.  Debt service coverage ratio estimates are updated annually or more frequently if conditions are warranted based on the Company’s credit monitoring process.
The following table reflects the carrying value of non-impaired fixed rate and variable rate mortgage loans summarized by debt service coverage ratio distribution.
($ in millions)	September 30, 2014									December 31, 2013
Debt service coverage	Fixed rate			Variable rate			Total			Fixed rate				Variable rate				Total
ratio distribution	mortgage			mortgage						mortgage				mortgage
	loans			loans						loans				loans
Below 1.0	$	186		$	—		$	186		$	153			$	—			$	153
1.0 - 1.25	351			—			351			560				—				560
1.26 - 1.50	1,178			2			1,180			1,167				2				1,169
Above 1.50	1,917			—			1,917			2,176				38				2,214
Total non-impaired mortgage loans	$	3,632		$	2		$	3,634		$	4,056			$	40			$	4,096
Mortgage loans with a debt service coverage ratio below 1.0 that are not considered impaired primarily relate to instances where the borrower has the financial capacity to fund the revenue shortfalls from the properties for the foreseeable term, the decrease in cash flows from the properties is considered temporary, or there are other risk mitigating circumstances such as additional collateral, escrow balances or borrower guarantees.
The net carrying value of impaired mortgage loans is as follows:
($ in millions)	September 30, 2014			December 31, 2013
Impaired mortgage loans with a valuation allowance	$	10		$	77
Impaired mortgage loans without a valuation allowance	—			—
Total impaired mortgage loans	$	10		$	77
Valuation allowance on impaired mortgage loans	$	7		$	21
The average balance of impaired loans was $29 million and $88 million for the nine months ended September 30, 2014 and 2013, respectively.
The rollforward of the valuation allowance on impaired mortgage loans is as follows:
($ in millions)	Three months ended September 30,						Nine months ended September 30,
	2014			2013			2014			2013
Beginning balance	$	9		$	21		$	21		$	42
Net (decrease) increase in valuation allowance	(2		)	6			(6		)	(11		)
Charge offs	—			—			(8		)	(4		)
Mortgage loans classified as held for sale	—			(2		)	—			(2		)
Ending balance	$	7		$	25		$	7		$	25
Payments on all mortgage loans were current as of September 30, 2014 and December 31, 2013.

Fair_Value_of_Assets_and_Liabi

Fair Value of Assets and Liabilities	9 Months Ended
	Sep. 30, 2014
Fair Value Disclosures [Abstract]	'
Fair Value of Assets and Liabilities	'
	Fair Value of Assets and Liabilities
	Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.  The hierarchy for inputs used in determining fair value maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that observable inputs be used when available.  Assets and liabilities recorded on the Condensed Consolidated Statements of Financial Position at fair value are categorized in the fair value hierarchy based on the observability of inputs to the valuation techniques as follows:
	Level 1:     Assets and liabilities whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market that the Company can access.
	Level 2:     Assets and liabilities whose values are based on the following:
	(a)	Quoted prices for similar assets or liabilities in active markets;
	(b)	Quoted prices for identical or similar assets or liabilities in markets that are not active; or
	(c)	Valuation models whose inputs are observable, directly or indirectly, for substantially the full term of the asset or liability.
	Level 3:    Assets and liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement.  Unobservable inputs reflect the Company’s estimates of the assumptions that market participants would use in valuing the assets and liabilities.
	The availability of observable inputs varies by instrument.  In situations where fair value is based on internally developed pricing models or inputs that are unobservable in the market, the determination of fair value requires more judgment.  The degree of judgment exercised by the Company in determining fair value is typically greatest for instruments categorized in Level 3.  In many instances, valuation inputs used to measure fair value fall into different levels of the fair value hierarchy.  The category level in the fair value hierarchy is determined based on the lowest level input that is significant to the fair value measurement in its entirety.  The Company uses prices and inputs that are current as of the measurement date, including during periods of market disruption.  In periods of market disruption, the ability to observe prices and inputs may be reduced for many instruments.
	The Company is responsible for the determination of fair value and the supporting assumptions and methodologies.  The Company gains assurance that assets and liabilities are appropriately valued through the execution of various processes and controls designed to ensure the overall reasonableness and consistent application of valuation methodologies, including inputs and assumptions, and compliance with accounting standards.  For fair values received from third parties or internally estimated, the Company’s processes and controls are designed to ensure that the valuation methodologies are appropriate and consistently applied, the inputs and assumptions are reasonable and consistent with the objective of determining fair value, and the fair values are accurately recorded.  For example, on a continuing basis, the Company assesses the reasonableness of individual fair values that have stale security prices or that exceed certain thresholds as compared to previous fair values received from valuation service providers or brokers or derived from internal models.  The Company performs procedures to understand and assess the methodologies, processes and controls of valuation service providers.  In addition, the Company may validate the reasonableness of fair values by comparing information obtained from valuation service providers or brokers to other third party valuation sources for selected securities.  The Company performs ongoing price validation procedures such as back-testing of actual sales, which corroborate the various inputs used in internal models to market observable data.  When fair value determinations are expected to be more variable, the Company validates them through reviews by members of management who have relevant expertise and who are independent of those charged with executing investment transactions.
	The Company has two types of situations where investments are classified as Level 3 in the fair value hierarchy.  The first is where quotes continue to be received from independent third-party valuation service providers and all significant inputs are market observable; however, there has been a significant decrease in the volume and level of activity for the asset when compared to normal market activity such that the degree of market observability has declined to a point where categorization as a Level 3 measurement is considered appropriate.  The indicators considered in determining whether a significant decrease in the volume and level of activity for a specific asset has occurred include the level of new issuances in the primary market, trading volume in the secondary market, the level of credit spreads over historical levels, applicable bid-ask spreads, and price consensus among market participants and other pricing sources.
	The second situation where the Company classifies securities in Level 3 is where specific inputs significant to the fair value estimation models are not market observable.  This primarily occurs in the Company’s use of broker quotes to value certain securities where the inputs have not been corroborated to be market observable, and the use of valuation models that use significant non-market observable inputs.
	Certain assets are not carried at fair value on a recurring basis, including investments such as mortgage loans, limited partnership interests, bank loans and policy loans.  Accordingly, such investments are only included in the fair value hierarchy disclosure when the investment is subject to remeasurement at fair value after initial recognition and the resulting remeasurement is reflected in the condensed consolidated financial statements.  In addition, derivatives embedded in fixed income securities are not disclosed in the hierarchy as free-standing derivatives since they are presented with the host contracts in fixed income securities.
	In determining fair value, the Company principally uses the market approach which generally utilizes market transaction data for the same or similar instruments.  To a lesser extent, the Company uses the income approach which involves determining fair values from discounted cash flow methodologies.  For the majority of Level 2 and Level 3 valuations, a combination of the market and income approaches is used.
	Summary of significant valuation techniques for assets and liabilities measured at fair value on a recurring basis
	Level 1 measurements
	•	Fixed income securities:  Comprise certain U.S. Treasury fixed income securities.  Valuation is based on unadjusted quoted prices for identical assets in active markets that the Company can access.
	•	Equity securities:  Comprise actively traded, exchange-listed equity securities. Valuation is based on unadjusted quoted prices for identical assets in active markets that the Company can access.
	•	Short-term:  Comprise actively traded money market funds that have daily quoted net asset values for identical assets that the Company can access.
	•	Separate account assets:  Comprise actively traded mutual funds that have daily quoted net asset values for identical assets that the Company can access.  Net asset values for the actively traded mutual funds in which the separate account assets are invested are obtained daily from the fund managers.
	•	Assets held for sale:  Comprise U.S. Treasury fixed income securities, short-term investments and separate account assets.  The valuation is based on the respective asset type as described above.
	Level 2 measurements
	•	Fixed income securities:
	U.S. government and agencies:  The primary inputs to the valuation include quoted prices for identical or similar assets in markets that are not active, contractual cash flows, benchmark yields and credit spreads.
	Municipal:  The primary inputs to the valuation include quoted prices for identical or similar assets in markets that are not active, contractual cash flows, benchmark yields and credit spreads.
	Corporate, including privately placed:  The primary inputs to the valuation include quoted prices for identical or similar assets in markets that are not active, contractual cash flows, benchmark yields and credit spreads.  Also included are privately placed securities valued using a discounted cash flow model that is widely accepted in the financial services industry and uses market observable inputs and inputs derived principally from, or corroborated by, observable market data.  The primary inputs to the discounted cash flow model include an interest rate yield curve, as well as published credit spreads for similar assets in markets that are not active that incorporate the credit quality and industry sector of the issuer.
	Foreign government:  The primary inputs to the valuation include quoted prices for identical or similar assets in markets that are not active, contractual cash flows, benchmark yields and credit spreads.
	ABS and RMBS:  The primary inputs to the valuation include quoted prices for identical or similar assets in markets that are not active, contractual cash flows, benchmark yields, prepayment speeds, collateral performance and credit spreads.  Certain ABS are valued based on non-binding broker quotes whose inputs have been corroborated to be market observable.
	CMBS:  The primary inputs to the valuation include quoted prices for identical or similar assets in markets that are not active, contractual cash flows, benchmark yields, collateral performance and credit spreads.
	Redeemable preferred stock:  The primary inputs to the valuation include quoted prices for identical or similar assets in markets that are not active, contractual cash flows, benchmark yields, underlying stock prices and credit spreads.
	•	Equity securities:  The primary inputs to the valuation include quoted prices or quoted net asset values for identical or similar assets in markets that are not active.
	•	Short-term:  The primary inputs to the valuation include quoted prices for identical or similar assets in markets that are not active, contractual cash flows, benchmark yields and credit spreads.  For certain short-term investments, amortized cost is used as the best estimate of fair value.
	•	Other investments:  Free-standing exchange listed derivatives that are not actively traded are valued based on quoted prices for identical instruments in markets that are not active.
	OTC derivatives, including interest rate swaps, foreign currency swaps, foreign exchange forward contracts, certain options and certain credit default swaps, are valued using models that rely on inputs such as interest rate yield curves, currency rates, and counterparty credit spreads that are observable for substantially the full term of the contract.  The valuation techniques underlying the models are widely accepted in the financial services industry and do not involve significant judgment.
	•	Assets held for sale:  Comprise U.S. government and agencies, municipal, corporate, foreign government, ABS, RMBS and CMBS fixed income securities, and short-term investments.  The valuation is based on the respective asset type as described above.
	Level 3 measurements
	•	Fixed income securities:
	Municipal:  Comprise municipal bonds that are not rated by third party credit rating agencies but are rated by the National Association of Insurance Commissioners (“NAIC”).  The primary inputs to the valuation of these municipal bonds include quoted prices for identical or similar assets in markets that exhibit less liquidity relative to those markets supporting Level 2 fair value measurements, contractual cash flows, benchmark yields and credit spreads.  Also included are municipal bonds valued based on non-binding broker quotes where the inputs have not been corroborated to be market observable.  Also includes auction rate securities (“ARS”) primarily backed by student loans that have become illiquid due to failures in the auction market and are valued using a discounted cash flow model that is widely accepted in the financial services industry and uses significant non-market observable inputs, including the anticipated date liquidity will return to the market.
	Corporate, including privately placed:  Primarily valued based on non-binding broker quotes where the inputs have not been corroborated to be market observable.  Also included are equity-indexed notes which are valued using a discounted cash flow model that is widely accepted in the financial services industry and uses significant non-market observable inputs, such as volatility.  Other inputs include an interest rate yield curve, as well as published credit spreads for similar assets that incorporate the credit quality and industry sector of the issuer.
	ABS and CMBS:  Valued based on non-binding broker quotes received from brokers who are familiar with the investments and where the inputs have not been corroborated to be market observable.
	•	Equity securities:  The primary inputs to the valuation include quoted prices or quoted net asset values for identical or similar assets in markets that exhibit less liquidity relative to those markets supporting Level 2 fair value measurements.
	•	Other investments:  Certain OTC derivatives, such as interest rate caps, certain credit default swaps and certain options (including swaptions), are valued using models that are widely accepted in the financial services industry.  These are categorized as Level 3 as a result of the significance of non-market observable inputs such as volatility.  Other primary inputs include interest rate yield curves and credit spreads.
	•	Assets held for sale:  Comprise municipal, corporate, ABS and CMBS fixed income securities.  The valuation is based on the respective asset type as described above.
	•	Contractholder funds:  Derivatives embedded in certain life and annuity contracts are valued internally using models widely accepted in the financial services industry that determine a single best estimate of fair value for the embedded derivatives within a block of contractholder liabilities.  The models primarily use stochastically determined cash flows based on the contractual elements of embedded derivatives, projected option cost and applicable market data, such as interest rate yield curves and equity index volatility assumptions.  These are categorized as Level 3 as a result of the significance of non-market observable inputs.
	•	Liabilities held for sale:  Comprise derivatives embedded in life and annuity contracts.  The valuation is the same as described above for contractholder funds.
	Assets and liabilities measured at fair value on a non-recurring basis
	Mortgage loans written-down to fair value in connection with recognizing impairments are valued based on the fair value of the underlying collateral less costs to sell.  Limited partnership interests written-down to fair value in connection with recognizing other-than-temporary impairments are valued using net asset values.  The carrying value of the LBL business was written-down to fair value in connection with being classified as held for sale.
	The following table summarizes the Company’s assets and liabilities measured at fair value on a recurring and non-recurring basis as of September 30, 2014.
	($ in millions)	Quoted prices			Significant			Significant				Counterparty			Balance as of September 30, 2014
		in active			other			unobservable				and cash
		markets for			observable			inputs				collateral
		identical assets			inputs			(Level 3)				netting
		(Level 1)			(Level 2)
	Assets
	Fixed income securities:
	U.S. government and agencies	$	146		$	634		$	—						$	780
	Municipal	—			3,446			101							3,547
	Corporate	—			20,177			839							21,016
	Foreign government	—			739			—							739
	ABS	—			604			114							718
	RMBS	—			656			—							656
	CMBS	—			612			5							617
	Redeemable preferred stock	—			17			—							17
Total fixed income securities	146			26,885			1,059							28,090
Equity securities	1,138			54			37							1,229
Short-term investments	76			686			—							762
Other investments: Free-standing derivatives	—			75			3				$	(5	)	73
Separate account assets	4,521			—			—							4,521
Other assets	—			—			1							1
Total recurring basis assets	5,881			27,700			1,100				(5		)	34,676
Non-recurring basis (1)	—			—			15							15
Total assets at fair value	$	5,881		$	27,700		$	1,115			$	(5	)	$	34,691
% of total assets at fair value	17		%	79.8		%	3.2		%		—		%	100		%
Liabilities
Contractholder funds: Derivatives embedded in life and annuity contracts	$	—		$	—		$	(321	)					$	(321	)
Other liabilities: Free-standing derivatives	—			(27		)	(9		)		$	5		(31		)
Total liabilities at fair value	$	—		$	(27	)	$	(330	)		$	5		$	(352	)
% of total liabilities at fair value	—		%	7.7		%	93.7		%		(1.4		)%	100		%
____________
(1)	Includes $15 million of limited partnership interests written-down to fair value in connection with recognizing other-than-temporary impairments.
The following table summarizes the Company’s assets and liabilities measured at fair value on a recurring and non-recurring basis as of December 31, 2013.
($ in millions)	Quoted prices			Significant			Significant				Counterparty			Balance as of December 31, 2013
	in active			other			unobservable				and cash
	markets for			observable			inputs				collateral
	identical assets			inputs			(Level 3)				netting
	(Level 1)			(Level 2)
Assets
Fixed income securities:
U.S. government and agencies	$	145		$	621		$	—						$	766
Municipal	—			3,185			119							3,304
Corporate	—			20,308			1,008							21,316
Foreign government	—			792			—							792
ABS	—			895			112							1,007
RMBS	—			790			—							790
CMBS	—			763			1							764
Redeemable preferred stock	—			16			1							17
Total fixed income securities	145			27,370			1,241							28,756
Equity securities	593			51			6							650
Short-term investments	129			461			—							590
Other investments: Free-standing derivatives	—			268			9				$	(11	)	266
Separate account assets	5,039			—			—							5,039
Assets held for sale	1,854			9,812			362							12,028
Total recurring basis assets	7,760			37,962			1,618				(11		)	47,329
Non-recurring basis (1)	—			—			17							17
Total assets at fair value	$	7,760		$	37,962		$	1,635			$	(11	)	$	47,346
% of total assets at fair value	16.4		%	80.2		%	3.4		%		—		%	100		%
Liabilities
Contractholder funds: Derivatives embedded in life and annuity contracts	$	—		$	—		$	(307	)					$	(307	)
Other liabilities: Free-standing derivatives	—			(185		)	(14		)		$	7		(192		)
Liabilities held for sale	—			—			(246		)					(246		)
Total recurring basis liabilities	—			(185		)	(567		)		7			(745		)
Non-recurring basis (2)	—			—			(11,088		)					(11,088		)
Total liabilities at fair value	$	—		$	(185	)	$	(11,655	)		$	7		$	(11,833	)
% of total liabilities at fair value	—		%	1.6		%	98.5		%		(0.1		)%	100		%
____________
(1)	Includes $8 million of mortgage loans and $9 million of limited partnership interests written-down to fair value in connection with recognizing other-than-temporary impairments.
(2)	Relates to LBL business held for sale (see Note 2).  The total fair value measurement includes $15,593 million of assets held for sale and $(14,899) million of liabilities held for sale, less $12,028 million of assets and $(246) million of liabilities measured at fair value on a recurring basis.
The following table summarizes quantitative information about the significant unobservable inputs used in Level 3 fair value measurements.
($ in millions)	Fair value			Valuation		Unobservable	Range		Weighted
				technique		input			average
September 30, 2014
Derivatives embedded in life and annuity contracts – Equity-indexed and forward starting options	$	(269	)	Stochastic cash flow model		Projected option cost	1.0 - 2.0%		1.76	%
December 31, 2013
Derivatives embedded in life and annuity contracts – Equity-indexed and forward starting options	$	(247	)	Stochastic cash flow model		Projected option cost	1.0 - 2.0%		1.75	%
Liabilities held for sale – Equity-indexed and forward starting options	$	(246	)	Stochastic cash flow model		Projected option cost	1.0 - 2.0%		1.91	%
If the projected option cost increased (decreased), it would result in a higher (lower) liability fair value.
As of September 30, 2014 and December 31, 2013, Level 3 fair value measurements include $980 million and $1.15 billion, respectively, of fixed income securities valued based on non-binding broker quotes where the inputs have not been corroborated to be market observable.  As of December 31, 2013, Level 3 fair value measurements for assets held for sale include $319 million of fixed income securities valued based on non-binding broker quotes where the inputs have not been corroborated to be market observable.  The Company does not develop the unobservable inputs used in measuring fair value; therefore, these are not included in the table above.  However, an increase (decrease) in credit spreads for fixed income securities valued based on non-binding broker quotes would result in a lower (higher) fair value.
The following table presents the rollforward of Level 3 assets and liabilities held at fair value on a recurring basis during the three months ended September 30, 2014.
($ in millions)				Total gains (losses)
				included in:
	Balance as of June 30, 2014			Net			OCI				Transfers			Transfers
				income (1)							into			out of
											Level 3			Level 3
Assets
Fixed income securities:
Municipal	$	102		$	—		$	—			$	—		$	—
Corporate	883			3			(13		)		18			—
ABS	105			—			1				—			—
CMBS	5			—			—				—			—
Total fixed income securities	1,095			3			(12		)		18			—
Equity securities	7			—			—				—			—
Free-standing derivatives, net	(5		)	—			—				—			—
Other assets	1			—			—				—			—
Total recurring Level 3 assets	$	1,098		$	3		$	(12	)		$	18		$	—
Liabilities
Contractholder funds: Derivatives embedded in life and annuity contracts	$	(331	)	$	9		$	—			$	—		$	—
Total recurring Level 3 liabilities	$	(331	)	$	9		$	—			$	—		$	—
	Purchases			Sales			Issues				Settlements			Balance as of September 30, 2014
Assets
Fixed income securities:
Municipal	$	—		$	(1	)	$	—			$	—		$	101
Corporate	4			(3		)	—				(53		)	839
ABS	10			—			—				(2		)	114
CMBS	—			—			—				—			5
Total fixed income securities	14			(4		)	—				(55		)	1,059
Equity securities	30			—			—				—			37
Free-standing derivatives, net	—			—			—				(1		)	(6		)	(2)
Other assets	—			—			—				—			1
Total recurring Level 3 assets	$	44		$	(4	)	$	—			$	(56	)	$	1,091
Liabilities
Contractholder funds: Derivatives embedded in life and annuity contracts	$	—		$	—		$	—			$	1		$	(321	)
Total recurring Level 3 liabilities	$	—		$	—		$	—			$	1		$	(321	)
____________
(1)	The effect to net income totals $12 million and is reported in the Condensed Consolidated Statements of Operations and Comprehensive Income as follows: $3 million in net investment income, $5 million in interest credited to contractholder funds and $4 million in contract benefits.
(2)	Comprises $3 million of assets and $9 million of liabilities.
The following table presents the rollforward of Level 3 assets and liabilities held at fair value on a recurring basis during the nine months ended September 30, 2014.
($ in millions)				Total gains (losses)
				included in:
	Balance as of December 31, 2013			Net			OCI				Transfers			Transfers
				income (1)							into			out of
											Level 3			Level 3
Assets
Fixed income securities:
Municipal	$	119		$	(1	)	$	3			$	—		$	(17	)
Corporate	1,008			14			(4		)		18			(26		)
ABS	112			—			2				—			(12		)
CMBS	1			—			—				—			—
Redeemable preferred stock	1			—			—				—			—
Total fixed income securities	1,241			13			1				18			(55		)
Equity securities	6			—			—				—			—
Free-standing derivatives, net	(5		)	1			—				—			—
Other assets	—			1			—				—			—
Assets held for sale	362			(1		)	2				4			(2		)
Total recurring Level 3 assets	$	1,604		$	14		$	3			$	22		$	(57	)
Liabilities
Contractholder funds: Derivatives embedded in life and annuity contracts	$	(307	)	$	(5	)	$	—			$	—		$	—
Liabilities held for sale	(246		)	17			—				—			—
Total recurring Level 3 liabilities	$	(553	)	$	12		$	—			$	—		$	—
	Sold in LBL			Purchases/			Sales				Settlements			Balance as of September 30, 2014
	disposition (3)			Issues (4)
Assets
Fixed income securities:
Municipal	$	—		$	—		$	(3	)		$	—		$	101
Corporate	—			16			(92		)		(95		)	839
ABS	—			21			—				(9		)	114
CMBS	4			—			—				—			5
Redeemable preferred stock	—			—			(1		)		—			—
Total fixed income securities	4			37			(96		)		(104		)	1,059
Equity securities	—			31			—				—			37
Free-standing derivatives, net	—			2			—				(4		)	(6		)	(2)
Other assets	—			—			—				—			1
Assets held for sale	(351		)	—			(8		)		(6		)	—
Total recurring Level 3 assets	$	(347	)	$	70		$	(104	)		$	(114	)	$	1,091
Liabilities
Contractholder funds: Derivatives embedded in life and annuity contracts	$	—		$	(13	)	$	—			$	4		$	(321	)
Liabilities held for sale	230			(4		)	—				3			—
Total recurring Level 3 liabilities	$	230		$	(17	)	$	—			$	7		$	(321	)
____________
(1)	The effect to net income totals $26 million and is reported in the Condensed Consolidated Statements of Operations and Comprehensive Income as follows: $8 million in realized capital gains and losses, $9 million in net investment income, $5 million in interest credited to contractholder funds, $8 million in contract benefits and $(4) million in loss on disposition of operations.
(2)	Comprises $3 million of assets and $9 million of liabilities.
(3)	Includes transfers from held for sale that took place in first quarter 2014 of $4 million for CMBS and $(4) million for Assets held for sale.
(4)	Represents purchases for assets and issues for liabilities.
The following table presents the rollforward of Level 3 assets and liabilities held at fair value on a recurring basis during the three months ended September 30, 2013.
($ in millions)				Total gains (losses)
				included in:
	Balance as of June 30, 2013			Net			OCI				Transfers			Transfers
				income (1)							into			out of
											Level 3			Level 3
Assets
Fixed income securities:
Municipal	$	225		$	—		$	1			$	—		$	—
Corporate	1,255			8			1				21			—
ABS	190			—			15				—			—
CMBS	5			—			2				—			—
Redeemable preferred stock	1			—			—				—			—
Total fixed income securities	1,676			8			19				21			—
Equity securities	6			—			—				—			—
Free-standing derivatives, net	(7		)	(2		)	—				—			—
Other assets	1			—			—				—			—
Assets held for sale	—			(1		)	(8		)		3			(2		)
Total recurring Level 3 assets	$	1,676		$	5		$	11			$	24		$	(2	)
Liabilities
Contractholder funds: Derivatives embedded in life and annuity contracts	$	(533	)	$	8		$	—			$	—		$	—
Liabilities held for sale	—			16			—				—			—
Total recurring Level 3 liabilities	$	(533	)	$	24		$	—			$	—		$	—
	Transfer to held for sale			Purchases/Issues (2)			Sales				Settlements			Balance as of September 30, 2013
Assets
Fixed income securities:
Municipal	$	(51	)	$	—		$	(1	)		$	—		$	174
Corporate	(244		)	39			(28		)		(49		)	1,003
ABS	(85		)	—			—				(5		)	115
CMBS	(5		)	—			—				—			2
Redeemable preferred stock	—			—			—				—			1
Total fixed income securities	(385		)	39			(29		)		(54		)	1,295
Equity securities	—			—			—				—			6
Free-standing derivatives, net	—			1			—				(2		)	(10		)	(3)
Other assets	—			—			—				—			1
Assets held for sale	385			—			(10		)		(2		)	365
Total recurring Level 3 assets	$	—		$	40		$	(39	)		$	(58	)	$	1,657
Liabilities
Contractholder funds: Derivatives embedded in life and annuity contracts	$	265		$	(24	)	$	—			$	1		$	(283	)
Liabilities held for sale	(265		)	(2		)	—				2			(249		)
Total recurring Level 3 liabilities	$	—		$	(26	)	$	—			$	3		$	(532	)
__________
(1)	The effect to net income totals $29 million and is reported in the Condensed Consolidated Statements of Operations and Comprehensive Income as follows: $1 million in realized capital gains and losses, $3 million in net investment income, $15 million in interest credited to contractholder funds and $10 million in contract benefits.
(2)	Represents purchases for assets and issues for liabilities.
(3)	Comprises $6 million of assets and $16 million of liabilities.
The following table presents the rollforward of Level 3 assets and liabilities held at fair value on a recurring basis during the nine months ended September 30, 2013.
($ in millions)				Total gains (losses)
				included in:
	Balance as of December 31, 2012			Net			OCI				Transfers			Transfers
				income (1)							into			out of
											Level 3			Level 3
Assets
Fixed income securities:
Municipal	$	338		$	(12	)	$	21			$	—		$	—
Corporate	1,501			28			(37		)		84			(168		)
ABS	199			(1		)	30				17			(16		)
CMBS	21			(1		)	4				—			—
Redeemable preferred stock	1			—			—				—			—
Total fixed income securities	2,060			14			18				101			(184		)
Equity securities	7			—			—				—			—
Free-standing derivatives, net	(27		)	20			—				—			—
Other assets	1			—			—				—			—
Assets held for sale	—			(1		)	(8		)		3			(2		)
Total recurring Level 3 assets	$	2,041		$	33		$	10			$	104		$	(186	)
Liabilities
Contractholder funds: Derivatives embedded in life and annuity contracts	$	(553	)	$	77		$	—			$	—		$	—
Liabilities held for sale	—			16			—				—			—
Total recurring Level 3 liabilities	$	(553	)	$	93		$	—			$	—		$	—
	Transfer to			Purchases/Issues (2)			Sales				Settlements			Balance as of September 30, 2013
	held for sale
Assets
Fixed income securities:
Municipal	$	(51	)	$	—		$	(122	)		$	—		$	174
Corporate	(244		)	132			(164		)		(129		)	1,003
ABS	(85		)	—			(8		)		(21		)	115
CMBS	(5		)	—			(17		)		—			2
Redeemable preferred stock	—			—			—				—			1
Total fixed income securities	(385		)	132			(311		)		(150		)	1,295
Equity securities	—			—			(1		)		—			6
Free-standing derivatives, net	—			2			—				(5		)	(10		)	(3)
Other assets	—			—			—				—			1
Assets held for sale	385			—			(10		)		(2		)	365
Total recurring Level 3 assets	$	—		$	134		$	(322	)		$	(157	)	$	1,657
Liabilities
Contractholder funds: Derivatives embedded in life and annuity contracts	$	265		$	(74	)	$	—			$	2		$	(283	)
Liabilities held for sale	(265		)	(2		)	—				2			(249		)
Total recurring Level 3 liabilities	$	—		$	(76	)	$	—			$	4		$	(532	)
____________
-1	The effect to net income totals $126 million and is reported in the Condensed Consolidated Statements of Operations and Comprehensive Income as follows: $18 million in realized capital gains and losses, $12 million in net investment income, $40 million in interest credited to contractholder funds and $56 million in contract benefits.
(2)	Represents purchases for assets and issues for liabilities
-3	Comprises $6 million of assets and $16 million of liabilities.
Transfers between level categorizations may occur due to changes in the availability of market observable inputs, which generally are caused by changes in market conditions such as liquidity, trading volume or bid-ask spreads.  Transfers between level categorizations may also occur due to changes in the valuation source.  For example, in situations where a fair value quote is not provided by the Company’s independent third-party valuation service provider and as a result the price is stale or has been replaced with a broker quote whose inputs have not been corroborated to be market observable, the security is transferred into Level 3.  Transfers in and out of level categorizations are reported as having occurred at the beginning of the quarter in which the transfer occurred.  Therefore, for all transfers into Level 3, all realized and changes in unrealized gains and losses in the quarter of transfer are reflected in the Level 3 rollforward table.
There were no transfers between Level 1 and Level 2 during the three months and nine months ended September 30, 2014 or 2013.
Transfers into Level 3 during the three months and nine months ended September 30, 2014 and 2013 included situations where a fair value quote was not provided by the Company’s independent third-party valuation service provider and as a result the price was stale or had been replaced with a broker quote where the inputs had not been corroborated to be market observable resulting in the security being classified as Level 3.  Transfers out of Level 3 during the three months and nine months ended September 30, 2014 and 2013 included situations where a broker quote was used in the prior period and a fair value quote became available from the Company’s independent third-party valuation service provider in the current period.  A quote utilizing the new pricing source was not available as of the prior period, and any gains or losses related to the change in valuation source for individual securities were not significant.
The following table provides the change in unrealized gains and losses included in net income for Level 3 assets and liabilities held as of September 30.
($ in millions)	Three months ended September 30,						Nine months ended September 30,
	2014			2013			2014				2013
Assets
Fixed income securities:
Municipal	$	—		$	—		$	(1	)		$	(5	)
Corporate	3			3			8				9
ABS	—			—			—				(1		)
CMBS	—			—			(1		)		(1		)
Total fixed income securities	3			3			6				2
Free-standing derivatives, net	—			(2		)	6				14
Other assets	—			—			1				—
Assets held for sale	—			(1		)	(1		)		(1		)
Total recurring Level 3 assets	$	3		$	—		$	12			$	15
Liabilities
Contractholder funds: Derivatives embedded in life and annuity contracts	$	9		$	8		$	(5	)		$	77
Liabilities held for sale	—			16			17				16
Total recurring Level 3 liabilities	$	9		$	24		$	12			$	93
The amounts in the table above represent the change in unrealized gains and losses included in net income for the period of time that the asset or liability was determined to be in Level 3.  These gains and losses total $12 million for the three months ended September 30, 2014 and are reported as follows: $3 million in net investment income, $5 million in interest credited to contractholder funds and $4 million in contract benefits.  These gains and losses total $24 million for the three months ended September 30, 2013 and are reported as follows: $(2) million in realized capital gains and losses, $2 million in net investment income, $14 million in interest credited to contractholder funds and $10 million in contract benefits.  These gains and losses total $24 million for the nine months ended September 30, 2014 and are reported as follows: $5 million in realized capital gains and losses, $6 million in net investment income, $5 million in interest credited to contractholder funds and $8 million in contract benefits.  These gains and losses total $108 million for the nine months ended September 30, 2013 and are reported as follows: $7 million in realized capital gains and losses, $8 million in net investment income, $37 million in interest credited to contractholder funds and $56 million in contract benefits.
Presented below are the carrying values and fair value estimates of financial instruments not carried at fair value.
Financial assets
($ in millions)	September 30, 2014						December 31, 2013
	Carrying			Fair			Carrying				Fair
	value			value			value				value
Mortgage loans	$	3,644		$	3,856		$	4,173			$	4,300
Cost method limited partnerships	526			729			605				799
Agent loans	364			357			341				325
Bank loans	339			337			160				161
Notes due from related party	275			275			275				275
Assets held for sale	—			—			1,458				1,532
The fair value of mortgage loans, including those classified as assets held for sale, is based on discounted contractual cash flows or, if the loans are impaired due to credit reasons, the fair value of collateral less costs to sell.  Risk adjusted discount rates are selected using current rates at which similar loans would be made to borrowers with similar characteristics, using similar types of properties as collateral.  The fair value of cost method limited partnerships is determined using reported net asset values of the underlying funds.  The fair value of agent loans, which are reported in other investments, is based on discounted cash flow calculations that use discount rates with a spread over U.S. Treasury rates.  Assumptions used in developing estimated cash flows and discount rates consider the loan’s credit and liquidity risks.  The fair value of bank loans, which are reported in other investments or assets held for sale, is based on broker quotes from brokers familiar with the loans and current market conditions.  The fair value of notes due from related party, which are reported in other investments, is based on discounted cash flow calculations using current interest rates for instruments with comparable terms.  The fair value measurements for mortgage loans, cost method limited partnerships, agent loans, bank loans, notes due from related party and assets held for sale are categorized as Level 3.
Financial liabilities
($ in millions)	September 30, 2014						December 31, 2013
	Carrying			Fair			Carrying				Fair
	value			value			value				value
Contractholder funds on investment contracts	$	14,059		$	14,741		$	15,542			$	16,198
Notes due to related parties	275			275			282				282
Liability for collateral	479			479			328				328
Liabilities held for sale	—			—			7,417				7,298
The fair value of contractholder funds on investment contracts, including those classified as liabilities held for sale, is based on the terms of the underlying contracts utilizing prevailing market rates for similar contracts adjusted for the Company’s own credit risk.  Deferred annuities included in contractholder funds are valued using discounted cash flow models that incorporate market value margins, which are based on the cost of holding economic capital, and the Company’s own credit risk.  Immediate annuities without life contingencies and fixed rate funding agreements are valued at the present value of future benefits using market implied interest rates which include the Company’s own credit risk.  The fair value measurements for contractholder funds on investment contracts and liabilities held for sale are categorized as Level 3.
The fair value of notes due to related parties is based on discounted cash flow calculations using current interest rates for instruments with comparable terms and considers the Company’s own credit risk.  The liability for collateral is valued at carrying value due to its short-term nature.  The fair value measurements for liability for collateral are categorized as Level 2.  The fair value measurements for notes due to related parties are categorized as Level 3.

Derivative_Financial_Instrumen

Derivative Financial Instruments	9 Months Ended
	Sep. 30, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Derivative Financial Instruments	'
	Derivative Financial Instruments
	The Company uses derivatives to manage risks with certain assets and liabilities arising from the potential adverse impacts from changes in risk-free interest rates, changes in equity market valuations, increases in credit spreads and foreign currency fluctuations, and for asset replication.  The Company does not use derivatives for speculative purposes.
	Asset-liability management is a risk management strategy that is principally employed to balance the respective interest-rate sensitivities of the Company’s assets and liabilities.  Depending upon the attributes of the assets acquired and liabilities issued, derivative instruments such as interest rate swaps, caps, swaptions and futures are utilized to change the interest rate characteristics of existing assets and liabilities to ensure the relationship is maintained within specified ranges and to reduce exposure to rising or falling interest rates.  The Company uses financial futures and interest rate swaps to hedge anticipated asset purchases and liability issuances and futures and options for hedging the equity exposure contained in its equity indexed life and annuity product contracts that offer equity returns to contractholders.  In addition, the Company uses interest rate swaps to hedge interest rate risk inherent in funding agreements.  The Company uses foreign currency swaps and forwards primarily to reduce the foreign currency risk associated with issuing foreign currency denominated funding agreements and holding foreign currency denominated investments.  Credit default swaps are typically used to mitigate the credit risk within the Company’s fixed income portfolio.
	The Company may also use derivatives to manage the risk associated with corporate actions, including the sale of a business. During 2014 and December 2013, swaptions were utilized to hedge the expected proceeds from the disposition of LBL.
	Asset replication refers to the “synthetic” creation of assets through the use of derivatives and primarily investment grade host bonds to replicate securities that are either unavailable in the cash markets or more economical to acquire in synthetic form.  The Company replicates fixed income securities using a combination of a credit default swap and one or more highly rated fixed income securities to synthetically replicate the economic characteristics of one or more cash market securities.
	The Company also has derivatives embedded in non-derivative host contracts that are required to be separated from the host contracts and accounted for at fair value with changes in fair value of embedded derivatives reported in net income.  The Company’s primary embedded derivatives are equity options in life and annuity product contracts, which provide equity returns to contractholders; equity-indexed notes containing equity call options, which provide a coupon payout that is determined using one or more equity-based indices; credit default swaps in synthetic collateralized debt obligations, which provide enhanced coupon rates as a result of selling credit protection; and conversion options in fixed income securities, which provide the Company with the right to convert the instrument into a predetermined number of shares of common stock.
	When derivatives meet specific criteria, they may be designated as accounting hedges and accounted for as fair value, cash flow, foreign currency fair value or foreign currency cash flow hedges.  The Company designates certain of its interest rate and foreign currency swap contracts and certain investment risk transfer reinsurance agreements as fair value hedges when the hedging instrument is highly effective in offsetting the risk of changes in the fair value of the hedged item.  The Company designates certain of its foreign currency swap contracts as cash flow hedges when the hedging instrument is highly effective in offsetting the exposure of variations in cash flows for the hedged risk that could affect net income.  Amounts are reclassified to net investment income or realized capital gains and losses as the hedged item affects net income.
	The notional amounts specified in the contracts are used to calculate the exchange of contractual payments under the agreements and are generally not representative of the potential for gain or loss on these agreements.  However, the notional amounts specified in credit default swaps where the Company has sold credit protection represent the maximum amount of potential loss, assuming no recoveries.
	Fair value, which is equal to the carrying value, is the estimated amount that the Company would receive or pay to terminate the derivative contracts at the reporting date.  The carrying value amounts for OTC derivatives are further adjusted for the effects, if any, of enforceable master netting agreements and are presented on a net basis, by counterparty agreement, in the Condensed Consolidated Statements of Financial Position.  For certain exchange traded and cleared derivatives, margin deposits are required as well as daily cash settlements of margin accounts.  As of September 30, 2014, the Company pledged $28 million of cash and securities in the form of margin deposits.
	For those derivatives which qualify for fair value hedge accounting, net income includes the changes in the fair value of both the derivative instrument and the hedged risk, and therefore reflects any hedging ineffectiveness.  For cash flow hedges, gains and losses are amortized from accumulated other comprehensive income and are reported in net income in the same period the forecasted transactions being hedged impact net income.
	Non-hedge accounting is generally used for “portfolio” level hedging strategies where the terms of the individual hedged items do not meet the strict homogeneity requirements to permit the application of hedge accounting.  For non-hedge derivatives, net income includes changes in fair value and accrued periodic settlements, when applicable.  With the exception of non-hedge derivatives used for asset replication and non-hedge embedded derivatives, all of the Company’s derivatives are evaluated for their ongoing effectiveness as either accounting hedge or non-hedge derivative financial instruments on at least a quarterly basis.
	The following table provides a summary of the volume and fair value positions of derivative instruments as well as their reporting location in the Condensed Consolidated Statement of Financial Position as of September 30, 2014.
	($ in millions, except number of contracts)			Volume (1)
		Balance sheet location		Notional				Number		Fair				Gross			Gross
				amount				of		value,				asset			liability
								contracts		net
	Asset derivatives
	Derivatives designated as accounting hedging instruments
	Foreign currency swap agreements	Other investments		$	16			n/a		$	2			$	2		$	—
	Derivatives not designated as accounting hedging instruments
	Interest rate contracts
	Interest rate cap agreements	Other investments		95				n/a		—				—			—
	Financial futures contracts	Other assets		—				50		—				—			—
	Equity and index contracts
	Options	Other investments		—				2,932		65				65			—
	Financial futures contracts	Other assets		—				200		—				—			—
	Foreign currency contracts
	Foreign currency forwards	Other investments		62				n/a		4				4			—
	Credit default contracts
	Credit default swaps – buying protection	Other investments		22				n/a		—				—			—
	Credit default swaps – selling protection	Other investments		80				n/a		2				2			—
	Other contracts
	Other contracts	Other assets		3				n/a		1				1			—
	Subtotal			262				3,182		72				72			—
	Total asset derivatives			$	278			3,182		$	74			$	74		$	—
	Liability derivatives
	Derivatives designated as accounting hedging instruments
	Foreign currency swap agreements	Other liabilities & accrued expenses		$	119			n/a		$	(6	)		$	—		$	(6	)
	Derivatives not designated as accounting hedging instruments
	Interest rate contracts
	Interest rate swap agreements	Other liabilities & accrued expenses		85				n/a		3				3			—
	Interest rate cap agreements	Other liabilities & accrued expenses		90				n/a		2				2			—
	Equity and index contracts
	Options and futures	Other liabilities & accrued expenses		—				3,365		(20		)		—			(20		)
	Foreign currency contracts
	Foreign currency forwards	Other liabilities & accrued expenses		69				n/a		—				—			—
	Embedded derivative financial instruments
	Guaranteed accumulation benefits	Contractholder funds		650				n/a		(36		)		—			(36		)
	Guaranteed withdrawal benefits	Contractholder funds		453				n/a		(13		)		—			(13		)
	Equity-indexed and forward starting options in life and annuity product contracts	Contractholder funds		1,773				n/a		(269		)		—			(269		)
	Other embedded derivative financial instruments	Contractholder funds		85				n/a		(3		)		—			(3		)
	Credit default contracts
	Credit default swaps – buying protection	Other liabilities & accrued expenses		68				n/a		(1		)		—			(1		)
	Credit default swaps – selling protection	Other liabilities & accrued expenses		100				n/a		(9		)		—			(9		)
	Subtotal			3,373				3,365		(346		)		5			(351		)
	Total liability derivatives			3,492				3,365		(352		)		$	5		$	(357	)
	Total derivatives			$	3,770			6,547		$	(278	)
	___________
	(1)	Volume for OTC derivative contracts is represented by their notional amounts.  Volume for exchange traded derivatives is represented by the number of contracts, which is the basis on which they are traded.  (n/a =ot applicable)
	The following table provides a summary of the volume and fair value positions of derivative instruments as well as their reporting location in the Consolidated Statement of Financial Position as of December 31, 2013.
	($ in millions, except number of contracts)			Volume (1)
		Balance sheet location		Notional				Number		Fair				Gross			Gross
				amount				of		value,				asset			liability
				contracts	net
Asset derivatives
Derivatives designated as accounting hedging instruments
Foreign currency swap agreements	Other investments		$	16			n/a		$	1			$	1		$	—
Derivatives not designated as accounting hedging instruments
Interest rate contracts
Interest rate swaption agreements	Other investments		1,420				n/a		—				—			—
Interest rate cap agreements	Other investments		61				n/a		2				2			—
Equity and index contracts
Options and warrants (2)	Other investments		3				10,035		261				261			—
Financial futures contracts	Other assets		—				627		—				—			—
Foreign currency contracts
Foreign currency forwards	Other investments		47				n/a		—				—			—
Embedded derivative financial instruments
Credit default swaps	Fixed income securities		12				n/a		(12		)		—			(12		)
Credit default contracts
Credit default swaps – buying protection	Other investments		1				n/a		—				—			—
Credit default swaps – selling protection	Other investments		85				n/a		2				2			—
Other contracts
Other contracts	Other assets		4				n/a		—				—			—
Subtotal			1,633				10,662		253				265			(12		)
Total asset derivatives			$	1,649			10,662		$	254			$	266		$	(12	)
Liability derivatives
Derivatives designated as accounting hedging instruments
Foreign currency swap agreements	Other liabilities & accrued expenses		$	132			n/a		$	(15	)		$	—		$	(15	)
Derivatives not designated as accounting hedging instruments
Interest rate contracts
Interest rate swap agreements	Other liabilities & accrued expenses		85				n/a		4				4			—
Interest rate swaption agreements	Other liabilities & accrued expenses		4,570				n/a		1				1			—
Interest rate cap agreements	Other liabilities & accrued expenses		262				n/a		4				4			—
Equity and index contracts
Options	Other liabilities & accrued expenses		55				10,035		(165		)		2			(167		)
Embedded derivative financial instruments
Guaranteed accumulation benefits	Contractholder funds		738				n/a		(43		)		—			(43		)
Guaranteed withdrawal benefits	Contractholder funds		506				n/a		(13		)		—			(13		)
Equity-indexed and forward starting options in life and annuity product contracts	Contractholder funds		1,693				n/a		(247		)		—			(247		)
	Liabilities held for sale		2,363				n/a		(246		)		—			(246		)
Other embedded derivative financial instruments	Contractholder funds		85				n/a		(4		)		—			(4		)
Credit default contracts
Credit default swaps – buying protection	Other liabilities & accrued expenses		171				n/a		(2		)		—			(2		)
Credit default swaps – selling protection	Other liabilities & accrued expenses		100				n/a		(15		)		—			(15		)
Subtotal			10,628				10,035		(726		)		11			(737		)
Total liability derivatives			10,760				10,035		(741		)		$	11		$	(752	)
Total derivatives			$	12,409			20,697		$	(487	)
____________
(1)	Volume for OTC derivative contracts is represented by their notional amounts.  Volume for exchange traded derivatives is represented by the number of contracts, which is the basis on which they are traded.  (n/a =ot applicable)
(2)	In addition to the number of contracts presented in the table, the Company held 837,100 stock warrants.  Stock warrants can be converted to cash upon sale of those instruments or exercised for shares of common stock.
The following table provides gross and net amounts for the Company’s OTC derivatives, all of which are subject to enforceable master netting agreements.
($ in millions)					Offsets
	Gross				Counter-			Cash				Net			Securities				Net
	amount				party			collateral				amount on			collateral				amount
					netting			(received)				balance			(received)
								pledged				sheet			pledged
September 30, 2014
Asset derivatives	$	12			$	(5	)	$	—			$	7		$	(2	)		$	5
Liability derivatives	(16		)		5			—				(11		)	13				2
December 31, 2013
Asset derivatives	$	14			$	(11	)	$	—			$	3		$	(3	)		$	—
Liability derivatives	(33		)		11			(4		)		(26		)	22				(4		)
The following table provides a summary of the impacts of the Company’s foreign currency contracts in cash flow hedging relationships.  Amortization of net losses from accumulated other comprehensive income related to cash flow hedges is expected to be $1 million during the next twelve months.  There was no hedge ineffectiveness reported in realized gains and losses for the three months and nine months ended September 30, 2014 or 2013.
($ in millions)	Three months ended September 30,							Nine months ended September 30,
	2014				2013			2014				2013
Gain (loss) recognized in OCI on derivatives during the period	$	10			$	(7	)	$	6			$	2
Loss recognized in OCI on derivatives during the term of the hedging relationship	(4		)		(14		)	(4		)		(14		)
Loss reclassified from AOCI into income (net investment income)	(1		)		—			(1		)		(1		)
Loss reclassified from AOCI into income (realized capital gains and losses)	—				—			(2		)		—
The following tables present gains and losses from valuation, settlements and hedge ineffectiveness reported on derivatives not designated as accounting hedging instruments in the Condensed Consolidated Statements of Operations and Comprehensive Income.  For the three months and nine months ended September 30, 2014 and 2013, the Company had no derivatives used in fair value hedging relationships.
($ in millions)	Realized				Contract			Interest				Loss on			Total gain (loss)
	capital				benefits			credited to				disposition			recognized in
	gains and							contractholder				of			net income on
	losses							funds				operations			derivatives
Three months ended September 30, 2014
Interest rate contracts	$	—			$	—		$	—			$	—		$	—
Equity and index contracts	—				—			4				—			4
Embedded derivative financial instruments	—				4			6				—			10
Foreign currency contracts	4				—			—				—			4
Credit default contracts	—				—			—				—			—
Other contracts	—				—			(1		)		—			(1		)
Total	$	4			$	4		$	9			$	—		$	17
Nine months ended September 30, 2014
Interest rate contracts	$	(2	)		$	—		$	—			$	(4	)	$	(6	)
Equity and index contracts	—				—			25				—			25
Embedded derivative financial instruments	—				8			(5		)		—			3
Foreign currency contracts	4				—			—				—			4
Credit default contracts	7				—			—				—			7
Other contracts	—				—			—				—			—
Total	$	9			$	8		$	20			$	(4	)	$	33
	Realized				Contract			Interest				Total gain (loss)
	capital				benefits			credited to				recognized in
	gains and							contractholder				net income on
	losses							funds				derivatives
Three months ended September 30, 2013
Interest rate contracts	$	—			$	—		$	—			$	—
Equity and index contracts	—				—			16				16
Embedded derivative financial instruments	—				10			(9		)		1
Foreign currency contracts	(2		)		—			—				(2		)
Credit default contracts	(3		)		—			—				(3		)
Other contracts	—				—			—				—
Total	$	(5	)		$	10		$	7			$	12
Nine months ended September 30, 2013
Interest rate contracts	$	3			$	—		$	—			$	3
Equity and index contracts	—				—			63				63
Embedded derivative financial instruments	(1		)		56			(35		)		20
Foreign currency contracts	(1		)		—			—				(1		)
Credit default contracts	13				—			—				13
Other contracts	—				—			(3		)		(3		)
Total	$	14			$	56		$	25			$	95
The Company manages its exposure to credit risk by utilizing highly rated counterparties, establishing risk control limits, executing legally enforceable master netting agreements (“MNAs”) and obtaining collateral where appropriate.  The Company uses MNAs for OTC derivative transactions that permit either party to net payments due for transactions and collateral is either pledged or obtained when certain predetermined exposure limits are exceeded.  As of September 30, 2014 counterparties pledged $3 million in cash and securities to the Company, and the Company pledged $14 million in securities to counterparties which includes $5 million of collateral posted under MNAs for contracts containing credit-risk-contingent provisions that are in a liability position and $9 million of collateral posted under MNAs for contracts without credit-risk-contingent liabilities.  The Company has not incurred any losses on derivative financial instruments due to counterparty nonperformance.  Other derivatives, including futures and certain option contracts, are traded on organized exchanges which require margin deposits and guarantee the execution of trades, thereby mitigating any potential credit risk.
Counterparty credit exposure represents the Company’s potential loss if all of the counterparties concurrently fail to perform under the contractual terms of the contracts and all collateral, if any, becomes worthless.  This exposure is measured by the fair value of OTC derivative contracts with a positive fair value at the reporting date reduced by the effect, if any, of legally enforceable master netting agreements.
The following table summarizes the counterparty credit exposure by counterparty credit rating as it relates to the Company’s OTC derivatives.
($ in millions)		September 30, 2014													December 31, 2013
Rating (1)		Number of			Notional			Credit				Exposure,			Number of			Notional				Credit		Exposure,
		counter-			amount (2)			exposure (2)				net of			counter-			amount (2)				exposure (2)		net of
		parties										collateral (2)			parties									collateral (2)
A+		1			$	16		$	—			$	—		1			$	22			$	1	$	1
A		3			97			6				3			4			1,523				2		—
A-		1			8			1				1			1			24				1		—
BBB+		1			11			—				—			1			3				—		—
BBB		1			62			—				—			1			76				1		—
Total		7			$	194		$	7			$	4		8			$	1,648			$	5	$	1
__________
(1)	Rating is the lower of S&P or Moody’s ratings.
(2)	Only OTC derivatives with a net positive fair value are included for each counterparty.
Market risk is the risk that the Company will incur losses due to adverse changes in market rates and prices.  Market risk exists for all of the derivative financial instruments the Company currently holds, as these instruments may become less valuable due to adverse changes in market conditions.  To limit this risk, the Company’s senior management has established risk control limits.  In addition, changes in fair value of the derivative financial instruments that the Company uses for risk management purposes are generally offset by the change in the fair value or cash flows of the hedged risk component of the related assets, liabilities or forecasted transactions.
Certain of the Company’s derivative instruments contain credit-risk-contingent termination events, cross-default provisions and credit support annex agreements.  Credit-risk-contingent termination events allow the counterparties to terminate the derivative on certain dates if AIC’s, ALIC’s or Allstate Life Insurance Company of New York’s (“ALNY”) financial strength credit ratings by Moody’s or S&P fall below a certain level or in the event AIC, ALIC or ALNY are no longer rated by either Moody’s or S&P.  Credit-risk-contingent cross-default provisions allow the counterparties to terminate the derivative instruments if the Company defaults by pre-determined threshold amounts on certain debt instruments.  Credit-risk-contingent credit support annex agreements specify the amount of collateral the Company must post to counterparties based on AIC’s. ALIC’s or ALNY’s financial strength credit ratings by Moody’s or S&P, or in the event AIC, ALIC or ALNY are no longer rated by either Moody’s or S&P.
The following summarizes the fair value of derivative instruments with termination, cross-default or collateral credit-risk-contingent features that are in a liability position, as well as the fair value of assets and collateral that are netted against the liability in accordance with provisions within legally enforceable MNAs.
($ in millions)	September 30, 2014				31-Dec-13
Gross liability fair value of contracts containing credit-risk-contingent features	$	10			$	25
Gross asset fair value of contracts containing credit-risk-contingent features and subject to MNAs	(3		)		(9		)
Collateral posted under MNAs for contracts containing credit-risk-contingent features	(5		)		(14		)
Maximum amount of additional exposure for contracts with credit-risk-contingent features if all features were triggered concurrently	$	2			$	2
Credit derivatives - selling protection
Free-standing credit default swaps (“CDS”) are utilized for selling credit protection against a specified credit event.  A credit default swap is a derivative instrument, representing an agreement between two parties to exchange the credit risk of a specified entity (or a group of entities), or an index based on the credit risk of a group of entities (all commonly referred to as the “reference entity” or a portfolio of “reference entities”), in return for a periodic premium.  In selling protection, CDS are used to replicate fixed income securities and to complement the cash market when credit exposure to certain issuers is not available or when the derivative alternative is less expensive than the cash market alternative.  CDS typically have a five-year term.
The following table shows the CDS notional amounts by credit rating and fair value of protection sold.
($ in millions)	Notional amount
	AA				A			BBB				BB and			Total				Fair
												lower							value
30-Sep-14
Single name
Corporate debt	$	—			$	—		$	—			$	—		$	—			$	—
First-to-default Basket
Municipal	—				100			—				—			100				(9		)
Index
Corporate debt	1				26			50				3			80				2
Total	$	1			$	126		$	50			$	3		$	180			$	(7	)
31-Dec-13
Single name
Corporate debt	$	—			$	5		$	—			$	—		$	5			$	—
First-to-default Basket
Municipal	—				100			—				—			100				(15		)
Index
Corporate debt	1				20			55				4			80				2
Total	$	1			$	125		$	55			$	4		$	185			$	(13	)
In selling protection with CDS, the Company sells credit protection on an identified single name, a basket of names in a first-to-default (“FTD”) structure or credit derivative index (“CDX”) that is generally investment grade, and in return receives periodic premiums through expiration or termination of the agreement.  With single name CDS, this premium or credit spread generally corresponds to the difference between the yield on the reference entity’s public fixed maturity cash instruments and swap rates at the time the agreement is executed.  With a FTD basket, because of the additional credit risk inherent in a basket of named reference entities, the premium generally corresponds to a high proportion of the sum of the credit spreads of the names in the basket and the correlation between the names.  CDX is utilized to take a position on multiple (generally 125) reference entities.  Credit events are typically defined as bankruptcy, failure to pay, or restructuring, depending on the nature of the reference entities.  If a credit event occurs, the Company settles with the counterparty, either through physical settlement or cash settlement.  In a physical settlement, a reference asset is delivered by the buyer of protection to the Company, in exchange for cash payment at par, whereas in a cash settlement, the Company pays the difference between par and the prescribed value of the reference asset.  When a credit event occurs in a single name or FTD basket (for FTD, the first credit event occurring for any one name in the basket), the contract terminates at the time of settlement.  For CDX, the reference entity’s name incurring the credit event is removed from the index while the contract continues until expiration.  The maximum payout on a CDS is the contract notional amount.  A physical settlement may afford the Company with recovery rights as the new owner of the asset.
The Company monitors risk associated with credit derivatives through individual name credit limits at both a credit derivative and a combined cash instrument/credit derivative level.  The ratings of individual names for which protection has been sold are also monitored.
In addition to the CDS described above, the Company’s synthetic collateralized debt obligations contain embedded credit default swaps which sell protection on a basket of reference entities.  The synthetic collateralized debt obligations are fully funded; therefore, the Company is not obligated to contribute additional funds when credit events occur related to the reference entities named in the embedded credit default swaps.  The Company’s maximum amount at risk equals the amount of its aggregate initial investment in the synthetic collateralized debt obligations.

Reinsurance

Reinsurance	9 Months Ended
	Sep. 30, 2014
Reinsurance Disclosures [Abstract]	'
Reinsurance	'
	Reinsurance
	The effects of reinsurance on premiums and contract charges are as follows:
	($ in millions)	Three months ended September 30,						Nine months ended September 30,
		2014			2013			2014			2013
	Direct	$	185		$	518		$	893		$	1,553
	Assumed
	Affiliate	32			31			97			92
	Non-affiliate	199			17			410			51
	Ceded-non-affiliate	(82		)	(155		)	(307		)	(466		)
	Premiums and contract charges, net of reinsurance	$	334		$	411		$	1,093		$	1,230
	The effects of reinsurance on contract benefits are as follows:
	($ in millions)	Three months ended September 30,						Nine months ended September 30,
		2014			2013			2014			2013
	Direct	$	277		$	499		$	1,023		$	1,370
	Assumed
	Affiliate	20			20			66			60
	Non-affiliate	135			13			277			38
	Ceded-non-affiliate	(76		)	(110		)	(265		)	(269		)
	Contract benefits, net of reinsurance	$	356		$	422		$	1,101		$	1,199
	The effects of reinsurance on interest credited to contractholder funds are as follows:
	($ in millions)	Three months ended September 30,						Nine months ended September 30,
		2014			2013			2014			2013
	Direct	$	167		$	309		$	656		$	946
	Assumed
	Affiliate	2			2			6			7
	Non-affiliate	27			7			54			22
	Ceded-non-affiliate	(5		)	(8		)	(20		)	(22		)
	Interest credited to contractholder funds, net of reinsurance	$	191		$	310		$	696		$	953

Guarantees_and_Contingent_Liab

Guarantees and Contingent Liabilities	9 Months Ended
	Sep. 30, 2014
Guarantees [Abstract]	'
Guarantees and Contingent Liabilities	'
	Guarantees and Contingent Liabilities
	Guarantees
	The Company owns certain investments that obligate the Company to exchange credit risk or to forfeit principal due, depending on the nature or occurrence of specified credit events for the reference entities.  In the event all such specified credit events were to occur, the Company’s maximum amount at risk on these investments, as measured by the amount of the aggregate initial investment, was $4 million as of September 30, 2014.  The obligations associated with these investments expire at various dates on or before March 11, 2018.
	Related to the sale of LBL on April 1, 2014, the Company has agreed to indemnify Resolution Life Holdings, Inc. related to representations, warranties and covenants of the Company, subject to certain contractual limitations as to the Company’s maximum obligation.  The representations and warranties made by the Company will expire by March 31, 2015, except for those pertaining to certain tax items and certain liabilities specifically excluded from the transaction.  Management does not believe these indemnification provisions will have a material effect on results of operations, cash flows or financial position of the Company.
	Related to the disposal through reinsurance of substantially all of the Company’s variable annuity business to Prudential in 2006, the Company and the Corporation have agreed to indemnify Prudential for certain pre-closing contingent liabilities (including extra-contractual liabilities of the Company and liabilities specifically excluded from the transaction) that the Company has agreed to retain.  In addition, the Company and the Corporation will each indemnify Prudential for certain post-closing liabilities that may arise from the acts of the Company and its agents, including certain liabilities arising from the Company’s provision of transition services.  The reinsurance agreements contain no limitations or indemnifications with regard to insurance risk transfer, and transferred all of the future risks and responsibilities for performance on the underlying variable annuity contracts to Prudential, including those related to benefit guarantees.  Management does not believe this agreement will have a material effect on results of operations, cash flows or financial position of the Company.
	In the normal course of business, the Company provides standard indemnifications to contractual counterparties in connection with numerous transactions, including acquisitions and divestitures.  The types of indemnifications typically provided include indemnifications for breaches of representations and warranties, taxes and certain other liabilities, such as third party lawsuits.  The indemnification clauses are often standard contractual terms and are entered into in the normal course of business based on an assessment that the risk of loss would be remote.  The terms of the indemnifications vary in duration and nature.  In many cases, the maximum obligation is not explicitly stated and the contingencies triggering the obligation to indemnify have not occurred and are not expected to occur.  Consequently, the maximum amount of the obligation under such indemnifications is not determinable.  Historically, the Company has not made any material payments pursuant to these obligations.
	The aggregate liability balance related to all guarantees was not material as of September 30, 2014.
	Regulation and Compliance
	The Company is subject to changing social, economic and regulatory conditions.  From time to time, regulatory authorities or legislative bodies seek to impose additional regulations regarding agent and broker compensation, regulate the nature of and amount of investments, and otherwise expand overall regulation of insurance products and the insurance industry.  The Company has established procedures and policies to facilitate compliance with laws and regulations, to foster prudent business operations, and to support financial reporting.  The Company routinely reviews its practices to validate compliance with laws and regulations and with internal procedures and policies.  As a result of these reviews, from time to time the Company may decide to modify some of its procedures and policies.  Such modifications, and the reviews that led to them, may be accompanied by payments being made and costs being incurred.  The ultimate changes and eventual effects of these actions on the Company’s business, if any, are uncertain.
	The Company is currently being examined by certain states for compliance with unclaimed property laws.  It is possible that this examination may result in additional payments of abandoned funds to states and to changes in the Company’s practices and procedures for the identification of escheatable funds, which could impact benefit payments and reserves, among other consequences; however, it is not likely to have a material effect on the condensed consolidated financial statements of the Company.

Other_Comprehensive_Income

Other Comprehensive Income	9 Months Ended
	Sep. 30, 2014
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]	'
Other Comprehensive Income	'
	Other Comprehensive Income
	The components of other comprehensive income (loss) on a pre-tax and after-tax basis are as follows:
	($ in millions)	Three months ended September 30,
		2014									2013
		Pre-			Tax			After-			Pre-			Tax			After-
		tax						tax			tax						tax
	Unrealized net holding gains and losses arising during the period, net of related offsets	$	58		$	(20	)	$	38		$	(76	)	$	27		$	(49	)
	Less: reclassification adjustment of realized capital gains and losses	21			(7		)	14			(6		)	2			(4		)
	Unrealized net capital gains and losses	37			(13		)	24			(70		)	25			(45		)
	Unrealized foreign currency translation adjustments	—			—			—			—			—			—
	Other comprehensive income (loss)	$	37		$	(13	)	$	24		$	(70	)	$	25		$	(45	)
	Net income (loss)							84									(394		)
	Comprehensive income (loss)							$	108								$	(439	)
		Nine months ended September 30,
		2014									2013
		Pre-			Tax			After-			Pre-			Tax			After-
		tax						tax			tax						tax
	Unrealized net holding gains and losses arising during the period, net of related offsets	$	525		$	(185	)	$	340		$	(860	)	$	302		$	(558	)
	Less: reclassification adjustment of realized capital gains and losses	(7		)	2			(5		)	35			(12		)	23
	Unrealized net capital gains and losses	532			(187		)	345			(895		)	314			(581		)
	Unrealized foreign currency translation adjustments	2			(1		)	1			—			—			—
	Other comprehensive income (loss)	$	534		$	(188	)	$	346		$	(895	)	$	314		$	(581	)
	Net income (loss)							343									(135		)
	Comprehensive income (loss)							$	689								$	(716	)

General_Tables

General (Tables)	9 Months Ended
	Sep. 30, 2014
General	'
Summary of premiums and contract charges by product	'
	The following table summarizes premiums and contract charges by product.
	($ in millions)	Three months ended September 30,				Nine months ended September 30,
		2014		2013		2014		2013
	Premiums
	Traditional life insurance	$	120	$	114	$	365	$	342
	Immediate annuities with life contingencies	—		6		5		22
	Accident and health insurance	22		27		71		78
	Total premiums	142		147		441		442
	Contract charges
	Interest-sensitive life insurance	188		258		638		775
	Fixed annuities	4		6		14		13
	Total contract charges	192		264		652		788
	Total premiums and contract charges	$	334	$	411	$	1,093	$	1,230

Disposition_Tables

Disposition (Tables)	9 Months Ended
	Sep. 30, 2014
Discontinued Operations and Disposal Groups [Abstract]	'
Summary of assets and liabilities classified as held for sale	'
	The following table summarizes the assets and liabilities classified as held for sale as of December 31, 2013.
	($ in millions)
	Assets
	Investments
	Fixed income securities	$	10,167
	Mortgage loans	1,367
	Short-term investments	160
	Policy loans	198
	Other investments	91
	Total investments	11,983
	Cash	—
	Deferred policy acquisition costs	743
	Reinsurance recoverables, net	1,660
	Accrued investment income	109
	Other assets	79
	Separate Accounts	1,701
	Assets held for sale	16,275
	Less: Loss accrual	(682		)
	Total assets held for sale	$	15,593
	Liabilities
	Reserve for life-contingent contract benefits	$	1,894
	Contractholder funds	10,945
	Unearned premiums	12
	Deferred income taxes	151
	Other liabilities and accrued expenses	196
	Separate Accounts	1,701
	Total liabilities held for sale	$	14,899

Supplemental_Cash_Flow_Informa1

Supplemental Cash Flow Information (Tables)	9 Months Ended
	Sep. 30, 2014
Supplemental Cash Flow Information [Abstract]	'
Schedule of supplemental cash flow information from collateralized securities received	'
	The accompanying cash flows are included in cash flows from operating activities in the Condensed Consolidated Statements of Cash Flows along with the activities resulting from management of the proceeds, which are as follows:
	($ in millions)	Nine months ended September 30,
		2014			2013
	Net change in proceeds managed
	Net change in short-term investments	$	(151	)	$	199
	Operating cash flow (used) provided	(151		)	199
	Net change in cash	—			(1		)
	Net change in proceeds managed	$	(151	)	$	198
	Net change in liabilities
	Liabilities for collateral, beginning of period	$	(328	)	$	(561	)
	Liabilities for collateral, end of period	(479		)	(363		)
	Operating cash flow provided (used)	$	151		$	(198	)

Investments_Tables

Investments (Tables)	9 Months Ended
	Sep. 30, 2014
Investments [Abstract]	'
Schedule for fixed income securities at amortized cost, gross unrealized gains and losses and fair value	'
	The amortized cost, gross unrealized gains and losses and fair value for fixed income securities are as follows:
	($ in millions)	Amortized			Gross unrealized						Fair
		cost			Gains			Losses			value
	30-Sep-14
	U.S. government and agencies	$	683		$	97		$	—		$	780
	Municipal	3,129			432			(14		)	3,547
	Corporate	19,550			1,579			(113		)	21,016
	Foreign government	660			80			(1		)	739
	Asset-backed securities (“ABS”)	723			18			(23		)	718
	Residential mortgage-backed securities (“RMBS”)	602			59			(5		)	656
	Commercial mortgage-backed securities (“CMBS”)	570			50			(3		)	617
	Redeemable preferred stock	14			3			—			17
	Total fixed income securities	$	25,931		$	2,318		$	(159	)	$	28,090
	31-Dec-13
	U.S. government and agencies	$	678		$	90		$	(2	)	$	766
	Municipal	3,135			231			(62		)	3,304
	Corporate	20,397			1,214			(295		)	21,316
	Foreign government	715			83			(6		)	792
	ABS	1,011			30			(34		)	1,007
	RMBS	752			50			(12		)	790
	CMBS	724			47			(7		)	764
	Redeemable preferred stock	15			2			—			17
	Total fixed income securities	$	27,427		$	1,747		$	(418	)	$	28,756
Schedule for fixed income securities based on contractual maturities	'
	The scheduled maturities for fixed income securities are as follows as of September 30, 2014:
	($ in millions)	Amortized			Fair
		cost			value
	Due in one year or less	$	1,282		$	1,304
	Due after one year through five years	5,163			5,602
	Due after five years through ten years	10,155			10,709
	Due after ten years	7,436			8,484
		24,036			26,099
	ABS, RMBS and CMBS	1,895			1,991
	Total	$	25,931		$	28,090
Schedule of net investment income	'
	Net investment income is as follows:
	($ in millions)	Three months ended September 30,						Nine months ended September 30,
		2014			2013			2014			2013
	Fixed income securities	$	349		$	487		$	1,179		$	1,477
	Mortgage loans	48			91			188			269
	Equity securities	7			3			17			8
	Limited partnership interests	51			37			209			104
	Short-term investments	—			—			1			1
	Policy loans	10			12			30			36
	Other	15			18			43			50
	Investment income, before expense	480			648			1,667			1,945
	Investment expense	(19		)	(27		)	(55		)	(84		)
	Net investment income	$	461		$	621		$	1,612		$	1,861
Schedule of realized capital gains and losses by asset type	'
	Realized capital gains and losses by asset type are as follows:
	($ in millions)	Three months ended September 30,						Nine months ended September 30,
		2014			2013			2014			2013
	Fixed income securities	$	(1	)	$	(12	)	$	(1	)	$	(6	)
	Mortgage loans	2			(6		)	3			19
	Equity securities	(5		)	5			11			37
	Limited partnership interests	28			—			(5		)	(3		)
	Derivatives	4			(5		)	7			14
	Other	—			2			3			—
	Realized capital gains and losses	$	28		$	(16	)	$	18		$	61
Schedule of realized capital gains and losses by transaction type	'
	Realized capital gains and losses by transaction type are as follows:
	($ in millions)	Three months ended September 30,						Nine months ended September 30,
		2014			2013			2014			2013
	Impairment write-downs	$	2		$	(10	)	$	(2	)	$	(28	)
	Change in intent write-downs	(21		)	(7		)	(40		)	(15		)
	Net other-than-temporary impairment losses recognized in earnings	(19		)	(17		)	(42		)	(43		)
	Sales	43			6			51			90
	Valuation and settlements of derivative instruments	4			(5		)	9			14
	Realized capital gains and losses	$	28		$	(16	)	$	18		$	61
Schedule of other-than-temporary impairment losses by asset type	'
	Other-than-temporary impairment losses by asset type are as follows:
	($ in millions)	Three months ended September 30, 2014									Nine months ended September 30, 2014
		Gross			Included			Net			Gross				Included				Net
					in OCI										in OCI
	Fixed income securities:
	Municipal	$	—		$	—		$	—		$	(1	)		$	—			$	(1	)
	Corporate	(3		)	—			(3		)	(3		)		—				(3		)
	ABS	—			—			—			(1		)		—				(1		)
	RMBS	—			—			—			3				(1		)		2
	Total fixed income securities	(3		)	—			(3		)	(2		)		(1		)		(3		)
	Mortgage loans	2			—			2			6				—				6
	Equity securities	(21		)	—			(21		)	(29		)		—				(29		)
	Limited partnership interests	3			—			3			(16		)		—				(16		)
	Other-than-temporary impairment losses	$	(19	)	$	—		$	(19	)	$	(41	)		$	(1	)		$	(42	)
		Three months ended September 30, 2013									Nine months ended September 30, 2013
		Gross			Included			Net			Gross				Included				Net
					in OCI										in OCI
	Fixed income securities:
	Municipal	$	—		$	—		$	—		$	(8	)		$	—			$	(8	)
	ABS	—			—			—			—				(1		)		(1		)
	RMBS	(5		)	4			(1		)	(4		)		3				(1		)
	CMBS	(8		)	4			(4		)	(27		)		(4		)		(31		)
	Total fixed income securities	(13		)	8			(5		)	(39		)		(2		)		(41		)
	Mortgage loans	(6		)	—			(6		)	11				—				11
	Equity securities	(4		)	—			(4		)	(5		)		—				(5		)
	Limited partnership interests	(1		)	—			(1		)	(5		)		—				(5		)
	Other	(1		)	—			(1		)	(3		)		—				(3		)
	Other-than-temporary impairment losses	$	(25	)	$	8		$	(17	)	$	(41	)		$	(2	)		$	(43	)
Schedule of other-than-temporary impairment losses on fixed income securities included in accumulated other comprehensive income	'
	The total amount of other-than-temporary impairment losses included in accumulated other comprehensive income at the time of impairment for fixed income securities, which were not included in earnings, are presented in the following table.  The amounts exclude $139 million and $164 million as of September 30, 2014 and December 31, 2013, respectively, of net unrealized gains related to changes in valuation of the fixed income securities subsequent to the impairment measurement date.
	($ in millions)	September 30, 2014			December 31, 2013
	Municipal	$	(5	)	$	(5	)
	ABS	(6		)	(10		)
	RMBS	(56		)	(90		)
	CMBS	(5		)	(12		)
	Total	$	(72	)	$	(117	)
Schedule of rollforwards of the cumulative credit losses recognized in earnings for fixed income securities held	'
	Rollforwards of the cumulative credit losses recognized in earnings for fixed income securities held as of the end of the period are as follows:
	($ in millions)	Three months ended September 30,						Nine months ended September 30,
		2014			2013			2014			2013
	Beginning balance	$	(229	)	$	(318	)	$	(299	)	$	(345	)
	Additional credit loss for securities previously other-than-temporarily impaired	—			—			2			(12		)
	Additional credit loss for securities not previously other-than-temporarily impaired	(3		)	(2		)	(4		)	(19		)
	Reduction in credit loss for securities disposed or collected	9			12			19			68
	Reduction in credit loss for securities the Company has made the decision to sell or more likely than not will be required to sell	—			—			—			—
	Change in credit loss due to accretion of increase in cash flows	1			—			1			—
	Reduction in credit loss for securities sold in LBL disposition	—			—			59			—
	Ending balance	$	(222	)	$	(308	)	$	(222	)	$	(308	)
Schedule of unrealized net capital gains and losses included in accumulated other comprehensive income	'
	Unrealized net capital gains and losses included in accumulated other comprehensive income are as follows:
	($ in millions)	Fair value			Gross unrealized						Unrealized net gains (losses)
	September 30, 2014				Gains			Losses
	Fixed income securities	$	28,090		$	2,318		$	(159	)	$	2,159
	Equity securities	1,229			138			—			138
	Short-term investments	762			—			—			—
	Derivative instruments (1)	(4		)	1			(5		)	(4		)
	Equity method (“EMA”) limited partnerships (2)										(2		)
	Unrealized net capital gains and losses, pre-tax										2,291
	Amounts recognized for:
	Insurance reserves (3)										(169		)
	DAC and DSI (4)										(157		)
	Amounts recognized										(326		)
	Deferred income taxes										(693		)
	Unrealized net capital gains and losses, after-tax										$	1,272
	_______________
	(1)	Included in the fair value of derivative instruments are $1 million classified as assets and $5 million classified as liabilities.
	(2)	Unrealized net capital gains and losses for limited partnership interests represent the Company’s share of EMA limited partnerships’ other comprehensive income. Fair value and gross unrealized gains and losses are not applicable.
	(3)	The insurance reserves adjustment represents the amount by which the reserve balance would increase if the net unrealized gains in the applicable product portfolios were realized and reinvested at current lower interest rates, resulting in a premium deficiency. Although the Company evaluates premium deficiencies on the combined performance of life insurance and immediate annuities with life contingencies, the adjustment primarily relates to structured settlement annuities with life contingencies, in addition to annuity buy-outs and certain payout annuities with life contingencies.
	(4)	The DAC and DSI adjustment balance represents the amount by which the amortization of DAC and DSI would increase or decrease if the unrealized gains or losses in the respective product portfolios were realized.
	($ in millions)	Fair value			Gross unrealized						Unrealized net gains (losses)
	December 31, 2013				Gains			Losses
	Fixed income securities	$	28,756		$	1,747		$	(418	)	$	1,329
	Equity securities	650			90			(5		)	85
	Short-term investments	590			—			—			—
	Derivative instruments (1)	(13		)	1			(14		)	(13		)
	EMA limited partnerships										(2		)
	Investments classified as held for sale										190
	Unrealized net capital gains and losses, pre-tax										1,589
	Amounts recognized for:
	Insurance reserves										—
	DAC and DSI										(156		)
	Amounts recognized										(156		)
	Deferred income taxes										(506		)
	Unrealized net capital gains and losses, after-tax										$	927
	_______________
	(1)	Included in the fair value of derivative instruments are $1 million classified as assets and $14 million classified as liabilities.
Schedule of change in unrealized net capital gains and losses	'
	The change in unrealized net capital gains and losses for the nine months ended September 30, 2014 is as follows:
	($ in millions)
	Fixed income securities	$	830
	Equity securities	53
	Derivative instruments	9
	Investments classified as held for sale	(190		)
	Total	702
	Amounts recognized for:
	Insurance reserves	(169		)
	DAC and DSI	(1		)
	Amounts recognized	(170		)
	Deferred income taxes	(187		)
	Increase in unrealized net capital gains and losses, after-tax	$	345
Summary of gross unrealized losses and fair value of fixed income and equity securities by length of time	'
	The following table summarizes the gross unrealized losses and fair value of fixed income and equity securities by the length of time that individual securities have been in a continuous unrealized loss position.
		($ in millions)	Less than 12 months								12 months or more											Total
			Number		Fair			Unrealized			Number			Fair				Unrealized				unrealized
			of issues		value			losses			of issues			value				losses				losses
		September 30, 2014
		Fixed income securities
		U.S. government and agencies	2		$	21		$	—		—			$	—			$	—			$	—
		Municipal	12		98			(2		)	25			143				(12		)		(14		)
		Corporate	278		1,844			(33		)	119			1,064				(80		)		(113		)
		Foreign government	1		7			—			1			14				(1		)		(1		)
		ABS	18		129			(1		)	26			239				(22		)		(23		)
		RMBS	18		2			—			47			77				(5		)		(5		)
		CMBS	4		3			—			4			43				(3		)		(3		)
		Total fixed income securities	333		2,104			(36		)	222			1,580				(123		)		(159		)
		Equity securities	2		8			—			—			—				—				—
		Total fixed income and equity securities	335		$	2,112		$	(36	)	222			$	1,580			$	(123	)		$	(159	)
		Investment grade fixed income securities	143		$	1,133		$	(12	)	172			$	1,294			$	(87	)		$	(99	)
		Below investment grade fixed income securities	190		971			(24		)	50			286				(36		)		(60		)
		Total fixed income securities	333		$	2,104		$	(36	)	222			$	1,580			$	(123	)		$	(159	)
		December 31, 2013
		Fixed income securities
		U.S. government and agencies	4		$	76		$	(2	)	—			$	—			$	—			$	(2	)
		Municipal	63		347			(24		)	21			99				(38		)		(62		)
		Corporate	530		5,191			(224		)	48			467				(71		)		(295		)
		Foreign government	7		76			(4		)	1			13				(2		)		(6		)
		ABS	17		162			(1		)	42			400				(33		)		(34		)
		RMBS	35		42			(2		)	47			129				(10		)		(12		)
		CMBS	5		14			—			6			52				(7		)		(7		)
		Total fixed income securities	661		5,908			(257		)	165			1,160				(161		)		(418		)
		Equity securities	25		80			(5		)	—			—				—				(5		)
		Total fixed income and equity securities	686		$	5,988		$	(262	)	165			$	1,160			$	(161	)		$	(423	)
		Investment grade fixed income securities	526		$	5,272		$	(236	)	110			$	834			$	(112	)		$	(348	)
		Below investment grade fixed income securities	135		636			(21		)	55			326				(49		)		(70		)
		Total fixed income securities	661		$	5,908		$	(257	)	165			$	1,160			$	(161	)		$	(418	)
Summary of carrying value of non-impaired fixed and variable rate mortgage loans by debt service coverage ratio distribution	'
	The following table reflects the carrying value of non-impaired fixed rate and variable rate mortgage loans summarized by debt service coverage ratio distribution.
	($ in millions)	September 30, 2014									December 31, 2013
	Debt service coverage	Fixed rate			Variable rate			Total			Fixed rate				Variable rate				Total
	ratio distribution	mortgage			mortgage						mortgage				mortgage
		loans			loans						loans				loans
	Below 1.0	$	186		$	—		$	186		$	153			$	—			$	153
	1.0 - 1.25	351			—			351			560				—				560
	1.26 - 1.50	1,178			2			1,180			1,167				2				1,169
	Above 1.50	1,917			—			1,917			2,176				38				2,214
	Total non-impaired mortgage loans	$	3,632		$	2		$	3,634		$	4,056			$	40			$	4,096
Schedule of net carrying value of impaired mortgage loans	'
	The net carrying value of impaired mortgage loans is as follows:
	($ in millions)	September 30, 2014			December 31, 2013
	Impaired mortgage loans with a valuation allowance	$	10		$	77
	Impaired mortgage loans without a valuation allowance	—			—
	Total impaired mortgage loans	$	10		$	77
	Valuation allowance on impaired mortgage loans	$	7		$	21
Schedule of rollforward of the valuation allowance on impaired mortgage loans	'
	The rollforward of the valuation allowance on impaired mortgage loans is as follows:
	($ in millions)	Three months ended September 30,						Nine months ended September 30,
		2014			2013			2014			2013
	Beginning balance	$	9		$	21		$	21		$	42
	Net (decrease) increase in valuation allowance	(2		)	6			(6		)	(11		)
	Charge offs	—			—			(8		)	(4		)
	Mortgage loans classified as held for sale	—			(2		)	—			(2		)
	Ending balance	$	7		$	25		$	7		$	25

Fair_Value_of_Assets_and_Liabi1

Fair Value of Assets and Liabilities (Tables)	9 Months Ended
	Sep. 30, 2014
Fair Value Disclosures [Abstract]	'
Summary of assets and liabilities measured at fair value on a recurring and non-recurring basis	'
	The following table summarizes the Company’s assets and liabilities measured at fair value on a recurring and non-recurring basis as of December 31, 2013.
	($ in millions)	Quoted prices			Significant			Significant				Counterparty			Balance as of December 31, 2013
		in active			other			unobservable				and cash
		markets for			observable			inputs				collateral
		identical assets			inputs			(Level 3)				netting
		(Level 1)			(Level 2)
	Assets
	Fixed income securities:
	U.S. government and agencies	$	145		$	621		$	—						$	766
	Municipal	—			3,185			119							3,304
	Corporate	—			20,308			1,008							21,316
	Foreign government	—			792			—							792
	ABS	—			895			112							1,007
	RMBS	—			790			—							790
	CMBS	—			763			1							764
	Redeemable preferred stock	—			16			1							17
	Total fixed income securities	145			27,370			1,241							28,756
	Equity securities	593			51			6							650
	Short-term investments	129			461			—							590
	Other investments: Free-standing derivatives	—			268			9				$	(11	)	266
	Separate account assets	5,039			—			—							5,039
	Assets held for sale	1,854			9,812			362							12,028
	Total recurring basis assets	7,760			37,962			1,618				(11		)	47,329
	Non-recurring basis (1)	—			—			17							17
	Total assets at fair value	$	7,760		$	37,962		$	1,635			$	(11	)	$	47,346
	% of total assets at fair value	16.4		%	80.2		%	3.4		%		—		%	100		%
	Liabilities
	Contractholder funds: Derivatives embedded in life and annuity contracts	$	—		$	—		$	(307	)					$	(307	)
	Other liabilities: Free-standing derivatives	—			(185		)	(14		)		$	7		(192		)
	Liabilities held for sale	—			—			(246		)					(246		)
	Total recurring basis liabilities	—			(185		)	(567		)		7			(745		)
	Non-recurring basis (2)	—			—			(11,088		)					(11,088		)
	Total liabilities at fair value	$	—		$	(185	)	$	(11,655	)		$	7		$	(11,833	)
	% of total liabilities at fair value	—		%	1.6		%	98.5		%		(0.1		)%	100		%
	____________
	(1)	Includes $8 million of mortgage loans and $9 million of limited partnership interests written-down to fair value in connection with recognizing other-than-temporary impairments.
	(2)	Relates to LBL business held for sale (see Note 2).  The total fair value measurement includes $15,593 million of assets held for sale and $(14,899) million of liabilities held for sale, less $12,028 million of assets and $(246) million of liabilities measured at fair value on a recurring basis.
	The following table summarizes the Company’s assets and liabilities measured at fair value on a recurring and non-recurring basis as of September 30, 2014.
	($ in millions)	Quoted prices			Significant			Significant				Counterparty			Balance as of September 30, 2014
		in active			other			unobservable				and cash
		markets for			observable			inputs				collateral
		identical assets			inputs			(Level 3)				netting
		(Level 1)			(Level 2)
	Assets
	Fixed income securities:
	U.S. government and agencies	$	146		$	634		$	—						$	780
	Municipal	—			3,446			101							3,547
	Corporate	—			20,177			839							21,016
	Foreign government	—			739			—							739
	ABS	—			604			114							718
	RMBS	—			656			—							656
	CMBS	—			612			5							617
	Redeemable preferred stock	—			17			—							17
	Total fixed income securities	146			26,885			1,059							28,090
	Equity securities	1,138			54			37							1,229
	Short-term investments	76			686			—							762
	Other investments: Free-standing derivatives	—			75			3				$	(5	)	73
	Separate account assets	4,521			—			—							4,521
	Other assets	—			—			1							1
	Total recurring basis assets	5,881			27,700			1,100				(5		)	34,676
	Non-recurring basis (1)	—			—			15							15
	Total assets at fair value	$	5,881		$	27,700		$	1,115			$	(5	)	$	34,691
	% of total assets at fair value	17		%	79.8		%	3.2		%		—		%	100		%
Liabilities
Contractholder funds: Derivatives embedded in life and annuity contracts	$	—		$	—		$	(321	)					$	(321	)
Other liabilities: Free-standing derivatives	—			(27		)	(9		)		$	5		(31		)
Total liabilities at fair value	$	—		$	(27	)	$	(330	)		$	5		$	(352	)
% of total liabilities at fair value	—		%	7.7		%	93.7		%		(1.4		)%	100		%
____________
(1)	Includes $15 million of limited partnership interests written-down to fair value in connection with recognizing other-than-temporary impairments.
Summary of quantitative information about the significant unobservable inputs used in Level 3 fair value measurements	'
	The following table summarizes quantitative information about the significant unobservable inputs used in Level 3 fair value measurements.
	($ in millions)	Fair value			Valuation		Unobservable	Range		Weighted
					technique		input			average
	September 30, 2014
	Derivatives embedded in life and annuity contracts – Equity-indexed and forward starting options	$	(269	)	Stochastic cash flow model		Projected option cost	1.0 - 2.0%		1.76	%
	December 31, 2013
	Derivatives embedded in life and annuity contracts – Equity-indexed and forward starting options	$	(247	)	Stochastic cash flow model		Projected option cost	1.0 - 2.0%		1.75	%
	Liabilities held for sale – Equity-indexed and forward starting options	$	(246	)	Stochastic cash flow model		Projected option cost	1.0 - 2.0%		1.91	%
Schedule of rollforward of Level 3 assets and liabilities held at fair value on a recurring basis	'
	The following table presents the rollforward of Level 3 assets and liabilities held at fair value on a recurring basis during the three months ended September 30, 2013.
	($ in millions)				Total gains (losses)
					included in:
		Balance as of June 30, 2013			Net			OCI				Transfers			Transfers
					income (1)							into			out of
												Level 3			Level 3
	Assets
	Fixed income securities:
	Municipal	$	225		$	—		$	1			$	—		$	—
	Corporate	1,255			8			1				21			—
	ABS	190			—			15				—			—
	CMBS	5			—			2				—			—
	Redeemable preferred stock	1			—			—				—			—
	Total fixed income securities	1,676			8			19				21			—
	Equity securities	6			—			—				—			—
	Free-standing derivatives, net	(7		)	(2		)	—				—			—
	Other assets	1			—			—				—			—
	Assets held for sale	—			(1		)	(8		)		3			(2		)
	Total recurring Level 3 assets	$	1,676		$	5		$	11			$	24		$	(2	)
	Liabilities
	Contractholder funds: Derivatives embedded in life and annuity contracts	$	(533	)	$	8		$	—			$	—		$	—
	Liabilities held for sale	—			16			—				—			—
	Total recurring Level 3 liabilities	$	(533	)	$	24		$	—			$	—		$	—
		Transfer to held for sale			Purchases/Issues (2)			Sales				Settlements			Balance as of September 30, 2013
	Assets
	Fixed income securities:
	Municipal	$	(51	)	$	—		$	(1	)		$	—		$	174
	Corporate	(244		)	39			(28		)		(49		)	1,003
	ABS	(85		)	—			—				(5		)	115
	CMBS	(5		)	—			—				—			2
	Redeemable preferred stock	—			—			—				—			1
	Total fixed income securities	(385		)	39			(29		)		(54		)	1,295
	Equity securities	—			—			—				—			6
	Free-standing derivatives, net	—			1			—				(2		)	(10		)	(3)
	Other assets	—			—			—				—			1
	Assets held for sale	385			—			(10		)		(2		)	365
	Total recurring Level 3 assets	$	—		$	40		$	(39	)		$	(58	)	$	1,657
	Liabilities
	Contractholder funds: Derivatives embedded in life and annuity contracts	$	265		$	(24	)	$	—			$	1		$	(283	)
	Liabilities held for sale	(265		)	(2		)	—				2			(249		)
	Total recurring Level 3 liabilities	$	—		$	(26	)	$	—			$	3		$	(532	)
	__________
	(1)	The effect to net income totals $29 million and is reported in the Condensed Consolidated Statements of Operations and Comprehensive Income as follows: $1 million in realized capital gains and losses, $3 million in net investment income, $15 million in interest credited to contractholder funds and $10 million in contract benefits.
	(2)	Represents purchases for assets and issues for liabilities.
	(3)	Comprises $6 million of assets and $16 million of liabilities.
	The following table presents the rollforward of Level 3 assets and liabilities held at fair value on a recurring basis during the nine months ended September 30, 2014.
	($ in millions)				Total gains (losses)
					included in:
		Balance as of December 31, 2013			Net			OCI				Transfers			Transfers
					income (1)							into			out of
												Level 3			Level 3
	Assets
	Fixed income securities:
	Municipal	$	119		$	(1	)	$	3			$	—		$	(17	)
	Corporate	1,008			14			(4		)		18			(26		)
	ABS	112			—			2				—			(12		)
	CMBS	1			—			—				—			—
	Redeemable preferred stock	1			—			—				—			—
	Total fixed income securities	1,241			13			1				18			(55		)
	Equity securities	6			—			—				—			—
	Free-standing derivatives, net	(5		)	1			—				—			—
	Other assets	—			1			—				—			—
	Assets held for sale	362			(1		)	2				4			(2		)
Total recurring Level 3 assets	$	1,604		$	14		$	3			$	22		$	(57	)
Liabilities
Contractholder funds: Derivatives embedded in life and annuity contracts	$	(307	)	$	(5	)	$	—			$	—		$	—
Liabilities held for sale	(246		)	17			—				—			—
Total recurring Level 3 liabilities	$	(553	)	$	12		$	—			$	—		$	—
	Sold in LBL			Purchases/			Sales				Settlements			Balance as of September 30, 2014
	disposition (3)			Issues (4)
Assets
Fixed income securities:
Municipal	$	—		$	—		$	(3	)		$	—		$	101
Corporate	—			16			(92		)		(95		)	839
ABS	—			21			—				(9		)	114
CMBS	4			—			—				—			5
Redeemable preferred stock	—			—			(1		)		—			—
Total fixed income securities	4			37			(96		)		(104		)	1,059
Equity securities	—			31			—				—			37
Free-standing derivatives, net	—			2			—				(4		)	(6		)	(2)
Other assets	—			—			—				—			1
Assets held for sale	(351		)	—			(8		)		(6		)	—
Total recurring Level 3 assets	$	(347	)	$	70		$	(104	)		$	(114	)	$	1,091
Liabilities
Contractholder funds: Derivatives embedded in life and annuity contracts	$	—		$	(13	)	$	—			$	4		$	(321	)
Liabilities held for sale	230			(4		)	—				3			—
Total recurring Level 3 liabilities	$	230		$	(17	)	$	—			$	7		$	(321	)
____________
(1)	The effect to net income totals $26 million and is reported in the Condensed Consolidated Statements of Operations and Comprehensive Income as follows: $8 million in realized capital gains and losses, $9 million in net investment income, $5 million in interest credited to contractholder funds, $8 million in contract benefits and $(4) million in loss on disposition of operations.
(2)	Comprises $3 million of assets and $9 million of liabilities.
(3)	Includes transfers from held for sale that took place in first quarter 2014 of $4 million for CMBS and $(4) million for Assets held for sale.
(4)	Represents purchases for assets and issues for liabilities.
The following table presents the rollforward of Level 3 assets and liabilities held at fair value on a recurring basis during the nine months ended September 30, 2013.
($ in millions)				Total gains (losses)
				included in:
	Balance as of December 31, 2012			Net			OCI				Transfers			Transfers
				income (1)							into			out of
											Level 3			Level 3
Assets
Fixed income securities:
Municipal	$	338		$	(12	)	$	21			$	—		$	—
Corporate	1,501			28			(37		)		84			(168		)
ABS	199			(1		)	30				17			(16		)
CMBS	21			(1		)	4				—			—
Redeemable preferred stock	1			—			—				—			—
Total fixed income securities	2,060			14			18				101			(184		)
Equity securities	7			—			—				—			—
Free-standing derivatives, net	(27		)	20			—				—			—
Other assets	1			—			—				—			—
Assets held for sale	—			(1		)	(8		)		3			(2		)
Total recurring Level 3 assets	$	2,041		$	33		$	10			$	104		$	(186	)
Liabilities
Contractholder funds: Derivatives embedded in life and annuity contracts	$	(553	)	$	77		$	—			$	—		$	—
Liabilities held for sale	—			16			—				—			—
Total recurring Level 3 liabilities	$	(553	)	$	93		$	—			$	—		$	—
	Transfer to			Purchases/Issues (2)			Sales				Settlements			Balance as of September 30, 2013
	held for sale
Assets
Fixed income securities:
Municipal	$	(51	)	$	—		$	(122	)		$	—		$	174
Corporate	(244		)	132			(164		)		(129		)	1,003
ABS	(85		)	—			(8		)		(21		)	115
CMBS	(5		)	—			(17		)		—			2
Redeemable preferred stock	—			—			—				—			1
Total fixed income securities	(385		)	132			(311		)		(150		)	1,295
Equity securities	—			—			(1		)		—			6
Free-standing derivatives, net	—			2			—				(5		)	(10		)	(3)
Other assets	—			—			—				—			1
Assets held for sale	385			—			(10		)		(2		)	365
Total recurring Level 3 assets	$	—		$	134		$	(322	)		$	(157	)	$	1,657
Liabilities
Contractholder funds: Derivatives embedded in life and annuity contracts	$	265		$	(74	)	$	—			$	2		$	(283	)
Liabilities held for sale	(265		)	(2		)	—				2			(249		)
Total recurring Level 3 liabilities	$	—		$	(76	)	$	—			$	4		$	(532	)
____________
-1	The effect to net income totals $126 million and is reported in the Condensed Consolidated Statements of Operations and Comprehensive Income as follows: $18 million in realized capital gains and losses, $12 million in net investment income, $40 million in interest credited to contractholder funds and $56 million in contract benefits.
(2)	Represents purchases for assets and issues for liabilities
-3	Comprises $6 million of assets and $16 million of liabilities.
The following table presents the rollforward of Level 3 assets and liabilities held at fair value on a recurring basis during the three months ended September 30, 2014.
($ in millions)				Total gains (losses)
				included in:
	Balance as of June 30, 2014			Net			OCI				Transfers			Transfers
				income (1)							into			out of
											Level 3			Level 3
Assets
Fixed income securities:
Municipal	$	102		$	—		$	—			$	—		$	—
Corporate	883			3			(13		)		18			—
ABS	105			—			1				—			—
CMBS	5			—			—				—			—
Total fixed income securities	1,095			3			(12		)		18			—
Equity securities	7			—			—				—			—
Free-standing derivatives, net	(5		)	—			—				—			—
Other assets	1			—			—				—			—
Total recurring Level 3 assets	$	1,098		$	3		$	(12	)		$	18		$	—
Liabilities
Contractholder funds: Derivatives embedded in life and annuity contracts	$	(331	)	$	9		$	—			$	—		$	—
Total recurring Level 3 liabilities	$	(331	)	$	9		$	—			$	—		$	—
	Purchases			Sales			Issues				Settlements			Balance as of September 30, 2014
Assets
Fixed income securities:
Municipal	$	—		$	(1	)	$	—			$	—		$	101
Corporate	4			(3		)	—				(53		)	839
ABS	10			—			—				(2		)	114
CMBS	—			—			—				—			5
Total fixed income securities	14			(4		)	—				(55		)	1,059
Equity securities	30			—			—				—			37
Free-standing derivatives, net	—			—			—				(1		)	(6		)	(2)
Other assets	—			—			—				—			1
Total recurring Level 3 assets	$	44		$	(4	)	$	—			$	(56	)	$	1,091
Liabilities
Contractholder funds: Derivatives embedded in life and annuity contracts	$	—		$	—		$	—			$	1		$	(321	)
Total recurring Level 3 liabilities	$	—		$	—		$	—			$	1		$	(321	)
____________
(1)	The effect to net income totals $12 million and is reported in the Condensed Consolidated Statements of Operations and Comprehensive Income as follows: $3 million in net investment income, $5 million in interest credited to contractholder funds and $4 million in contract benefits.
(2)	Comprises $3 million of assets and $9 million of liabilities.
Schedule of change in unrealized gains and losses included in net income for Level 3 assets and liabilities held	'
	The following table provides the change in unrealized gains and losses included in net income for Level 3 assets and liabilities held as of September 30.
	($ in millions)	Three months ended September 30,						Nine months ended September 30,
		2014			2013			2014				2013
	Assets
	Fixed income securities:
	Municipal	$	—		$	—		$	(1	)		$	(5	)
	Corporate	3			3			8				9
	ABS	—			—			—				(1		)
	CMBS	—			—			(1		)		(1		)
	Total fixed income securities	3			3			6				2
	Free-standing derivatives, net	—			(2		)	6				14
	Other assets	—			—			1				—
	Assets held for sale	—			(1		)	(1		)		(1		)
	Total recurring Level 3 assets	$	3		$	—		$	12			$	15
	Liabilities
	Contractholder funds: Derivatives embedded in life and annuity contracts	$	9		$	8		$	(5	)		$	77
	Liabilities held for sale	—			16			17				16
	Total recurring Level 3 liabilities	$	9		$	24		$	12			$	93
Schedule of carrying values and fair value estimates of financial instruments not carried at fair value	'
	Financial assets
	($ in millions)	September 30, 2014						December 31, 2013
		Carrying			Fair			Carrying				Fair
		value			value			value				value
	Mortgage loans	$	3,644		$	3,856		$	4,173			$	4,300
	Cost method limited partnerships	526			729			605				799
	Agent loans	364			357			341				325
	Bank loans	339			337			160				161
	Notes due from related party	275			275			275				275
	Assets held for sale	—			—			1,458				1,532
	Financial liabilities
	($ in millions)	September 30, 2014						December 31, 2013
		Carrying			Fair			Carrying				Fair
		value			value			value				value
	Contractholder funds on investment contracts	$	14,059		$	14,741		$	15,542			$	16,198
	Notes due to related parties	275			275			282				282
	Liability for collateral	479			479			328				328
	Liabilities held for sale	—			—			7,417				7,298

Derivative_Financial_Instrumen1

Derivative Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Summary of volume and fair value positions of derivative instruments and reporting location in the Condensed Consolidated Statement of Financial Position	'
	The following table provides a summary of the volume and fair value positions of derivative instruments as well as their reporting location in the Condensed Consolidated Statement of Financial Position as of September 30, 2014.
	($ in millions, except number of contracts)			Volume (1)
		Balance sheet location		Notional				Number		Fair				Gross			Gross
				amount				of		value,				asset			liability
								contracts		net
	Asset derivatives
	Derivatives designated as accounting hedging instruments
	Foreign currency swap agreements	Other investments		$	16			n/a		$	2			$	2		$	—
	Derivatives not designated as accounting hedging instruments
	Interest rate contracts
	Interest rate cap agreements	Other investments		95				n/a		—				—			—
	Financial futures contracts	Other assets		—				50		—				—			—
	Equity and index contracts
	Options	Other investments		—				2,932		65				65			—
	Financial futures contracts	Other assets		—				200		—				—			—
	Foreign currency contracts
	Foreign currency forwards	Other investments		62				n/a		4				4			—
	Credit default contracts
	Credit default swaps – buying protection	Other investments		22				n/a		—				—			—
	Credit default swaps – selling protection	Other investments		80				n/a		2				2			—
	Other contracts
	Other contracts	Other assets		3				n/a		1				1			—
	Subtotal			262				3,182		72				72			—
	Total asset derivatives			$	278			3,182		$	74			$	74		$	—
	Liability derivatives
	Derivatives designated as accounting hedging instruments
	Foreign currency swap agreements	Other liabilities & accrued expenses		$	119			n/a		$	(6	)		$	—		$	(6	)
	Derivatives not designated as accounting hedging instruments
	Interest rate contracts
	Interest rate swap agreements	Other liabilities & accrued expenses		85				n/a		3				3			—
	Interest rate cap agreements	Other liabilities & accrued expenses		90				n/a		2				2			—
	Equity and index contracts
	Options and futures	Other liabilities & accrued expenses		—				3,365		(20		)		—			(20		)
	Foreign currency contracts
	Foreign currency forwards	Other liabilities & accrued expenses		69				n/a		—				—			—
	Embedded derivative financial instruments
	Guaranteed accumulation benefits	Contractholder funds		650				n/a		(36		)		—			(36		)
	Guaranteed withdrawal benefits	Contractholder funds		453				n/a		(13		)		—			(13		)
	Equity-indexed and forward starting options in life and annuity product contracts	Contractholder funds		1,773				n/a		(269		)		—			(269		)
	Other embedded derivative financial instruments	Contractholder funds		85				n/a		(3		)		—			(3		)
	Credit default contracts
	Credit default swaps – buying protection	Other liabilities & accrued expenses		68				n/a		(1		)		—			(1		)
	Credit default swaps – selling protection	Other liabilities & accrued expenses		100				n/a		(9		)		—			(9		)
	Subtotal			3,373				3,365		(346		)		5			(351		)
	Total liability derivatives			3,492				3,365		(352		)		$	5		$	(357	)
	Total derivatives			$	3,770			6,547		$	(278	)
	___________
	(1)	Volume for OTC derivative contracts is represented by their notional amounts.  Volume for exchange traded derivatives is represented by the number of contracts, which is the basis on which they are traded.  (n/a =ot applicable)
	The following table provides a summary of the volume and fair value positions of derivative instruments as well as their reporting location in the Consolidated Statement of Financial Position as of December 31, 2013.
	($ in millions, except number of contracts)			Volume (1)
		Balance sheet location		Notional				Number		Fair				Gross			Gross
				amount				of		value,				asset			liability
								contracts		net
	Asset derivatives
	Derivatives designated as accounting hedging instruments
	Foreign currency swap agreements	Other investments		$	16			n/a		$	1			$	1		$	—
	Derivatives not designated as accounting hedging instruments
	Interest rate contracts
	Interest rate swaption agreements	Other investments		1,420				n/a		—				—			—
	Interest rate cap agreements	Other investments		61				n/a		2				2			—
	Equity and index contracts
	Options and warrants (2)	Other investments		3				10,035		261				261			—
	Financial futures contracts	Other assets		—				627		—				—			—
Foreign currency contracts
Foreign currency forwards	Other investments		47				n/a		—				—			—
Embedded derivative financial instruments
Credit default swaps	Fixed income securities		12				n/a		(12		)		—			(12		)
Credit default contracts
Credit default swaps – buying protection	Other investments		1				n/a		—				—			—
Credit default swaps – selling protection	Other investments		85				n/a		2				2			—
Other contracts
Other contracts	Other assets		4				n/a		—				—			—
Subtotal			1,633				10,662		253				265			(12		)
Total asset derivatives			$	1,649			10,662		$	254			$	266		$	(12	)
Liability derivatives
Derivatives designated as accounting hedging instruments
Foreign currency swap agreements	Other liabilities & accrued expenses		$	132			n/a		$	(15	)		$	—		$	(15	)
Derivatives not designated as accounting hedging instruments
Interest rate contracts
Interest rate swap agreements	Other liabilities & accrued expenses		85				n/a		4				4			—
Interest rate swaption agreements	Other liabilities & accrued expenses		4,570				n/a		1				1			—
Interest rate cap agreements	Other liabilities & accrued expenses		262				n/a		4				4			—
Equity and index contracts
Options	Other liabilities & accrued expenses		55				10,035		(165		)		2			(167		)
Embedded derivative financial instruments
Guaranteed accumulation benefits	Contractholder funds		738				n/a		(43		)		—			(43		)
Guaranteed withdrawal benefits	Contractholder funds		506				n/a		(13		)		—			(13		)
Equity-indexed and forward starting options in life and annuity product contracts	Contractholder funds		1,693				n/a		(247		)		—			(247		)
	Liabilities held for sale		2,363				n/a		(246		)		—			(246		)
Other embedded derivative financial instruments	Contractholder funds		85				n/a		(4		)		—			(4		)
Credit default contracts
Credit default swaps – buying protection	Other liabilities & accrued expenses		171				n/a		(2		)		—			(2		)
Credit default swaps – selling protection	Other liabilities & accrued expenses		100				n/a		(15		)		—			(15		)
Subtotal			10,628				10,035		(726		)		11			(737		)
Total liability derivatives			10,760				10,035		(741		)		$	11		$	(752	)
Total derivatives			$	12,409			20,697		$	(487	)
____________
(1)	Volume for OTC derivative contracts is represented by their notional amounts.  Volume for exchange traded derivatives is represented by the number of contracts, which is the basis on which they are traded.  (n/a =ot applicable)
(2)	In addition to the number of contracts presented in the table, the Company held 837,100 stock warrants.  Stock warrants can be converted to cash upon sale of those instruments or exercised for shares of common stock.
Schedule of gross and net amounts about the Company's OTC derivatives subject to enforceable master netting arrangements	'
	The following table provides gross and net amounts for the Company’s OTC derivatives, all of which are subject to enforceable master netting agreements.
	($ in millions)					Offsets
		Gross				Counter-			Cash				Net			Securities				Net
		amount				party			collateral				amount on			collateral				amount
						netting			(received)				balance			(received)
									pledged				sheet			pledged
	September 30, 2014
	Asset derivatives	$	12			$	(5	)	$	—			$	7		$	(2	)		$	5
	Liability derivatives	(16		)		5			—				(11		)	13				2
	December 31, 2013
	Asset derivatives	$	14			$	(11	)	$	—			$	3		$	(3	)		$	—
	Liability derivatives	(33		)		11			(4		)		(26		)	22				(4		)
Summary of impacts on operations and AOCI from foreign currency contracts, cash flow hedges	'
	The following table provides a summary of the impacts of the Company’s foreign currency contracts in cash flow hedging relationships.  Amortization of net losses from accumulated other comprehensive income related to cash flow hedges is expected to be $1 million during the next twelve months.  There was no hedge ineffectiveness reported in realized gains and losses for the three months and nine months ended September 30, 2014 or 2013.
	($ in millions)	Three months ended September 30,							Nine months ended September 30,
		2014				2013			2014				2013
	Gain (loss) recognized in OCI on derivatives during the period	$	10			$	(7	)	$	6			$	2
	Loss recognized in OCI on derivatives during the term of the hedging relationship	(4		)		(14		)	(4		)		(14		)
	Loss reclassified from AOCI into income (net investment income)	(1		)		—			(1		)		(1		)
	Loss reclassified from AOCI into income (realized capital gains and losses)	—				—			(2		)		—
Schedule of gains and losses from valuation, settlements, and hedge ineffectiveness, fair value hedges and derivatives not designated as hedges	'
	The following tables present gains and losses from valuation, settlements and hedge ineffectiveness reported on derivatives not designated as accounting hedging instruments in the Condensed Consolidated Statements of Operations and Comprehensive Income.  For the three months and nine months ended September 30, 2014 and 2013, the Company had no derivatives used in fair value hedging relationships.
	($ in millions)	Realized				Contract			Interest				Loss on			Total gain (loss)
		capital				benefits			credited to				disposition			recognized in
		gains and							contractholder				of			net income on
		losses							funds				operations			derivatives
	Three months ended September 30, 2014
	Interest rate contracts	$	—			$	—		$	—			$	—		$	—
	Equity and index contracts	—				—			4				—			4
	Embedded derivative financial instruments	—				4			6				—			10
	Foreign currency contracts	4				—			—				—			4
	Credit default contracts	—				—			—				—			—
	Other contracts	—				—			(1		)		—			(1		)
	Total	$	4			$	4		$	9			$	—		$	17
	Nine months ended September 30, 2014
	Interest rate contracts	$	(2	)		$	—		$	—			$	(4	)	$	(6	)
	Equity and index contracts	—				—			25				—			25
	Embedded derivative financial instruments	—				8			(5		)		—			3
	Foreign currency contracts	4				—			—				—			4
	Credit default contracts	7				—			—				—			7
	Other contracts	—				—			—				—			—
	Total	$	9			$	8		$	20			$	(4	)	$	33
		Realized				Contract			Interest				Total gain (loss)
		capital				benefits			credited to				recognized in
		gains and							contractholder				net income on
		losses							funds				derivatives
	Three months ended September 30, 2013
	Interest rate contracts	$	—			$	—		$	—			$	—
	Equity and index contracts	—				—			16				16
	Embedded derivative financial instruments	—				10			(9		)		1
	Foreign currency contracts	(2		)		—			—				(2		)
	Credit default contracts	(3		)		—			—				(3		)
	Other contracts	—				—			—				—
	Total	$	(5	)		$	10		$	7			$	12
	Nine months ended September 30, 2013
	Interest rate contracts	$	3			$	—		$	—			$	3
	Equity and index contracts	—				—			63				63
	Embedded derivative financial instruments	(1		)		56			(35		)		20
	Foreign currency contracts	(1		)		—			—				(1		)
	Credit default contracts	13				—			—				13
	Other contracts	—				—			(3		)		(3		)
	Total	$	14			$	56		$	25			$	95
Summary of counterparty credit exposure by counterparty credit rating	'
	The following table summarizes the counterparty credit exposure by counterparty credit rating as it relates to the Company’s OTC derivatives.
	($ in millions)		September 30, 2014													December 31, 2013
	Rating (1)		Number of			Notional			Credit				Exposure,			Number of			Notional				Credit		Exposure,
			counter-			amount (2)			exposure (2)				net of			counter-			amount (2)				exposure (2)		net of
			parties										collateral (2)			parties									collateral (2)
	A+		1			$	16		$	—			$	—		1			$	22			$	1	$	1
	A		3			97			6				3			4			1,523				2		—
	A-		1			8			1				1			1			24				1		—
	BBB+		1			11			—				—			1			3				—		—
	BBB		1			62			—				—			1			76				1		—
	Total		7			$	194		$	7			$	4		8			$	1,648			$	5	$	1
	__________
	(1)	Rating is the lower of S&P or Moody’s ratings.
	(2)	Only OTC derivatives with a net positive fair value are included for each counterparty.
Summary of derivative instruments with credit features in a liability position, including fair value of assets and collateral netted against the liability	'
	The following summarizes the fair value of derivative instruments with termination, cross-default or collateral credit-risk-contingent features that are in a liability position, as well as the fair value of assets and collateral that are netted against the liability in accordance with provisions within legally enforceable MNAs.
	($ in millions)	September 30, 2014				31-Dec-13
	Gross liability fair value of contracts containing credit-risk-contingent features	$	10			$	25
	Gross asset fair value of contracts containing credit-risk-contingent features and subject to MNAs	(3		)		(9		)
	Collateral posted under MNAs for contracts containing credit-risk-contingent features	(5		)		(14		)
	Maximum amount of additional exposure for contracts with credit-risk-contingent features if all features were triggered concurrently	$	2			$	2
Schedule of CDS notional amounts by credit rating and fair value of protection sold	'
	The following table shows the CDS notional amounts by credit rating and fair value of protection sold.
	($ in millions)	Notional amount
		AA				A			BBB				BB and			Total				Fair
													lower							value
	30-Sep-14
	Single name
	Corporate debt	$	—			$	—		$	—			$	—		$	—			$	—
	First-to-default Basket
	Municipal	—				100			—				—			100				(9		)
	Index
	Corporate debt	1				26			50				3			80				2
	Total	$	1			$	126		$	50			$	3		$	180			$	(7	)
	31-Dec-13
	Single name
	Corporate debt	$	—			$	5		$	—			$	—		$	5			$	—
	First-to-default Basket
	Municipal	—				100			—				—			100				(15		)
	Index
	Corporate debt	1				20			55				4			80				2
	Total	$	1			$	125		$	55			$	4		$	185			$	(13	)

Reinsurance_Tables

Reinsurance (Tables)	9 Months Ended
	Sep. 30, 2014
Reinsurance Disclosures [Abstract]	'
Effects of reinsurance on premiums and contract charges	'
	The effects of reinsurance on premiums and contract charges are as follows:
	($ in millions)	Three months ended September 30,						Nine months ended September 30,
		2014			2013			2014			2013
	Direct	$	185		$	518		$	893		$	1,553
	Assumed
	Affiliate	32			31			97			92
	Non-affiliate	199			17			410			51
	Ceded-non-affiliate	(82		)	(155		)	(307		)	(466		)
	Premiums and contract charges, net of reinsurance	$	334		$	411		$	1,093		$	1,230
Effects of reinsurance on contract benefits	'
	The effects of reinsurance on contract benefits are as follows:
	($ in millions)	Three months ended September 30,						Nine months ended September 30,
		2014			2013			2014			2013
	Direct	$	277		$	499		$	1,023		$	1,370
	Assumed
	Affiliate	20			20			66			60
	Non-affiliate	135			13			277			38
	Ceded-non-affiliate	(76		)	(110		)	(265		)	(269		)
	Contract benefits, net of reinsurance	$	356		$	422		$	1,101		$	1,199
Effects of reinsurance on interest credited to contractholder funds	'
	The effects of reinsurance on interest credited to contractholder funds are as follows:
	($ in millions)	Three months ended September 30,						Nine months ended September 30,
		2014			2013			2014			2013
	Direct	$	167		$	309		$	656		$	946
	Assumed
	Affiliate	2			2			6			7
	Non-affiliate	27			7			54			22
	Ceded-non-affiliate	(5		)	(8		)	(20		)	(22		)
	Interest credited to contractholder funds, net of reinsurance	$	191		$	310		$	696		$	953

Other_Comprehensive_Income_Tab

Other Comprehensive Income (Tables)	9 Months Ended
	Sep. 30, 2014
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]	'
Schedule of components of other comprehensive income on a pre-tax and after-tax basis	'
	The components of other comprehensive income (loss) on a pre-tax and after-tax basis are as follows:
	($ in millions)	Three months ended September 30,
		2014									2013
		Pre-			Tax			After-			Pre-			Tax			After-
		tax						tax			tax						tax
	Unrealized net holding gains and losses arising during the period, net of related offsets	$	58		$	(20	)	$	38		$	(76	)	$	27		$	(49	)
	Less: reclassification adjustment of realized capital gains and losses	21			(7		)	14			(6		)	2			(4		)
	Unrealized net capital gains and losses	37			(13		)	24			(70		)	25			(45		)
	Unrealized foreign currency translation adjustments	—			—			—			—			—			—
	Other comprehensive income (loss)	$	37		$	(13	)	$	24		$	(70	)	$	25		$	(45	)
	Net income (loss)							84									(394		)
	Comprehensive income (loss)							$	108								$	(439	)
		Nine months ended September 30,
		2014									2013
		Pre-			Tax			After-			Pre-			Tax			After-
		tax						tax			tax						tax
	Unrealized net holding gains and losses arising during the period, net of related offsets	$	525		$	(185	)	$	340		$	(860	)	$	302		$	(558	)
	Less: reclassification adjustment of realized capital gains and losses	(7		)	2			(5		)	35			(12		)	23
	Unrealized net capital gains and losses	532			(187		)	345			(895		)	314			(581		)
	Unrealized foreign currency translation adjustments	2			(1		)	1			—			—			—
	Other comprehensive income (loss)	$	534		$	(188	)	$	346		$	(895	)	$	314		$	(581	)
	Net income (loss)							343									(135		)
	Comprehensive income (loss)							$	689								$	(716	)

General_Details

General (Details) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Premiums and contract charges by product	'	'	'	'
Premiums	$142	$147	$441	$442
Contract charges	192	264	652	788
Total premiums and contract charges	334	411	1,093	1,230
Traditional life insurance	'	'	'	'
Premiums and contract charges by product	'	'	'	'
Premiums	120	114	365	342
Immediate annuities with life contingencies	'	'	'	'
Premiums and contract charges by product	'	'	'	'
Premiums	0	6	5	22
Accident and health insurance	'	'	'	'
Premiums and contract charges by product	'	'	'	'
Premiums	22	27	71	78
Interest-sensitive life insurance	'	'	'	'
Premiums and contract charges by product	'	'	'	'
Contract charges	188	258	638	775
Fixed annuities	'	'	'	'
Premiums and contract charges by product	'	'	'	'
Contract charges	$4	$6	$14	$13

Disposition_Details

Disposition (Details) (USD $)

3 Months Ended

9 Months Ended

0 Months Ended

3 Months Ended

9 Months Ended

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

Apr. 02, 2014

Sep. 30, 2014

Sep. 30, 2014

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Lincoln Benefit Life Company

Lincoln Benefit Life Company

Lincoln Benefit Life Company

Lincoln Benefit Life Company

Lincoln Benefit Life Company

Lincoln Benefit Life Company

Lincoln Benefit Life Company

Lincoln Benefit Life Company

Lincoln Benefit Life Company

Fixed income securities

Mortgage loans

Short-term investments

Policy loans

Other investments

Held for sale transaction

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from divestiture of businesses

'

'

$345,000,000

$0

'

$797,000,000

'

'

'

'

'

'

'

'

Cash proceeds from sale

'

'

'

'

'

596,000,000

'

'

'

'

'

'

'

'

Loss on disposition of operations

27,000,000

646,000,000

71,000,000

643,000,000

'

'

28,000,000

78,000,000

'

'

'

'

'

'

Loss on disposition, after-tax

'

'

'

'

'

'

29,000,000

38,000,000

'

'

'

'

'

'

Investments held by trust

'

'

'

'

'

'

5,080,000,000

5,080,000,000

'

'

'

'

'

'

Assets

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Investments

'

'

'

'

'

'

'

'

11,983,000,000

10,167,000,000

1,367,000,000

160,000,000

198,000,000

91,000,000

Cash

'

'

'

'

'

'

'

'

0

'

'

'

'

'

Deferred policy acquisition costs

'

'

'

'

'

'

'

'

743,000,000

'

'

'

'

'

Reinsurance recoverables, net

'

'

'

'

'

'

'

'

1,660,000,000

'

'

'

'

'

Accrued investment income

'

'

'

'

'

'

'

'

109,000,000

'

'

'

'

'

Other assets

'

'

'

'

'

'

'

'

79,000,000

'

'

'

'

'

Separate Accounts

'

'

'

'

'

'

'

'

1,701,000,000

'

'

'

'

'

Assets held for sale

'

'

'

'

'

'

'

'

16,275,000,000

'

'

'

'

'

Less: Loss accrual

'

'

'

'

'

'

'

'

-682,000,000

'

'

'

'

'

Total assets held for sale

0

'

0

'

15,593,000,000

'

'

'

15,593,000,000

'

'

'

'

'

Liabilities

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Reserve for life-contingent contract benefits

'

'

'

'

'

'

'

'

1,894,000,000

'

'

'

'

'

Contractholder funds

'

'

'

'

'

'

'

'

10,945,000,000

'

'

'

'

'

Unearned premiums

'

'

'

'

'

'

'

'

12,000,000

'

'

'

'

'

Deferred income taxes

'

'

'

'

'

'

'

'

151,000,000

'

'

'

'

'

Other liabilities and accrued expenses

'

'

'

'

'

'

'

'

196,000,000

'

'

'

'

'

Separate Accounts

'

'

'

'

'

'

'

'

1,701,000,000

'

'

'

'

'

Total liabilities held for sale

0

'

0

'

14,899,000,000

'

'

'

14,899,000,000

'

'

'

'

'

Accumulated other comprehensive income related to assets held for sale

'

'

'

'

'

'

'

'

$85,000,000

'

'

'

'

'

Supplemental_Cash_Flow_Informa2

Supplemental Cash Flow Information (Details) (USD $)	9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
Supplemental Cash Flow Information [Abstract]	'	'
Non-cash modifications of certain mortgage loans, fixed income securities, limited partnerships and other investments, as well as mergers completed with equity securities	$89	$259
Net change in proceeds managed	'	'
Net change in short-term investments	-151	199
Operating cash flow (used) provided	-151	199
Net change in cash	0	-1
Net change in proceeds managed	-151	198
Net change in liabilities	'	'
Liabilities for collateral, beginning of period	-328	-561
Liabilities for collateral, end of period	-479	-363
Operating cash flow provided (used)	$151	($198)

InvestmentsFair_Values_Details

Investments-Fair Values (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Millions, unless otherwise specified
Schedule of Available-for-sale Securities [Line Items]	'	'
Amortized cost	$25,931	$27,427
Gross unrealized gains	2,318	1,747
Gross unrealized losses	-159	-418
Fair value	28,090	28,756
U.S. government and agencies	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Amortized cost	683	678
Gross unrealized gains	97	90
Gross unrealized losses	0	-2
Fair value	780	766
Municipal	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Amortized cost	3,129	3,135
Gross unrealized gains	432	231
Gross unrealized losses	-14	-62
Fair value	3,547	3,304
Corporate	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Amortized cost	19,550	20,397
Gross unrealized gains	1,579	1,214
Gross unrealized losses	-113	-295
Fair value	21,016	21,316
Foreign government	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Amortized cost	660	715
Gross unrealized gains	80	83
Gross unrealized losses	-1	-6
Fair value	739	792
ABS	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Amortized cost	723	1,011
Gross unrealized gains	18	30
Gross unrealized losses	-23	-34
Fair value	718	1,007
Residential mortgage-backed securities ("RMBS")	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Amortized cost	602	752
Gross unrealized gains	59	50
Gross unrealized losses	-5	-12
Fair value	656	790
CMBS	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Amortized cost	570	724
Gross unrealized gains	50	47
Gross unrealized losses	-3	-7
Fair value	617	764
Redeemable preferred stock	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Amortized cost	14	15
Gross unrealized gains	3	2
Gross unrealized losses	0	0
Fair value	$17	$17

Investments_Scheduled_Maturiti

Investments- Scheduled Maturities (Details 2) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Millions, unless otherwise specified
Amortized cost	'	'
Due in one year or less	$1,282	'
Due after one year through five years	5,163	'
Due after five years through ten years	10,155	'
Due after ten years	7,436	'
Subtotal	24,036	'
ABS, RMBS and CMBS	1,895	'
Amortized cost	25,931	27,427
Fair value	'	'
Due in one year or less	1,304	'
Due after one year through five years	5,602	'
Due after five years through ten years	10,709	'
Due after ten years	8,484	'
Subtotal	26,099	'
ABS, RMBS and CMBS	1,991	'
Fair value	$28,090	$28,756

Investments_Net_Ivestment_Inco

Investments- Net Ivestment Income (Details 3) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Net investment income	'	'	'	'
Investment income, before expense	$480	$648	$1,667	$1,945
Investment expense	-19	-27	-55	-84
Net investment income	461	621	1,612	1,861
Fixed income securities	'	'	'	'
Net investment income	'	'	'	'
Investment income, before expense	349	487	1,179	1,477
Mortgage loans	'	'	'	'
Net investment income	'	'	'	'
Investment income, before expense	48	91	188	269
Equity securities	'	'	'	'
Net investment income	'	'	'	'
Investment income, before expense	7	3	17	8
Limited partnership interests	'	'	'	'
Net investment income	'	'	'	'
Investment income, before expense	51	37	209	104
Short-term investments	'	'	'	'
Net investment income	'	'	'	'
Investment income, before expense	0	0	1	1
Policy loans	'	'	'	'
Net investment income	'	'	'	'
Investment income, before expense	10	12	30	36
Other	'	'	'	'
Net investment income	'	'	'	'
Investment income, before expense	$15	$18	$43	$50

Investments_Realized_Capital_G

Investments- Realized Capital Gains and Losses (Details 4) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Realized capital gains and losses by asset type	'	'	'	'
Realized capital gains and losses	$28	($16)	$18	$61
Fixed income securities	'	'	'	'
Realized capital gains and losses by asset type	'	'	'	'
Realized capital gains and losses	-1	-12	-1	-6
Mortgage loans	'	'	'	'
Realized capital gains and losses by asset type	'	'	'	'
Realized capital gains and losses	2	-6	3	19
Equity securities	'	'	'	'
Realized capital gains and losses by asset type	'	'	'	'
Realized capital gains and losses	-5	5	11	37
Limited partnership interests	'	'	'	'
Realized capital gains and losses by asset type	'	'	'	'
Realized capital gains and losses	28	0	-5	-3
Derivatives	'	'	'	'
Realized capital gains and losses by asset type	'	'	'	'
Realized capital gains and losses	4	-5	7	14
Other	'	'	'	'
Realized capital gains and losses by asset type	'	'	'	'
Realized capital gains and losses	$0	$2	$3	$0

Investments_Realized_Capital_G1

Investments- Realized Capital Gains and Losses by Transaction Type (Details 5) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Investments [Abstract]	'	'	'	'
Impairment write-downs	$2	($10)	($2)	($28)
Change in intent write-downs	-21	-7	-40	-15
Net other-than-temporary impairment losses recognized in earnings	-19	-17	-42	-43
Sales	43	6	51	90
Valuation and settlements of derivative instruments	4	-5	9	14
Total realized capital gains and losses	28	-16	18	61
Fixed income securities	'	'	'	'
Investments [Abstract]	'	'	'	'
Net other-than-temporary impairment losses recognized in earnings	-3	-5	-3	-41
Total realized capital gains and losses	-1	-12	-1	-6
Schedule of Available for Sale Securities	'	'	'	'
Gross gains on sales of fixed income securities	23	18	76	117
Gross losses on sales of fixed income securities	$5	$16	$34	$40

Investments_Otherthantemporary

Investments- Other-than-temporary impairment losses (Details 6) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Other-than-temporary impairment losses by asset type	'	'	'	'
Total other-than-temporary impairment losses	($19)	($25)	($41)	($41)
Portion of loss recognized in other comprehensive income	0	8	-1	-2
Net other-than-temporary impairment losses recognized in earnings	-19	-17	-42	-43
Fixed income securities	'	'	'	'
Other-than-temporary impairment losses by asset type	'	'	'	'
Total other-than-temporary impairment losses	-3	-13	-2	-39
Portion of loss recognized in other comprehensive income	0	8	-1	-2
Net other-than-temporary impairment losses recognized in earnings	-3	-5	-3	-41
Municipal	'	'	'	'
Other-than-temporary impairment losses by asset type	'	'	'	'
Total other-than-temporary impairment losses	0	0	-1	-8
Portion of loss recognized in other comprehensive income	0	0	0	'
Net other-than-temporary impairment losses recognized in earnings	0	0	-1	-8
Corporate	'	'	'	'
Other-than-temporary impairment losses by asset type	'	'	'	'
Total other-than-temporary impairment losses	-3	'	-3	'
Portion of loss recognized in other comprehensive income	0	'	0	'
Net other-than-temporary impairment losses recognized in earnings	-3	'	-3	'
ABS	'	'	'	'
Other-than-temporary impairment losses by asset type	'	'	'	'
Total other-than-temporary impairment losses	0	0	-1	0
Portion of loss recognized in other comprehensive income	0	0	0	-1
Net other-than-temporary impairment losses recognized in earnings	0	0	-1	-1
RMBS	'	'	'	'
Other-than-temporary impairment losses by asset type	'	'	'	'
Total other-than-temporary impairment losses	0	-5	3	-4
Portion of loss recognized in other comprehensive income	0	4	-1	3
Net other-than-temporary impairment losses recognized in earnings	0	-1	2	-1
CMBS	'	'	'	'
Other-than-temporary impairment losses by asset type	'	'	'	'
Total other-than-temporary impairment losses	'	-8	'	-27
Portion of loss recognized in other comprehensive income	'	4	'	-4
Net other-than-temporary impairment losses recognized in earnings	'	-4	'	-31
Mortgage loans	'	'	'	'
Other-than-temporary impairment losses by asset type	'	'	'	'
Total other-than-temporary impairment losses	2	-6	6	11
Portion of loss recognized in other comprehensive income	0	0	0	0
Net other-than-temporary impairment losses recognized in earnings	2	-6	6	11
Equity securities	'	'	'	'
Other-than-temporary impairment losses by asset type	'	'	'	'
Total other-than-temporary impairment losses	-21	-4	-29	-5
Portion of loss recognized in other comprehensive income	0	0	0	0
Net other-than-temporary impairment losses recognized in earnings	-21	-4	-29	-5
Limited partnership interests	'	'	'	'
Other-than-temporary impairment losses by asset type	'	'	'	'
Total other-than-temporary impairment losses	3	-1	-16	-5
Portion of loss recognized in other comprehensive income	0	0	0	0
Net other-than-temporary impairment losses recognized in earnings	3	-1	-16	-5
Other	'	'	'	'
Other-than-temporary impairment losses by asset type	'	'	'	'
Total other-than-temporary impairment losses	'	-1	'	-3
Portion of loss recognized in other comprehensive income	'	0	'	0
Net other-than-temporary impairment losses recognized in earnings	'	($1)	'	($3)

Investments_Otherthantemporary1

Investments- Other-than-temporary losses included in AOCI (Details 7) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Millions, unless otherwise specified
Investments [Abstract]	'	'
Net unrealized gains related to changes in valuation of fixed income securities subsequent to impairment measurement date	$139	$164
Other-than-temporary impairment losses included in accumulated other comprehensive income	'	'
Amount of other-than-temporary impairment losses included in accumulated other comprehensive income for fixed income securities, not included in earnings	-72	-117
Municipal	'	'
Other-than-temporary impairment losses included in accumulated other comprehensive income	'	'
Amount of other-than-temporary impairment losses included in accumulated other comprehensive income for fixed income securities, not included in earnings	-5	-5
ABS	'	'
Other-than-temporary impairment losses included in accumulated other comprehensive income	'	'
Amount of other-than-temporary impairment losses included in accumulated other comprehensive income for fixed income securities, not included in earnings	-6	-10
RMBS	'	'
Other-than-temporary impairment losses included in accumulated other comprehensive income	'	'
Amount of other-than-temporary impairment losses included in accumulated other comprehensive income for fixed income securities, not included in earnings	-56	-90
CMBS	'	'
Other-than-temporary impairment losses included in accumulated other comprehensive income	'	'
Amount of other-than-temporary impairment losses included in accumulated other comprehensive income for fixed income securities, not included in earnings	($5)	($12)

Investments_Rollforward_of_Cum

Investments- Rollforward of Cumulative Credit Losses (Details 8) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Credit Losses on Fixed Income Securities	'	'	'	'
Beginning balance	($229)	($318)	($299)	($345)
Additional credit loss for securities previously other-than-temporarily impaired	0	0	2	-12
Additional credit loss for securities not previously other-than-temporarily impaired	-3	-2	-4	-19
Reduction in credit loss for securities disposed or collected	9	12	19	68
Reduction in credit loss for securities the Company has made the decision to sell or more likely than not will be required to sell	0	0	0	0
Change in credit loss due to accretion of increase in cash flows	1	0	1	0
Ending balance	-222	-308	-222	-308
LBL	'	'	'	'
Credit Losses on Fixed Income Securities	'	'	'	'
Reduction in credit loss for securities disposed or collected	$0	$0	$59	$0

InvestmentsUnrealized_Net_Capi

Investments-Unrealized Net Capitla Gains and Losses (Details 9) (USD $)	Sep. 30, 2014		Dec. 31, 2013
In Millions, unless otherwise specified
Fair value	'		'
Fixed income securities	$28,090		$28,756
Equity securities	1,229		650
Short-term investments	762		590
Derivative instruments	-4	[1]	-13
Gross unrealized Gains	'		'
Fixed income securities	2,318		1,747
Equity securities	138		90
Derivative instruments	1	[1]	1
Gross unrealized Losses	'		'
Fixed income securities	-159		-418
Equity securities	0		-5
Derivative instruments	-5	[1]	-14
Unrealized net gains (losses)	'		'
Fixed income securities	2,159		1,329
Equity securities	138		85
Derivative instruments	-4	[1]	-13
Equity method ("EMA") limited partnerships	-2		-2
Investments classified as held for sale	'		190
Unrealized net capital gains and losses, pre-tax	2,291		1,589
Amount recognized for:	'		'
Insurance reserves	-169	[2]	'
DAC and DSI	-157	[3]	-156
Amounts recognized	-326		-156
Deferred income taxes	-693		-506
Total unrealized net capital gains and losses	1,272		927
Fair value of derivative securities classified as assets, with unrealized net gains (losses) in AOCI	1		1
Fair value of derivative securities classified as liabilities, with unrealized net gains (losses) in AOCI	$5		$14
[1]	(1) Included in the fair value of derivative instruments are $1 million classified as assets and $5 million classified as liabilities.
[2]	(3) The insurance reserves adjustment represents the amount by which the reserve balance would increase if the net unrealized gains in the applicable product portfolios were realized and reinvested at current lower interest rates, resulting in a premium deficiency. Although the Company evaluates premium deficiencies on the combined performance of life insurance and immediate annuities with life contingencies, the adjustment primarily relates to structured settlement annuities with life contingencies, in addition to annuity buy-outs and certain payout annuities with life contingencies.
[3]	(4) The DAC and DSI adjustment balance represents the amount by which the amortization of DAC and DSI would increase or decrease if the unrealized gains or losses in the respective product portfolios were realized.

Investments_Change_in_Unrealiz

Investments- Change in Unrealized Net Capital Gains and Losses (Details 10) (USD $)	9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014
Change in Unrealized Gain (Loss) Recognized in Accumulated Other Comprehensive Income (Loss)	'
Change in unrealized net capital gains and losses	$702
Amount recognized for:	'
Insurance reserves	-169
DAC and DSI	-1
Amounts recognized	-170
Deferred income taxes	-187
Increase in unrealized net capital gains and losses, after-tax	345
Fixed income securities	'
Change in Unrealized Gain (Loss) Recognized in Accumulated Other Comprehensive Income (Loss)	'
Change in unrealized net capital gains and losses	830
Equity securities	'
Change in Unrealized Gain (Loss) Recognized in Accumulated Other Comprehensive Income (Loss)	'
Change in unrealized net capital gains and losses	53
Derivative instruments	'
Change in Unrealized Gain (Loss) Recognized in Accumulated Other Comprehensive Income (Loss)	'
Change in unrealized net capital gains and losses	9
Investments classified as held for sale	'
Change in Unrealized Gain (Loss) Recognized in Accumulated Other Comprehensive Income (Loss)	'
Change in unrealized net capital gains and losses	($190)

InvestmentsPortfolio_Monitorin

Investments-Portfolio Monitoring (Details 11) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Millions, unless otherwise specified	security	security
Fixed income and equity securities	'	'
Less than 12 months	'	'
Number of issues, continuous unrealized loss position for less than 12 months	335,000,000	686,000,000
Fair value, continuous unrealized loss position for less than 12 months	$2,112	$5,988
Unrealized losses, continuous unrealized loss position for less than 12 months	-36	-262
12 months or more	'	'
Number of issues, continuous unrealized loss position for 12 months or more (in Security)	222,000,000	165,000,000
Fair value, continuous unrealized loss position for 12 months or more	1,580	1,160
Unrealized losses, continuous unrealized loss position for 12 months or more	-123	-161
Total unrealized losses	'	'
Total unrealized losses	-159	-423
Fixed income securities	'	'
Less than 12 months	'	'
Number of issues, continuous unrealized loss position for less than 12 months	333,000,000	661,000,000
Fair value, continuous unrealized loss position for less than 12 months	2,104	5,908
Unrealized losses, continuous unrealized loss position for less than 12 months	-36	-257
12 months or more	'	'
Number of issues, continuous unrealized loss position for 12 months or more (in Security)	222,000,000	165,000,000
Fair value, continuous unrealized loss position for 12 months or more	1,580	1,160
Unrealized losses, continuous unrealized loss position for 12 months or more	-123	-161
Total unrealized losses	'	'
Gross unrealized losses	-159	-418
U.S. government and agencies	'	'
Less than 12 months	'	'
Number of issues, continuous unrealized loss position for less than 12 months	2,000,000	4,000,000
Fair value, continuous unrealized loss position for less than 12 months	21	76
Unrealized losses, continuous unrealized loss position for less than 12 months	0	-2
12 months or more	'	'
Number of issues, continuous unrealized loss position for 12 months or more (in Security)	0	0
Fair value, continuous unrealized loss position for 12 months or more	0	0
Unrealized losses, continuous unrealized loss position for 12 months or more	0	0
Total unrealized losses	'	'
Total unrealized losses	0	-2
Municipal	'	'
Less than 12 months	'	'
Number of issues, continuous unrealized loss position for less than 12 months	12,000,000	63,000,000
Fair value, continuous unrealized loss position for less than 12 months	98	347
Unrealized losses, continuous unrealized loss position for less than 12 months	-2	-24
12 months or more	'	'
Number of issues, continuous unrealized loss position for 12 months or more (in Security)	25,000,000	21,000,000
Fair value, continuous unrealized loss position for 12 months or more	143	99
Unrealized losses, continuous unrealized loss position for 12 months or more	-12	-38
Total unrealized losses	'	'
Total unrealized losses	-14	-62
Corporate	'	'
Less than 12 months	'	'
Number of issues, continuous unrealized loss position for less than 12 months	278,000,000	530,000,000
Fair value, continuous unrealized loss position for less than 12 months	1,844	5,191
Unrealized losses, continuous unrealized loss position for less than 12 months	-33	-224
12 months or more	'	'
Number of issues, continuous unrealized loss position for 12 months or more (in Security)	119,000,000	48,000,000
Fair value, continuous unrealized loss position for 12 months or more	1,064	467
Unrealized losses, continuous unrealized loss position for 12 months or more	-80	-71
Total unrealized losses	'	'
Total unrealized losses	-113	-295
Foreign government	'	'
Less than 12 months	'	'
Number of issues, continuous unrealized loss position for less than 12 months	1,000,000	7,000,000
Fair value, continuous unrealized loss position for less than 12 months	7	76
Unrealized losses, continuous unrealized loss position for less than 12 months	0	-4
12 months or more	'	'
Number of issues, continuous unrealized loss position for 12 months or more (in Security)	1,000,000	1,000,000
Fair value, continuous unrealized loss position for 12 months or more	14	13
Unrealized losses, continuous unrealized loss position for 12 months or more	-1	-2
Total unrealized losses	'	'
Total unrealized losses	-1	-6
ABS	'	'
Less than 12 months	'	'
Number of issues, continuous unrealized loss position for less than 12 months	18,000,000	17,000,000
Fair value, continuous unrealized loss position for less than 12 months	129	162
Unrealized losses, continuous unrealized loss position for less than 12 months	-1	-1
12 months or more	'	'
Number of issues, continuous unrealized loss position for 12 months or more (in Security)	26,000,000	42,000,000
Fair value, continuous unrealized loss position for 12 months or more	239	400
Unrealized losses, continuous unrealized loss position for 12 months or more	-22	-33
Total unrealized losses	'	'
Total unrealized losses	-23	-34
RMBS	'	'
Less than 12 months	'	'
Number of issues, continuous unrealized loss position for less than 12 months	18,000,000	35,000,000
Fair value, continuous unrealized loss position for less than 12 months	2	42
Unrealized losses, continuous unrealized loss position for less than 12 months	0	-2
12 months or more	'	'
Number of issues, continuous unrealized loss position for 12 months or more (in Security)	47,000,000	47,000,000
Fair value, continuous unrealized loss position for 12 months or more	77	129
Unrealized losses, continuous unrealized loss position for 12 months or more	-5	-10
Total unrealized losses	'	'
Total unrealized losses	-5	-12
CMBS	'	'
Less than 12 months	'	'
Number of issues, continuous unrealized loss position for less than 12 months	4,000,000	5,000,000
Fair value, continuous unrealized loss position for less than 12 months	3	14
Unrealized losses, continuous unrealized loss position for less than 12 months	0	0
12 months or more	'	'
Number of issues, continuous unrealized loss position for 12 months or more (in Security)	4,000,000	6,000,000
Fair value, continuous unrealized loss position for 12 months or more	43	52
Unrealized losses, continuous unrealized loss position for 12 months or more	-3	-7
Total unrealized losses	'	'
Total unrealized losses	-3	-7
Investment grade fixed income securities	'	'
Less than 12 months	'	'
Number of issues, continuous unrealized loss position for less than 12 months	143,000,000	526,000,000
Fair value, continuous unrealized loss position for less than 12 months	1,133	5,272
Unrealized losses, continuous unrealized loss position for less than 12 months	-12	-236
12 months or more	'	'
Number of issues, continuous unrealized loss position for 12 months or more (in Security)	172,000,000	110,000,000
Fair value, continuous unrealized loss position for 12 months or more	1,294	834
Unrealized losses, continuous unrealized loss position for 12 months or more	-87	-112
Total unrealized losses	'	'
Total unrealized losses	-99	-348
Below investment grade fixed income securities	'	'
Less than 12 months	'	'
Number of issues, continuous unrealized loss position for less than 12 months	190,000,000	135,000,000
Fair value, continuous unrealized loss position for less than 12 months	971	636
Unrealized losses, continuous unrealized loss position for less than 12 months	-24	-21
12 months or more	'	'
Number of issues, continuous unrealized loss position for 12 months or more (in Security)	50,000,000	55,000,000
Fair value, continuous unrealized loss position for 12 months or more	286	326
Unrealized losses, continuous unrealized loss position for 12 months or more	-36	-49
Total unrealized losses	'	'
Total unrealized losses	-60	-70
Equity securities	'	'
Less than 12 months	'	'
Number of issues, continuous unrealized loss position for less than 12 months	2,000,000	25,000,000
Fair value, continuous unrealized loss position for less than 12 months	8	80
Unrealized losses, continuous unrealized loss position for less than 12 months	0	-5
12 months or more	'	'
Number of issues, continuous unrealized loss position for 12 months or more (in Security)	0	0
Fair value, continuous unrealized loss position for 12 months or more	0	0
Unrealized losses, continuous unrealized loss position for 12 months or more	0	0
Total unrealized losses	'	'
Gross unrealized losses on equity securities	$0	($5)

Investments_Details_12

Investments (Details 12) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Millions, unless otherwise specified
Other details of unrealized loss	'	'
Unrealized losses related to securities with unrealized loss position less than 20% of amortized cost or cost	$121	'
Unrealized losses related to securities with unrealized loss position greater than or equal to 20% of amortized cost or cost	38	'
Limited partnership interests	1,933	2,064
Tax credit funds	285	'
Equity method limited partnerships	'	'
Other details of unrealized loss	'	'
Limited partnership interests	1,410	1,460
Cost method limited partnership interests	'	'
Other details of unrealized loss	'	'
Limited partnership interests	526	605
Investment grade fixed income securities	'	'
Other details of unrealized loss	'	'
Unrealized losses related to securities with unrealized loss position less than 20% of amortized cost or cost	75	'
Unrealized losses related to securities with unrealized loss position greater than or equal to 20% of amortized cost or cost	24	'
Below investment grade fixed income securities	'	'
Other details of unrealized loss	'	'
Unrealized losses related to securities with unrealized loss position greater than or equal to 20% of amortized cost or cost	14	'
Unrealized losses related to securities with unrealized loss position greater than 20% of cost or amortized cost, unrealized loss position of 12 or more consecutive months	$10	'

InvestmentsCarrying_Value_of_N

Investments-Carrying Value of Non-impaired Fixed Rate and Variable Rate Morgage Loans (Details 13) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013
Carrying value of non-impaired fixed rate and variable rate mortgage loans by debt service coverage ratio distribution	'	'	'	'	'
Total mortgage loans	$3,644	'	$3,644	'	$4,173
Net carrying value of impaired mortgage loans	'	'	'	'	'
Impaired mortgage loans with a valuation allowance	10	'	10	'	77
Impaired mortgage loans without a valuation allowance	0	'	0	'	0
Total impaired mortgage loans	10	'	10	'	77
Valuation allowance on impaired mortgage loans	7	25	7	25	'
Rollforward of the valuation allowance on impaired mortgage loans	'	'	'	'	'
Beginning balance	9	21	21	42	'
Valuation Allowances and Reserves, Period Increase (Decrease)	-2	6	-6	-11	'
Charge offs	0	0	-8	-4	'
Mortgage loans classified as held for sale	0	-2	0	-2	'
Ending balance	7	25	7	25	'
Non-impaired mortgage loans	'	'	'	'	'
Carrying value of non-impaired fixed rate and variable rate mortgage loans by debt service coverage ratio distribution	'	'	'	'	'
Fixed rate mortgage loans	3,632	'	3,632	'	4,056
Variable rate mortgage loans	2	'	2	'	40
Total mortgage loans	3,634	'	3,634	'	4,096
Non-impaired mortgage loans | Below 1.0	'	'	'	'	'
Carrying value of non-impaired fixed rate and variable rate mortgage loans by debt service coverage ratio distribution	'	'	'	'	'
Fixed rate mortgage loans	186	'	186	'	153
Variable rate mortgage loans	0	'	0	'	0
Total mortgage loans	186	'	186	'	153
Non-impaired mortgage loans | 1.0 - 1.25	'	'	'	'	'
Carrying value of non-impaired fixed rate and variable rate mortgage loans by debt service coverage ratio distribution	'	'	'	'	'
Fixed rate mortgage loans	351	'	351	'	560
Variable rate mortgage loans	0	'	0	'	0
Total mortgage loans	351	'	351	'	560
Non-impaired mortgage loans | 1.26 - 1.50	'	'	'	'	'
Carrying value of non-impaired fixed rate and variable rate mortgage loans by debt service coverage ratio distribution	'	'	'	'	'
Fixed rate mortgage loans	1,178	'	1,178	'	1,167
Variable rate mortgage loans	2	'	2	'	2
Total mortgage loans	1,180	'	1,180	'	1,169
Non-impaired mortgage loans | Above 1.50	'	'	'	'	'
Carrying value of non-impaired fixed rate and variable rate mortgage loans by debt service coverage ratio distribution	'	'	'	'	'
Fixed rate mortgage loans	1,917	'	1,917	'	2,176
Variable rate mortgage loans	0	'	0	'	38
Total mortgage loans	1,917	'	1,917	'	2,214
Mortgage loans	'	'	'	'	'
Average carrying value and interest income recognized on impaired mortgage loans	'	'	'	'	'
Average balance impaired mortgage loans	'	'	$29	$88	'

Fair_Value_of_Assets_and_Liabi2

Fair Value of Assets and Liabilities (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013	Sep. 30, 2013
In Millions, unless otherwise specified
Assets	'	'	'
Fixed income securities	$28,090	$28,756	'
Equity securities	1,229	650	'
Short-term Investments	762	590	'
Other investments:	'	'	'
Free-standing derivatives, assets	3	'	6
Separate account assets	4,521	5,039	'
Derivative asset, fair value, gross liability and obligation to return cash, offset	-5	-11	'
% of total assets at fair value	0.00%	0.00%	'
Other liabilities:	'	'	'
Free-standing derivatives, liabilities	-9	'	-16
Liabilities held for sale	0	-14,899	'
Total liabilities at fair value	5	7	'
% of total liabilities at fair value	-1.40%	-0.10%	'
LBL	'	'	'
Other investments:	'	'	'
Assets held for sale	'	15,593	'
Other liabilities:	'	'	'
Liabilities held for sale	'	-14,899	'
U.S. government and agencies	'	'	'
Assets	'	'	'
Fixed income securities	780	766	'
Municipal	'	'	'
Assets	'	'	'
Fixed income securities	3,547	3,304	'
Corporate	'	'	'
Assets	'	'	'
Fixed income securities	21,016	21,316	'
Foreign government	'	'	'
Assets	'	'	'
Fixed income securities	739	792	'
ABS	'	'	'
Assets	'	'	'
Fixed income securities	718	1,007	'
RMBS	'	'	'
Assets	'	'	'
Fixed income securities	656	790	'
CMBS	'	'	'
Assets	'	'	'
Fixed income securities	617	764	'
Redeemable preferred stock	'	'	'
Assets	'	'	'
Fixed income securities	17	17	'
Quoted prices in active markets for identical assets (Level 1)	'	'	'
Other investments:	'	'	'
Total assets at fair value	5,881	7,760	'
% of total assets at fair value	17.00%	16.40%	'
Other liabilities:	'	'	'
Total liabilities at fair value	0	0	'
% of total liabilities at fair value	0.00%	0.00%	'
Significant other observable inputs (Level 2)	'	'	'
Other investments:	'	'	'
Total assets at fair value	27,700	37,962	'
% of total assets at fair value	79.80%	80.20%	'
Other liabilities:	'	'	'
Total liabilities at fair value	-27	-185	'
% of total liabilities at fair value	7.70%	1.60%	'
Significant unobservable inputs (Level 3)	'	'	'
Other investments:	'	'	'
Total assets at fair value	1,115	1,635	'
% of total assets at fair value	3.20%	3.40%	'
Other liabilities:	'	'	'
Total liabilities at fair value	-330	-11,655	'
% of total liabilities at fair value	93.70%	98.50%	'
Recurring basis	'	'	'
Other investments:	'	'	'
Free standing derivative assets, derivative asset, fair value, gross asset and right to reclaim cash, offset	-5	-11	'
Derivative asset, fair value, gross liability and obligation to return cash, offset	-5	-11	'
Other liabilities:	'	'	'
Free standing derivative liabilities derivative liability, fair value, gross asset and right to reclaim cash, offset	5	7	'
Derivative liability, fair value, gross asset and right to reclaim cash, offset	'	7	'
Recurring basis | LBL	'	'	'
Other investments:	'	'	'
Assets held for sale	'	12,028	'
Other liabilities:	'	'	'
Liabilities held for sale	'	-246	'
Recurring basis | Quoted prices in active markets for identical assets (Level 1)	'	'	'
Assets	'	'	'
Fixed income securities	146	145	'
Equity securities	1,138	593	'
Short-term Investments	76	129	'
Other investments:	'	'	'
Free-standing derivatives, assets	0	0	'
Separate account assets	4,521	5,039	'
Other assets	0	'	'
Assets held for sale	'	1,854	'
Total assets at fair value	5,881	7,760	'
Other liabilities:	'	'	'
Free-standing derivatives, liabilities	0	0	'
Liabilities held for sale	'	0	'
Total liabilities at fair value	'	0	'
Recurring basis | Quoted prices in active markets for identical assets (Level 1) | U.S. government and agencies	'	'	'
Assets	'	'	'
Fixed income securities	146	145	'
Recurring basis | Quoted prices in active markets for identical assets (Level 1) | Municipal	'	'	'
Assets	'	'	'
Fixed income securities	0	0	'
Recurring basis | Quoted prices in active markets for identical assets (Level 1) | Corporate	'	'	'
Assets	'	'	'
Fixed income securities	0	0	'
Recurring basis | Quoted prices in active markets for identical assets (Level 1) | Foreign government	'	'	'
Assets	'	'	'
Fixed income securities	0	0	'
Recurring basis | Quoted prices in active markets for identical assets (Level 1) | ABS	'	'	'
Assets	'	'	'
Fixed income securities	0	0	'
Recurring basis | Quoted prices in active markets for identical assets (Level 1) | RMBS	'	'	'
Assets	'	'	'
Fixed income securities	0	0	'
Recurring basis | Quoted prices in active markets for identical assets (Level 1) | CMBS	'	'	'
Assets	'	'	'
Fixed income securities	0	0	'
Recurring basis | Quoted prices in active markets for identical assets (Level 1) | Redeemable preferred stock	'	'	'
Assets	'	'	'
Fixed income securities	0	0	'
Recurring basis | Significant other observable inputs (Level 2)	'	'	'
Assets	'	'	'
Fixed income securities	26,885	27,370	'
Equity securities	54	51	'
Short-term Investments	686	461	'
Other investments:	'	'	'
Free-standing derivatives, assets	75	268	'
Separate account assets	0	0	'
Other assets	0	'	'
Assets held for sale	'	9,812	'
Total assets at fair value	27,700	37,962	'
Other liabilities:	'	'	'
Free-standing derivatives, liabilities	-27	-185	'
Liabilities held for sale	'	0	'
Total liabilities at fair value	'	-185	'
Recurring basis | Significant other observable inputs (Level 2) | U.S. government and agencies	'	'	'
Assets	'	'	'
Fixed income securities	634	621	'
Recurring basis | Significant other observable inputs (Level 2) | Municipal	'	'	'
Assets	'	'	'
Fixed income securities	3,446	3,185	'
Recurring basis | Significant other observable inputs (Level 2) | Corporate	'	'	'
Assets	'	'	'
Fixed income securities	20,177	20,308	'
Recurring basis | Significant other observable inputs (Level 2) | Foreign government	'	'	'
Assets	'	'	'
Fixed income securities	739	792	'
Recurring basis | Significant other observable inputs (Level 2) | ABS	'	'	'
Assets	'	'	'
Fixed income securities	604	895	'
Recurring basis | Significant other observable inputs (Level 2) | RMBS	'	'	'
Assets	'	'	'
Fixed income securities	656	790	'
Recurring basis | Significant other observable inputs (Level 2) | CMBS	'	'	'
Assets	'	'	'
Fixed income securities	612	763	'
Recurring basis | Significant other observable inputs (Level 2) | Redeemable preferred stock	'	'	'
Assets	'	'	'
Fixed income securities	17	16	'
Recurring basis | Significant unobservable inputs (Level 3)	'	'	'
Assets	'	'	'
Fixed income securities	1,059	1,241	'
Equity securities	37	6	'
Short-term Investments	0	0	'
Other investments:	'	'	'
Free-standing derivatives, assets	3	9	'
Separate account assets	0	0	'
Other assets	1	'	'
Assets held for sale	'	362	'
Total assets at fair value	1,100	1,618	'
Other liabilities:	'	'	'
Free-standing derivatives, liabilities	-9	-14	'
Liabilities held for sale	'	-246	'
Total liabilities at fair value	'	-567	'
Recurring basis | Significant unobservable inputs (Level 3) | U.S. government and agencies	'	'	'
Assets	'	'	'
Fixed income securities	0	0	'
Recurring basis | Significant unobservable inputs (Level 3) | Municipal	'	'	'
Assets	'	'	'
Fixed income securities	101	119	'
Recurring basis | Significant unobservable inputs (Level 3) | Corporate	'	'	'
Assets	'	'	'
Fixed income securities	839	1,008	'
Recurring basis | Significant unobservable inputs (Level 3) | Foreign government	'	'	'
Assets	'	'	'
Fixed income securities	0	0	'
Recurring basis | Significant unobservable inputs (Level 3) | ABS	'	'	'
Assets	'	'	'
Fixed income securities	114	112	'
Recurring basis | Significant unobservable inputs (Level 3) | RMBS	'	'	'
Assets	'	'	'
Fixed income securities	0	0	'
Recurring basis | Significant unobservable inputs (Level 3) | CMBS	'	'	'
Assets	'	'	'
Fixed income securities	5	1	'
Recurring basis | Significant unobservable inputs (Level 3) | Redeemable preferred stock	'	'	'
Assets	'	'	'
Fixed income securities	0	1	'
Non-recurring basis	'	'	'
Other investments:	'	'	'
Derivative asset, fair value, gross liability and obligation to return cash, offset	'	'	'
Non-recurring basis | Quoted prices in active markets for identical assets (Level 1)	'	'	'
Other investments:	'	'	'
Total assets at fair value	0	0	'
Other liabilities:	'	'	'
Total liabilities at fair value	'	0	'
Non-recurring basis | Significant other observable inputs (Level 2)	'	'	'
Other investments:	'	'	'
Total assets at fair value	0	0	'
Other liabilities:	'	'	'
Total liabilities at fair value	'	0	'
Non-recurring basis | Significant unobservable inputs (Level 3)	'	'	'
Other investments:	'	'	'
Total assets at fair value	15	17	'
Other liabilities:	'	'	'
Total liabilities at fair value	'	-11,088	'
Derivatives embedded in life and annuity contracts | Recurring basis | Quoted prices in active markets for identical assets (Level 1)	'	'	'
Contract holder funds:	'	'	'
Derivatives embedded in life and annuity contracts	0	0	'
Derivatives embedded in life and annuity contracts | Recurring basis | Significant other observable inputs (Level 2)	'	'	'
Contract holder funds:	'	'	'
Derivatives embedded in life and annuity contracts	0	0	'
Derivatives embedded in life and annuity contracts | Recurring basis | Significant unobservable inputs (Level 3)	'	'	'
Contract holder funds:	'	'	'
Derivatives embedded in life and annuity contracts	-321	-307	'
Fair Value	'	'	'
Other investments:	'	'	'
Total assets at fair value	34,691	47,346	'
% of total assets at fair value	100.00%	100.00%	'
Mortgage loans	'	8	'
Limited partnership interests	15	9	'
Other liabilities:	'	'	'
Liabilities held for sale	0	-7,298	'
Total liabilities at fair value	-352	-11,833	'
% of total liabilities at fair value	100.00%	100.00%	'
Fair Value | Recurring basis	'	'	'
Assets	'	'	'
Fixed income securities	28,090	28,756	'
Equity securities	1,229	650	'
Short-term Investments	762	590	'
Other investments:	'	'	'
Free-standing derivatives, assets	73	266	'
Separate account assets	4,521	5,039	'
Other assets	1	'	'
Assets held for sale	'	12,028	'
Total assets at fair value	34,676	47,329	'
Other liabilities:	'	'	'
Free-standing derivatives, liabilities	-31	-192	'
Liabilities held for sale	'	-246	'
Total liabilities at fair value	'	-745	'
Fair Value | Recurring basis | U.S. government and agencies	'	'	'
Assets	'	'	'
Fixed income securities	780	766	'
Fair Value | Recurring basis | Municipal	'	'	'
Assets	'	'	'
Fixed income securities	3,547	3,304	'
Fair Value | Recurring basis | Corporate	'	'	'
Assets	'	'	'
Fixed income securities	21,016	21,316	'
Fair Value | Recurring basis | Foreign government	'	'	'
Assets	'	'	'
Fixed income securities	739	792	'
Fair Value | Recurring basis | ABS	'	'	'
Assets	'	'	'
Fixed income securities	718	1,007	'
Fair Value | Recurring basis | RMBS	'	'	'
Assets	'	'	'
Fixed income securities	656	790	'
Fair Value | Recurring basis | CMBS	'	'	'
Assets	'	'	'
Fixed income securities	617	764	'
Fair Value | Recurring basis | Redeemable preferred stock	'	'	'
Assets	'	'	'
Fixed income securities	17	17	'
Fair Value | Non-recurring basis	'	'	'
Other investments:	'	'	'
Total assets at fair value	15	17	'
Other liabilities:	'	'	'
Total liabilities at fair value	'	-11,088	'
Fair Value | Derivatives embedded in life and annuity contracts | Recurring basis	'	'	'
Contract holder funds:	'	'	'
Derivatives embedded in life and annuity contracts	($321)	($307)	'

Fair_Value_of_Assets_and_Liabi3

Fair Value of Assets and Liabilities (Level 3 Fair Value Measurment) (Details) (Significant unobservable inputs (Level 3), USD $)	9 Months Ended	12 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Quantitative information about the significant unobservable inputs	'	'
Fair value	$1,115	$1,635
Derivatives embedded in life and annuity contracts - Equity-indexed and forward starting options | Stochastic cash flow model	'	'
Quantitative information about the significant unobservable inputs	'	'
Fair value	-269	-247
Weighted average projected option cost (as a percent)	1.76%	1.75%
Derivatives embedded in life and annuity contracts - Equity-indexed and forward starting options | Minimum | Stochastic cash flow model	'	'
Quantitative information about the significant unobservable inputs	'	'
Projected option cost (as a percent)	1.00%	1.00%
Derivatives embedded in life and annuity contracts - Equity-indexed and forward starting options | Maximum | Stochastic cash flow model	'	'
Quantitative information about the significant unobservable inputs	'	'
Projected option cost (as a percent)	2.00%	2.00%
Fixed income securities - non-binding broker quotes	'	'
Quantitative information about the significant unobservable inputs	'	'
Fair value	980	1,150
Fair value	'	319
Liabilities held for sale - Equity-indexed and forward starting options | Stochastic cash flow model	'	'
Quantitative information about the significant unobservable inputs	'	'
Fair value	'	($246)
Weighted average projected option cost (as a percent)	'	1.91%
Liabilities held for sale - Equity-indexed and forward starting options | Minimum | Stochastic cash flow model	'	'
Quantitative information about the significant unobservable inputs	'	'
Projected option cost (as a percent)	'	1.00%
Liabilities held for sale - Equity-indexed and forward starting options | Maximum | Stochastic cash flow model	'	'
Quantitative information about the significant unobservable inputs	'	'
Projected option cost (as a percent)	'	2.00%

Fair_Value_of_Assets_and_Liabi4

Fair Value of Assets and Liabilities (Level 3 Assets and Liabilities) (Details) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Fair Value Disclosures [Abstract]	'	'	'	'
Assets transferred between Level 1 and Level 2	$0	$0	$0	$0
Liabilities transferred between Level 1 and Level 2	0	0	0	0
Rollforward of Level 3 assets held at fair value on a recurring basis	'	'	'	'
Balance at beginning of period	1,098	1,676	1,604	2,041
Total gains (losses) included in: Net income	3	5	14	33
Total gains (losses) included in: OCI	-12	11	3	10
Transfers into Level 3	18	24	22	104
Transfers out of Level 3	0	-2	-57	-186
Balance at beginning of period	-331	-533	-553	-553
Total gains (losses) included in: net income	9	24	12	93
Sold in LBL disposition	'	'	-347	'
Sold in LBL disposition	'	'	230	'
Transfer from held for sale	'	0	'	0
Transfer from held for sale	'	0	'	0
Purchases/Issues	44	40	70	134
Issues	0	-26	-17	-76
Sales	-4	-39	-104	-322
Sales	0	0	0	0
Settlements	-56	-58	-114	-157
Settlements	1	3	7	4
Balance at end of period	1,091	1,657	1,091	1,657
Balance at end of period	-321	-532	-321	-532
Fixed income securities	'	'	'	'
Rollforward of Level 3 assets held at fair value on a recurring basis	'	'	'	'
Balance at beginning of period	1,095	1,676	1,241	2,060
Total gains (losses) included in: Net income	3	8	13	14
Total gains (losses) included in: OCI	-12	19	1	18
Transfers into Level 3	18	21	18	101
Transfers out of Level 3	0	0	-55	-184
Sold in LBL disposition	'	'	4	'
Transfer from held for sale	'	-385	'	-385
Purchases/Issues	14	39	37	132
Sales	-4	-29	-96	-311
Settlements	-55	-54	-104	-150
Balance at end of period	1,059	1,295	1,059	1,295
Municipal	'	'	'	'
Rollforward of Level 3 assets held at fair value on a recurring basis	'	'	'	'
Balance at beginning of period	102	225	119	338
Total gains (losses) included in: Net income	0	0	-1	-12
Total gains (losses) included in: OCI	0	1	3	21
Transfers into Level 3	0	0	0	0
Transfers out of Level 3	0	0	-17	0
Sold in LBL disposition	'	'	0	'
Transfer from held for sale	'	-51	'	-51
Purchases/Issues	0	0	0	0
Sales	-1	-1	-3	-122
Settlements	0	0	0	0
Balance at end of period	101	174	101	174
Corporate	'	'	'	'
Rollforward of Level 3 assets held at fair value on a recurring basis	'	'	'	'
Balance at beginning of period	883	1,255	1,008	1,501
Total gains (losses) included in: Net income	3	8	14	28
Total gains (losses) included in: OCI	-13	1	-4	-37
Transfers into Level 3	18	21	18	84
Transfers out of Level 3	0	0	-26	-168
Sold in LBL disposition	'	'	0	'
Transfer from held for sale	'	-244	'	-244
Purchases/Issues	4	39	16	132
Sales	-3	-28	-92	-164
Settlements	-53	-49	-95	-129
Balance at end of period	839	1,003	839	1,003
ABS	'	'	'	'
Rollforward of Level 3 assets held at fair value on a recurring basis	'	'	'	'
Balance at beginning of period	105	190	112	199
Total gains (losses) included in: Net income	0	0	0	-1
Total gains (losses) included in: OCI	1	15	2	30
Transfers into Level 3	0	0	0	17
Transfers out of Level 3	0	0	-12	-16
Sold in LBL disposition	'	'	0	'
Transfer from held for sale	'	-85	'	-85
Purchases/Issues	10	0	21	0
Sales	0	0	0	-8
Settlements	-2	-5	-9	-21
Balance at end of period	114	115	114	115
CMBS	'	'	'	'
Rollforward of Level 3 assets held at fair value on a recurring basis	'	'	'	'
Balance at beginning of period	5	5	1	21
Total gains (losses) included in: Net income	0	0	0	-1
Total gains (losses) included in: OCI	0	2	0	4
Transfers into Level 3	0	0	0	0
Transfers out of Level 3	0	0	0	0
Sold in LBL disposition	'	'	4	'
Transfer from held for sale	'	-5	'	-5
Purchases/Issues	0	0	0	0
Sales	0	0	0	-17
Settlements	0	0	0	0
Balance at end of period	5	2	5	2
Redeemable preferred stock	'	'	'	'
Rollforward of Level 3 assets held at fair value on a recurring basis	'	'	'	'
Balance at beginning of period	'	1	1	1
Total gains (losses) included in: Net income	'	0	0	0
Total gains (losses) included in: OCI	'	0	0	0
Transfers into Level 3	'	0	0	0
Transfers out of Level 3	'	0	0	0
Sold in LBL disposition	'	'	0	'
Transfer from held for sale	'	0	'	0
Purchases/Issues	'	0	0	0
Sales	'	0	-1	0
Settlements	'	0	0	0
Balance at end of period	0	1	0	1
Equity securities	'	'	'	'
Rollforward of Level 3 assets held at fair value on a recurring basis	'	'	'	'
Balance at beginning of period	7	6	6	7
Total gains (losses) included in: Net income	0	0	0	0
Total gains (losses) included in: OCI	0	0	0	0
Transfers into Level 3	0	0	0	0
Transfers out of Level 3	0	0	0	0
Sold in LBL disposition	'	'	0	'
Transfer from held for sale	'	0	'	0
Purchases/Issues	30	0	31	0
Sales	0	0	0	-1
Settlements	0	0	0	0
Balance at end of period	37	6	37	6
Free-standing derivatives, net	'	'	'	'
Rollforward of Level 3 assets held at fair value on a recurring basis	'	'	'	'
Balance at beginning of period	-5	-7	-5	-27
Total gains (losses) included in: Net income	0	-2	1	20
Total gains (losses) included in: OCI	0	0	0	0
Transfers into Level 3	0	0	0	0
Transfers out of Level 3	0	0	0	0
Sold in LBL disposition	'	'	0	'
Transfer from held for sale	'	0	'	0
Purchases/Issues	0	1	2	2
Sales	0	0	0	0
Settlements	-1	-2	-4	-5
Balance at end of period	-6	-10	-6	-10
Other assets	'	'	'	'
Rollforward of Level 3 assets held at fair value on a recurring basis	'	'	'	'
Balance at beginning of period	1	1	0	1
Total gains (losses) included in: Net income	'	0	1	0
Total gains (losses) included in: OCI	0	0	0	0
Transfers into Level 3	0	0	0	0
Transfers out of Level 3	0	0	0	0
Sold in LBL disposition	'	'	0	'
Transfer from held for sale	'	0	'	0
Purchases/Issues	0	0	0	'
Sales	0	0	0	0
Settlements	0	0	0	0
Balance at end of period	1	1	1	1
Assets held for sale	'	'	'	'
Rollforward of Level 3 assets held at fair value on a recurring basis	'	'	'	'
Balance at beginning of period	'	0	362	0
Total gains (losses) included in: Net income	'	-1	-1	-1
Total gains (losses) included in: OCI	'	-8	2	-8
Transfers into Level 3	'	3	4	3
Transfers out of Level 3	'	-2	-2	-2
Sold in LBL disposition	'	'	-351	'
Transfer from held for sale	'	385	'	385
Purchases/Issues	'	0	0	0
Sales	'	-10	-8	-10
Settlements	'	-2	-6	-2
Balance at end of period	0	365	0	365
Derivatives embedded in life and annuity contracts	'	'	'	'
Rollforward of Level 3 assets held at fair value on a recurring basis	'	'	'	'
Balance at beginning of period	-331	-533	-307	-553
Total gains (losses) included in: net income	9	8	-5	77
Sold in LBL disposition	'	'	0	'
Transfer from held for sale	'	265	'	265
Issues	0	-24	-13	-74
Sales	0	0	0	0
Settlements	1	1	4	2
Balance at end of period	-321	-283	-321	-283
Liabilities held for sale	'	'	'	'
Rollforward of Level 3 assets held at fair value on a recurring basis	'	'	'	'
Balance at beginning of period	'	0	-246	0
Total gains (losses) included in: net income	0	16	17	16
Sold in LBL disposition	'	'	230	'
Transfer from held for sale	'	-265	'	-265
Issues	'	-2	-4	-2
Sales	'	0	0	0
Settlements	'	2	3	2
Balance at end of period	'	-249	'	-249
Balance at end of period	'	$0	'	$0

Fair_Value_of_Assets_and_Liabi5

Fair Value of Assets and Liabilities (Level 3 Assets and Liabilities)(Footnotes to Table) (Details) (USD $)

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

In Millions, unless otherwise specified

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Mar. 31, 2014

Mar. 31, 2014

Net investment income

Net investment income

Net investment income

Net investment income

Interest credited to contractholder funds

Interest credited to contractholder funds

Interest credited to contractholder funds

Interest credited to contractholder funds

Contract benefits

Contract benefits

Contract benefits

Contract benefits

Loss on disposition of operations

Realized capital gains and losses

Realized capital gains and losses

Realized capital gains and losses

CMBS

CMBS

CMBS

CMBS

ABS

ABS

ABS

ABS

LBL

LBL

CMBS

ABS

Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Fair Value, Assets and Liabilities Measured on Recurring Basis, Gain (Loss) Included in Earnings

$12

$29

$26

$126

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Total gains (losses) included in: Net income

3

5

14

33

3

3

9

12

5

15

'

40

-4

10

8

56

-4

1

8

18

0

0

0

-1

0

0

0

-1

'

'

Gains (losses) for Level 3 assets and liabilities still held at the balance sheet date

'

'

'

'

3

2

6

8

5

14

5

37

4

10

8

56

'

-2

5

7

'

'

'

'

'

'

'

'

'

'

Free-standing derivatives, assets

3

6

3

6

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Free Standing Derivative Liabilities, Fair Value Disclosure

9

16

9

16

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Fair Value Measurement with Unobservable Inputs Reconciliation Recurring Basis Asset Transfers to Held For Sale

'

$0

'

$0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$5

'

$5

'

$85

'

$85

$4

$4

Fair_Value_of_Assets_and_Liabi6

Fair Value of Assets and Liabilities (Details 5) (Details) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Gains (losses) included in net income for Level 3 assets and liabilities:	'	'	'	'
Gains (losses) for Level 3 assets still held at the balance sheet date, included in earnings	$3	$0	$12	$15
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings	9	24	12	93
Gains (losses) for Level 3 assets and liabilities still held at the balance sheet date, included in earnings	12	24	24	108
Realized capital gains and losses	'	'	'	'
Gains (losses) included in net income for Level 3 assets and liabilities:	'	'	'	'
Gains (losses) for Level 3 assets and liabilities still held at the balance sheet date	'	-2	5	7
Net investment income	'	'	'	'
Gains (losses) included in net income for Level 3 assets and liabilities:	'	'	'	'
Gains (losses) for Level 3 assets and liabilities still held at the balance sheet date	3	2	6	8
Interest credited to contractholder funds	'	'	'	'
Gains (losses) included in net income for Level 3 assets and liabilities:	'	'	'	'
Gains (losses) for Level 3 assets and liabilities still held at the balance sheet date	5	14	5	37
Contract benefits	'	'	'	'
Gains (losses) included in net income for Level 3 assets and liabilities:	'	'	'	'
Gains (losses) for Level 3 assets and liabilities still held at the balance sheet date	4	10	8	56
Derivatives embedded in life and annuity contracts	'	'	'	'
Gains (losses) included in net income for Level 3 assets and liabilities:	'	'	'	'
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings	9	8	-5	77
Liabilities held for sale	'	'	'	'
Gains (losses) included in net income for Level 3 assets and liabilities:	'	'	'	'
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings	0	16	17	16
Fixed income securities	'	'	'	'
Gains (losses) included in net income for Level 3 assets and liabilities:	'	'	'	'
Gains (losses) for Level 3 assets still held at the balance sheet date, included in earnings	3	3	6	2
Municipal	'	'	'	'
Gains (losses) included in net income for Level 3 assets and liabilities:	'	'	'	'
Gains (losses) for Level 3 assets still held at the balance sheet date, included in earnings	0	0	-1	-5
Corporate	'	'	'	'
Gains (losses) included in net income for Level 3 assets and liabilities:	'	'	'	'
Gains (losses) for Level 3 assets still held at the balance sheet date, included in earnings	3	3	8	9
ABS	'	'	'	'
Gains (losses) included in net income for Level 3 assets and liabilities:	'	'	'	'
Gains (losses) for Level 3 assets still held at the balance sheet date, included in earnings	0	0	0	-1
CMBS	'	'	'	'
Gains (losses) included in net income for Level 3 assets and liabilities:	'	'	'	'
Gains (losses) for Level 3 assets still held at the balance sheet date, included in earnings	0	0	-1	-1
Free-standing derivatives, net	'	'	'	'
Gains (losses) included in net income for Level 3 assets and liabilities:	'	'	'	'
Gains (losses) for Level 3 assets still held at the balance sheet date, included in earnings	0	-2	6	14
Other assets	'	'	'	'
Gains (losses) included in net income for Level 3 assets and liabilities:	'	'	'	'
Gains (losses) for Level 3 assets still held at the balance sheet date, included in earnings	0	0	1	0
Assets held for sale	'	'	'	'
Gains (losses) included in net income for Level 3 assets and liabilities:	'	'	'	'
Gains (losses) for Level 3 assets still held at the balance sheet date, included in earnings	$0	($1)	($1)	($1)

Fair_Value_of_Assets_and_Liabi7

Fair Value of Assets and Liabilities (Details 6) (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013	Sep. 30, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Financial assets	'	'	'	'
Mortgage loans	$3,644	$4,173	'	'
Assets held for sale	0	15,593	'	'
Financial liabilities	'	'	'	'
Notes due to related parties	275	282	'	'
Liability for collateral	479	328	363	561
Liabilities held for sale	0	14,899	'	'
Carrying value	'	'	'	'
Financial assets	'	'	'	'
Mortgage loans	3,644	4,173	'	'
Cost method limited partnerships	526	605	'	'
Agent Loans	364	341	'	'
Bank loans	339	160	'	'
Notes due from related party	275	275	'	'
Assets held for sale	0	1,458	'	'
Financial liabilities	'	'	'	'
Contract holder funds on investment contracts	14,059	15,542	'	'
Notes due to related parties	275	282	'	'
Liability for collateral	479	328	'	'
Liabilities held for sale	0	7,417	'	'
Fair Value	'	'	'	'
Financial assets	'	'	'	'
Mortgage loans	3,856	4,300	'	'
Cost method limited partnerships	729	799	'	'
Agent Loans	357	325	'	'
Bank loans	337	161	'	'
Notes due from related party	275	275	'	'
Assets held for sale	0	1,532	'	'
Financial liabilities	'	'	'	'
Contract holder funds on investment contracts	14,741	16,198	'	'
Notes due to related parties	275	282	'	'
Liability for collateral	479	328	'	'
Liabilities held for sale	$0	$7,298	'	'

Derivative_Financial_Instrumen2

Derivative Financial Instruments (Details) (USD $)	9 Months Ended
In Millions, except Share data, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
	contract	contract
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'	'
Assumed recoveries under sale of credit protection	$0	'
Securities pledged in the form of margin deposits	28	'
Derivatives, Fair Value	'	'
Total asset derivatives, Notional amount	278	1,649
Total liability derivatives, Notional amount	3,492	10,760
Total derivatives, Notional amount	3,770	12,409
Total asset derivatives, Number of contracts	3,182	10,662
Total liability derivatives, Number of contracts	3,365	10,035
Total derivatives, Number of contracts	6,547	20,697
Total asset derivatives, Fair value, net	74	254
Derivative liabilities net amount on balance sheet	-352	-741
Total derivatives, Fair value, net	-278	-487
Asset derivatives, Gross asset	74	266
Liability derivatives, Gross asset	5	11
Asset derivatives, Gross liability	0	-12
Liability derivatives, Gross liability	-357	-752
Number of stock warrants held by the company related to derivative contracts (in shares)	'	837,100
Derivatives not designated as accounting hedging instruments	'	'
Derivatives, Fair Value	'	'
Total asset derivatives, Notional amount	262	1,633
Total liability derivatives, Notional amount	3,373	10,628
Total asset derivatives, Number of contracts	3,182	10,662
Total liability derivatives, Number of contracts	'	10,035
Total asset derivatives, Fair value, net	72	253
Derivative liabilities net amount on balance sheet	-346	-726
Asset derivatives, Gross asset	72	265
Liability derivatives, Gross asset	5	11
Asset derivatives, Gross liability	0	-12
Liability derivatives, Gross liability	-351	-737
Foreign currency swap agreements | Derivatives designated as accounting hedging instruments | Other investments	'	'
Derivatives, Fair Value	'	'
Total asset derivatives, Notional amount	16	16
Total asset derivatives, Fair value, net	2	1
Asset derivatives, Gross asset	2	1
Asset derivatives, Gross liability	0	0
Foreign currency swap agreements | Derivatives designated as accounting hedging instruments | Other liabilities and accrued expenses	'	'
Derivatives, Fair Value	'	'
Total liability derivatives, Notional amount	119	132
Derivative liabilities net amount on balance sheet	-6	-15
Liability derivatives, Gross asset	0	0
Liability derivatives, Gross liability	-6	-15
Interest rate swap agreements | Derivatives not designated as accounting hedging instruments | Other liabilities and accrued expenses	'	'
Derivatives, Fair Value	'	'
Total liability derivatives, Notional amount	85	85
Derivative liabilities net amount on balance sheet	3	4
Liability derivatives, Gross asset	3	4
Liability derivatives, Gross liability	0	0
Other contracts | Derivatives not designated as accounting hedging instruments | Other assets	'	'
Derivatives, Fair Value	'	'
Total asset derivatives, Notional amount	3	4
Total asset derivatives, Fair value, net	1	0
Asset derivatives, Gross asset	1	0
Asset derivatives, Gross liability	0	0
Interest rate swaption agreements | Derivatives not designated as accounting hedging instruments | Other investments	'	'
Derivatives, Fair Value	'	'
Total asset derivatives, Notional amount	'	1,420
Total asset derivatives, Fair value, net	'	0
Asset derivatives, Gross asset	'	0
Asset derivatives, Gross liability	'	0
Interest rate swaption agreements | Derivatives not designated as accounting hedging instruments | Other liabilities and accrued expenses	'	'
Derivatives, Fair Value	'	'
Total liability derivatives, Notional amount	'	4,570
Derivative liabilities net amount on balance sheet	'	1
Liability derivatives, Gross asset	'	1
Liability derivatives, Gross liability	'	0
Interest rate cap agreements | Derivatives not designated as accounting hedging instruments | Other investments	'	'
Derivatives, Fair Value	'	'
Total asset derivatives, Notional amount	95	61
Total asset derivatives, Fair value, net	0	2
Asset derivatives, Gross asset	0	2
Asset derivatives, Gross liability	0	0
Interest rate cap agreements | Derivatives not designated as accounting hedging instruments | Other liabilities and accrued expenses	'	'
Derivatives, Fair Value	'	'
Total liability derivatives, Notional amount	90	262
Derivative liabilities net amount on balance sheet	2	4
Liability derivatives, Gross asset	2	4
Liability derivatives, Gross liability	0	0
Interest rate contracts- Financial futures contracts | Derivatives not designated as accounting hedging instruments | Other investments	'	'
Derivatives, Fair Value	'	'
Total asset derivatives, Notional amount	0	'
Total asset derivatives, Number of contracts	50	'
Total asset derivatives, Fair value, net	0	'
Asset derivatives, Gross asset	0	'
Asset derivatives, Gross liability	0	'
Financial futures contracts - Equity and index contracts | Derivatives not designated as accounting hedging instruments | Other assets	'	'
Derivatives, Fair Value	'	'
Total asset derivatives, Notional amount	0	0
Total asset derivatives, Number of contracts	200	627
Total asset derivatives, Fair value, net	0	0
Asset derivatives, Gross asset	0	0
Asset derivatives, Gross liability	0	0
Options and warrants | Derivatives not designated as accounting hedging instruments | Other investments	'	'
Derivatives, Fair Value	'	'
Total asset derivatives, Notional amount	'	3
Total asset derivatives, Number of contracts	'	10,035
Total asset derivatives, Fair value, net	'	261
Asset derivatives, Gross asset	'	261
Asset derivatives, Gross liability	'	0
Options | Derivatives not designated as accounting hedging instruments | Other investments	'	'
Derivatives, Fair Value	'	'
Total asset derivatives, Notional amount	0	'
Total asset derivatives, Number of contracts	2,932	'
Total asset derivatives, Fair value, net	65	'
Asset derivatives, Gross asset	65	'
Asset derivatives, Gross liability	0	'
Options and futures | Derivatives not designated as accounting hedging instruments | Other liabilities and accrued expenses	'	'
Derivatives, Fair Value	'	'
Total liability derivatives, Notional amount	0	55
Total liability derivatives, Number of contracts	3,365	10,035
Derivative liabilities net amount on balance sheet	-20	-165
Liability derivatives, Gross asset	0	2
Liability derivatives, Gross liability	-20	-167
Foreign currency forwards | Derivatives not designated as accounting hedging instruments | Other investments	'	'
Derivatives, Fair Value	'	'
Total asset derivatives, Notional amount	62	47
Total asset derivatives, Fair value, net	4	0
Asset derivatives, Gross asset	4	0
Asset derivatives, Gross liability	0	0
Foreign currency forwards | Derivatives not designated as accounting hedging instruments | Other liabilities and accrued expenses	'	'
Derivatives, Fair Value	'	'
Total liability derivatives, Notional amount	69	'
Derivative liabilities net amount on balance sheet	0	'
Liability derivatives, Gross asset	0	'
Liability derivatives, Gross liability	0	'
Credit default swaps | Derivatives not designated as accounting hedging instruments | Fixed income securities	'	'
Derivatives, Fair Value	'	'
Total asset derivatives, Notional amount	'	12
Total asset derivatives, Fair value, net	'	-12
Asset derivatives, Gross asset	'	0
Asset derivatives, Gross liability	'	-12
Guaranteed accumulation benefits | Derivatives not designated as accounting hedging instruments | Contractholder funds	'	'
Derivatives, Fair Value	'	'
Total liability derivatives, Notional amount	650	738
Derivative liabilities net amount on balance sheet	-36	-43
Liability derivatives, Gross asset	0	0
Liability derivatives, Gross liability	-36	-43
Guaranteed withdrawal benefits | Derivatives not designated as accounting hedging instruments | Contractholder funds	'	'
Derivatives, Fair Value	'	'
Total liability derivatives, Notional amount	453	506
Derivative liabilities net amount on balance sheet	-13	-13
Liability derivatives, Gross asset	0	0
Liability derivatives, Gross liability	-13	-13
Equity-indexed and forward starting options in life and annuity product contracts | Derivatives not designated as accounting hedging instruments | Contractholder funds	'	'
Derivatives, Fair Value	'	'
Total liability derivatives, Notional amount	1,773	1,693
Derivative liabilities net amount on balance sheet	-269	-247
Liability derivatives, Gross asset	0	0
Liability derivatives, Gross liability	-269	-247
Equity-indexed and forward starting options in life and annuity product contracts | Derivatives not designated as accounting hedging instruments | Liabilities held for sale	'	'
Derivatives, Fair Value	'	'
Total liability derivatives, Notional amount	'	2,363
Derivative liabilities net amount on balance sheet	'	-246
Liability derivatives, Gross asset	'	0
Liability derivatives, Gross liability	'	-246
Other embedded derivative financial instruments | Derivatives not designated as accounting hedging instruments | Contractholder funds	'	'
Derivatives, Fair Value	'	'
Total liability derivatives, Notional amount	85	85
Derivative liabilities net amount on balance sheet	-3	-4
Liability derivatives, Gross asset	0	0
Liability derivatives, Gross liability	-3	-4
Credit default swaps - buying protection | Derivatives not designated as accounting hedging instruments | Other investments	'	'
Derivatives, Fair Value	'	'
Total asset derivatives, Notional amount	22	1
Total asset derivatives, Fair value, net	0	0
Asset derivatives, Gross asset	0	0
Asset derivatives, Gross liability	0	0
Credit default swaps - buying protection | Derivatives not designated as accounting hedging instruments | Other liabilities and accrued expenses	'	'
Derivatives, Fair Value	'	'
Total liability derivatives, Notional amount	68	171
Derivative liabilities net amount on balance sheet	-1	-2
Liability derivatives, Gross asset	0	0
Liability derivatives, Gross liability	-1	-2
Credit default swaps - selling protection | Derivatives not designated as accounting hedging instruments | Other investments	'	'
Derivatives, Fair Value	'	'
Total asset derivatives, Notional amount	80	85
Total asset derivatives, Fair value, net	2	2
Asset derivatives, Gross asset	2	2
Asset derivatives, Gross liability	0	0
Credit default swaps - selling protection | Derivatives not designated as accounting hedging instruments | Other liabilities and accrued expenses	'	'
Derivatives, Fair Value	'	'
Total liability derivatives, Notional amount	100	100
Derivative liabilities net amount on balance sheet	-9	-15
Liability derivatives, Gross asset	0	0
Liability derivatives, Gross liability	($9)	($15)

Derivative_Financial_Instrumen3

Derivative Financial Instruments (Details 2) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Millions, unless otherwise specified
Asset derivatives	'	'
Asset derivatives gross amount	$74	$266
Total asset derivatives, Fair value, net	74	254
Liability derivatives	'	'
Liability derivatives gross amount	-357	-752
Derivative liabilities net amount on balance sheet	-352	-741
OTC derivatives	'	'
Asset derivatives	'	'
Asset derivatives gross amount	12	14
Offsets of derivative assets under counterparty netting	-5	-11
Derivative asset offsets under cash collateral received	0	0
Total asset derivatives, Fair value, net	7	3
Derivative assets pledged under securities collateral	-2	-3
Derivative assets net amount	5	0
Liability derivatives	'	'
Liability derivatives gross amount	-16	-33
Offsets of derivative liabilities under counterparty netting	5	11
Derivative liability offsets under cash collateral pledged	0	-4
Derivative liabilities net amount on balance sheet	-11	-26
Derivative liabilities received under securities collateral	13	22
Derivative liabilities net amount	$2	($4)

Derivative_Financial_Instrumen4

Derivative Financial Instruments (Details 3) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Derivative Instruments, Gain (Loss)	'	'	'	'
Cash flow hedge losses to be reclassified from AOCI during the next twelve months	$1	'	$1	'
Hedge ineffectiveness in realized gains	0	0	0	0
(Loss) gain recognized in OCI on derivatives during the period	10	-7	6	2
Loss recognized in OCI on derivatives during the term of the hedging relationship	-4	-14	-4	-14
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	17	12	33	95
Realized capital gains and losses	'	'	'	'
Derivative Instruments, Gain (Loss)	'	'	'	'
Loss reclassified from AOCI into income	0	0	-2	0
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	4	-5	9	14
Contract benefits	'	'	'	'
Derivative Instruments, Gain (Loss)	'	'	'	'
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	4	10	8	56
Interest credited to contractholder funds	'	'	'	'
Derivative Instruments, Gain (Loss)	'	'	'	'
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	9	7	20	25
Loss on disposition of operations	'	'	'	'
Derivative Instruments, Gain (Loss)	'	'	'	'
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	0	'	-4	'
Net investment income	'	'	'	'
Derivative Instruments, Gain (Loss)	'	'	'	'
Loss reclassified from AOCI into income	-1	0	-1	-1
Interest rate contracts	'	'	'	'
Derivative Instruments, Gain (Loss)	'	'	'	'
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	0	0	-6	3
Interest rate contracts | Realized capital gains and losses	'	'	'	'
Derivative Instruments, Gain (Loss)	'	'	'	'
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	0	0	-2	3
Interest rate contracts | Contract benefits	'	'	'	'
Derivative Instruments, Gain (Loss)	'	'	'	'
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	0	0	0	0
Interest rate contracts | Interest credited to contractholder funds	'	'	'	'
Derivative Instruments, Gain (Loss)	'	'	'	'
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	0	0	0	0
Interest rate contracts | Loss on disposition of operations	'	'	'	'
Derivative Instruments, Gain (Loss)	'	'	'	'
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	0	'	-4	'
Equity and index contracts	'	'	'	'
Derivative Instruments, Gain (Loss)	'	'	'	'
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	4	16	25	63
Equity and index contracts | Realized capital gains and losses	'	'	'	'
Derivative Instruments, Gain (Loss)	'	'	'	'
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	0	0	0	0
Equity and index contracts | Contract benefits	'	'	'	'
Derivative Instruments, Gain (Loss)	'	'	'	'
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	0	0	0	0
Equity and index contracts | Interest credited to contractholder funds	'	'	'	'
Derivative Instruments, Gain (Loss)	'	'	'	'
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	4	16	25	63
Equity and index contracts | Loss on disposition of operations	'	'	'	'
Derivative Instruments, Gain (Loss)	'	'	'	'
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	0	'	0	'
Embedded derivative financial instruments	'	'	'	'
Derivative Instruments, Gain (Loss)	'	'	'	'
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	10	1	3	20
Embedded derivative financial instruments | Realized capital gains and losses	'	'	'	'
Derivative Instruments, Gain (Loss)	'	'	'	'
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	0	0	0	-1
Embedded derivative financial instruments | Contract benefits	'	'	'	'
Derivative Instruments, Gain (Loss)	'	'	'	'
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	4	10	8	56
Embedded derivative financial instruments | Interest credited to contractholder funds	'	'	'	'
Derivative Instruments, Gain (Loss)	'	'	'	'
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	6	-9	-5	-35
Embedded derivative financial instruments | Loss on disposition of operations	'	'	'	'
Derivative Instruments, Gain (Loss)	'	'	'	'
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	0	'	0	'
Foreign currency contracts	'	'	'	'
Derivative Instruments, Gain (Loss)	'	'	'	'
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	'	-2	4	-1
Foreign currency contracts | Realized capital gains and losses	'	'	'	'
Derivative Instruments, Gain (Loss)	'	'	'	'
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	'	-2	4	-1
Foreign currency contracts | Contract benefits	'	'	'	'
Derivative Instruments, Gain (Loss)	'	'	'	'
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	'	0	0	0
Foreign currency contracts | Interest credited to contractholder funds	'	'	'	'
Derivative Instruments, Gain (Loss)	'	'	'	'
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	'	0	0	0
Foreign currency contracts | Loss on disposition of operations	'	'	'	'
Derivative Instruments, Gain (Loss)	'	'	'	'
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	'	'	0	'
Credit default swaps	'	'	'	'
Derivative Instruments, Gain (Loss)	'	'	'	'
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	0	-3	7	13
Credit default swaps | Realized capital gains and losses	'	'	'	'
Derivative Instruments, Gain (Loss)	'	'	'	'
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	0	-3	7	13
Credit default swaps | Contract benefits	'	'	'	'
Derivative Instruments, Gain (Loss)	'	'	'	'
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	0	0	0	0
Credit default swaps | Interest credited to contractholder funds	'	'	'	'
Derivative Instruments, Gain (Loss)	'	'	'	'
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	0	0	0	0
Credit default swaps | Loss on disposition of operations	'	'	'	'
Derivative Instruments, Gain (Loss)	'	'	'	'
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	0	'	0	'
Other contracts	'	'	'	'
Derivative Instruments, Gain (Loss)	'	'	'	'
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	-1	0	0	-3
Other contracts | Realized capital gains and losses	'	'	'	'
Derivative Instruments, Gain (Loss)	'	'	'	'
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	0	0	0	0
Other contracts | Contract benefits	'	'	'	'
Derivative Instruments, Gain (Loss)	'	'	'	'
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	0	0	0	0
Other contracts | Interest credited to contractholder funds	'	'	'	'
Derivative Instruments, Gain (Loss)	'	'	'	'
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	-1	0	0	-3
Other contracts | Loss on disposition of operations	'	'	'	'
Derivative Instruments, Gain (Loss)	'	'	'	'
Derivatives not designated as accounting hedging instruments, total gain (loss) recognized in net income on derivatives	$0	'	$0	'

Derivative_Financial_Instrumen5

Derivative Financial Instruments (Details 4) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Millions, unless otherwise specified	party	party
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'	'
Cash and securities pledged as collateral by counterparties	$3	'
Securities pledged as collateral to counterparties	14	'
Collateral posted under MNAs for contracts without credit-risk-contingent liabilities	9	'
Credit Derivatives	'	'
Number of counter-parties (in Party)	7,000,000	0
Notional amount	194	1,648
Credit exposure	7	5
Exposure, net of collateral	4	1
Gross liability fair value of contracts containing credit-risk-contingent features	10	25
Gross asset fair value of contracts containing credit-risk-contingent features and subject to MNAs	-3	-9
Collateral posted under MNAs for contracts containing credit-risk-contingent features	-5	-14
Maximum amount of additional exposure for contracts with credit-risk-contingent features if all features were triggered concurrently	2	2
A+	'	'
Credit Derivatives	'	'
Number of counter-parties (in Party)	1,000,000	0
Notional amount	16	22
Credit exposure	0	1
Exposure, net of collateral	0	1
A	'	'
Credit Derivatives	'	'
Number of counter-parties (in Party)	3,000,000	0
Notional amount	97	1,523
Credit exposure	6	2
Exposure, net of collateral	3	0
A-	'	'
Credit Derivatives	'	'
Number of counter-parties (in Party)	1,000,000	0
Notional amount	8	24
Credit exposure	1	1
Exposure, net of collateral	1	0
BBB+	'	'
Credit Derivatives	'	'
Number of counter-parties (in Party)	1,000,000	0
Notional amount	11	3
Credit exposure	0	0
Exposure, net of collateral	0	0
BBB	'	'
Credit Derivatives	'	'
Number of counter-parties (in Party)	1,000,000	0
Notional amount	62	76
Credit exposure	0	1
Exposure, net of collateral	$0	$0

Derivative_Financial_Instrumen6

Derivative Financial Instruments (Credit Derivatives-Selling Protection) (Details) (USD $)	9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
	entity
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'	'
Term of credit default swaps (in years)	'5 years	'
Credit Derivatives	'	'
Notional amount	$3,770	$12,409
The number of reference entities generally included in a CDX index	125	'
Credit default swaps	'	'
Credit Derivatives	'	'
Notional amount	180	185
Fair value	-7	-13
Credit default swaps | Single name | Corporate debt	'	'
Credit Derivatives	'	'
Notional amount	0	5
Fair value	0	0
Credit default swaps | First-to-default Basket | Municipal	'	'
Credit Derivatives	'	'
Notional amount	100	100
Fair value	-9	-15
Credit default swaps | Index | Corporate debt	'	'
Credit Derivatives	'	'
Notional amount	80	80
Fair value	2	2
AA | Credit default swaps	'	'
Credit Derivatives	'	'
Notional amount	1	1
AA | Credit default swaps | Single name | Corporate debt	'	'
Credit Derivatives	'	'
Notional amount	0	0
AA | Credit default swaps | First-to-default Basket | Municipal	'	'
Credit Derivatives	'	'
Notional amount	0	0
AA | Credit default swaps | Index | Corporate debt	'	'
Credit Derivatives	'	'
Notional amount	1	1
A | Credit default swaps	'	'
Credit Derivatives	'	'
Notional amount	126	125
A | Credit default swaps | Single name | Corporate debt	'	'
Credit Derivatives	'	'
Notional amount	0	5
A | Credit default swaps | First-to-default Basket | Municipal	'	'
Credit Derivatives	'	'
Notional amount	100	100
A | Credit default swaps | Index | Corporate debt	'	'
Credit Derivatives	'	'
Notional amount	26	20
BBB | Credit default swaps	'	'
Credit Derivatives	'	'
Notional amount	50	55
BBB | Credit default swaps | Single name | Corporate debt	'	'
Credit Derivatives	'	'
Notional amount	0	0
BBB | Credit default swaps | First-to-default Basket | Municipal	'	'
Credit Derivatives	'	'
Notional amount	0	0
BBB | Credit default swaps | Index | Corporate debt	'	'
Credit Derivatives	'	'
Notional amount	50	55
BB and lower | Credit default swaps	'	'
Credit Derivatives	'	'
Notional amount	3	4
BB and lower | Credit default swaps | Single name | Corporate debt	'	'
Credit Derivatives	'	'
Notional amount	0	0
BB and lower | Credit default swaps | First-to-default Basket | Municipal	'	'
Credit Derivatives	'	'
Notional amount	0	0
BB and lower | Credit default swaps | Index | Corporate debt	'	'
Credit Derivatives	'	'
Notional amount	$3	$4

Reinsurance_Details

Reinsurance (Details) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Effects of reinsurance on revenue	'	'	'	'
Direct premiums and contract charges	$185	$518	$893	$1,553
Total premiums and contract charges	334	411	1,093	1,230
Effects of reinsurance on cost and expenses	'	'	'	'
Direct contract benefits	277	499	1,023	1,370
Direct interest credited to contractholder funds	167	309	656	946
Contract benefits, net of reinsurance	356	422	1,101	1,199
Interest credited to contractholder funds, net of reinsurance	191	310	696	953
Affiliate	'	'	'	'
Effects of reinsurance on revenue	'	'	'	'
Assumed premiums and contract charges	32	31	97	92
Effects of reinsurance on cost and expenses	'	'	'	'
Assumed contract benefits	20	20	66	60
Assumed interest credited to contractholder funds	2	2	6	7
Non-affiliate	'	'	'	'
Effects of reinsurance on revenue	'	'	'	'
Assumed premiums and contract charges	199	17	410	51
Ceded premiums and contract charges	-82	-155	-307	-466
Effects of reinsurance on cost and expenses	'	'	'	'
Assumed contract benefits	135	13	277	38
Assumed interest credited to contractholder funds	27	7	54	22
Ceded contract benefits	-76	-110	-265	-269
Ceded interest credited to contractholder funds	($5)	($8)	($20)	($22)

Guarantees_and_Contingent_Liab1

Guarantees and Contingent Liabilities (Details) (Obligations of insolvent insurance companies, USD $)	Sep. 30, 2014
In Millions, unless otherwise specified
Obligations of insolvent insurance companies	'
Guarantees and Contingent Liabilities	'
Maximum amount at risk pursuant to a guarantee	$4

Other_Comprehensive_Income_Det

Other Comprehensive Income (Details) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Pre-tax	'	'	'	'
Unrealized net holding gains and losses arising during the period, net of related offsets	$58	($76)	$525	($860)
Less: reclassification adjustment of realized capital gains and losses	21	-6	-7	35
Unrealized net capital gains and losses	37	-70	532	-895
Unrealized foreign currency translation adjustments	0	0	2	0
Other comprehensive income (loss)	37	-70	534	-895
Tax	'	'	'	'
Unrealized net holding gains and losses arising during the period, net of related offsets	-20	27	-185	302
Less: reclassification adjustment of realized capital gains and losses	-7	2	2	-12
Unrealized net capital gains and losses	-13	25	-187	314
Unrealized foreign currency translation adjustments	0	0	-1	0
Other comprehensive income (loss)	-13	25	-188	314
After-tax	'	'	'	'
Unrealized net holding gains and losses arising during the period, net of related offsets	38	-49	340	-558
Less: reclassification adjustment of realized capital gains and losses	14	-4	-5	23
Unrealized net capital gains and losses	24	-45	345	-581
Unrealized foreign currency translation adjustments	0	0	1	0
Other comprehensive income (loss), after-tax	24	-45	346	-581
Net income	84	-394	343	-135
Comprehensive income (loss)	$108	($439)	$689	($716)